00001083853/312024Q3Falsehttp://worldacceptance.com/20231231#AccountingStandardsUpdate202302MemberP3Y00001083852023-04-012023-12-3100001083852024-02-01xbrli:shares00001083852023-12-31iso4217:USD00001083852023-03-31iso4217:USDxbrli:shares00001083852023-10-012023-12-3100001083852022-10-012022-12-3100001083852022-04-012022-12-310000108385us-gaap:CommonStockMember2023-09-300000108385us-gaap:AdditionalPaidInCapitalMember2023-09-300000108385us-gaap:RetainedEarningsMember2023-09-3000001083852023-09-300000108385us-gaap:CommonStockMember2023-10-012023-12-310000108385us-gaap:AdditionalPaidInCapitalMember2023-10-012023-12-310000108385us-gaap:RetainedEarningsMember2023-10-012023-12-310000108385us-gaap:CommonStockMember2023-12-310000108385us-gaap:AdditionalPaidInCapitalMember2023-12-310000108385us-gaap:RetainedEarningsMember2023-12-310000108385us-gaap:CommonStockMember2022-09-300000108385us-gaap:AdditionalPaidInCapitalMember2022-09-300000108385us-gaap:RetainedEarningsMember2022-09-3000001083852022-09-300000108385us-gaap:CommonStockMember2022-10-012022-12-310000108385us-gaap:AdditionalPaidInCapitalMember2022-10-012022-12-310000108385us-gaap:RetainedEarningsMember2022-10-012022-12-310000108385us-gaap:CommonStockMember2022-12-310000108385us-gaap:AdditionalPaidInCapitalMember2022-12-310000108385us-gaap:RetainedEarningsMember2022-12-3100001083852022-12-310000108385us-gaap:CommonStockMember2023-03-310000108385us-gaap:AdditionalPaidInCapitalMember2023-03-310000108385us-gaap:RetainedEarningsMember2023-03-310000108385us-gaap:CommonStockMember2023-04-012023-12-310000108385us-gaap:AdditionalPaidInCapitalMember2023-04-012023-12-310000108385us-gaap:RetainedEarningsMember2023-04-012023-12-310000108385us-gaap:CommonStockMember2022-03-310000108385us-gaap:AdditionalPaidInCapitalMember2022-03-310000108385us-gaap:RetainedEarningsMember2022-03-3100001083852022-03-310000108385us-gaap:CommonStockMember2022-04-012022-12-310000108385us-gaap:AdditionalPaidInCapitalMember2022-04-012022-12-310000108385us-gaap:RetainedEarningsMember2022-04-012022-12-3100001083852021-04-012022-03-310000108385us-gaap:RetainedEarningsMembersrt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2022-03-310000108385srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2022-03-310000108385us-gaap:FairValueInputsLevel1Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2023-12-310000108385us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel1Member2023-12-310000108385us-gaap:FairValueInputsLevel1Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2023-03-310000108385us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel1Member2023-03-310000108385us-gaap:FairValueInputsLevel3Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2023-12-310000108385us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Member2023-12-310000108385us-gaap:FairValueInputsLevel3Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2023-03-310000108385us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Member2023-03-310000108385us-gaap:FairValueInputsLevel2Memberus-gaap:SeniorNotesMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2023-12-310000108385us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Memberus-gaap:SeniorNotesMember2023-12-310000108385us-gaap:FairValueInputsLevel2Memberus-gaap:SeniorNotesMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2023-03-310000108385us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Memberus-gaap:SeniorNotesMember2023-03-310000108385us-gaap:FairValueInputsLevel3Memberus-gaap:SeniorNotesMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2023-12-310000108385us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Memberus-gaap:SeniorNotesMember2023-12-310000108385us-gaap:FairValueInputsLevel3Memberus-gaap:SeniorNotesMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2023-03-310000108385us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Memberus-gaap:SeniorNotesMember2023-03-310000108385us-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:A0To5MonthsMember2023-12-310000108385us-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:A0To5MonthsMember2023-03-310000108385us-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:A6To17MonthsMember2023-12-310000108385us-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:A6To17MonthsMember2023-03-310000108385us-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:A18To35MonthsMember2023-12-310000108385us-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:A18To35MonthsMember2023-03-310000108385us-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:A36To59MonthsMember2023-12-310000108385us-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:A36To59MonthsMember2023-03-310000108385us-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:A60MonthsMember2023-12-310000108385us-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:A60MonthsMember2023-03-310000108385wrld:TaxAdvanceLoanMember2023-12-310000108385wrld:TaxAdvanceLoanMember2023-03-310000108385us-gaap:ConsumerPortfolioSegmentMemberus-gaap:PerformingFinancingReceivableMember2023-12-310000108385us-gaap:ConsumerPortfolioSegmentMemberus-gaap:ConsumerLoanMemberus-gaap:PerformingFinancingReceivableMember2023-12-310000108385us-gaap:ConsumerPortfolioSegmentMemberus-gaap:FinancingReceivables30To59DaysPastDueMember2023-12-310000108385us-gaap:ConsumerPortfolioSegmentMemberus-gaap:FinancingReceivables60To89DaysPastDueMember2023-12-310000108385us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberus-gaap:ConsumerPortfolioSegmentMember2023-12-310000108385us-gaap:ConsumerPortfolioSegmentMember2023-12-310000108385us-gaap:ConsumerPortfolioSegmentMemberus-gaap:ConsumerLoanMember2023-12-310000108385wrld:TaxAdvanceLoanMemberus-gaap:PerformingFinancingReceivableMember2023-12-310000108385us-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:TaxAdvanceLoanMember2023-12-310000108385us-gaap:FinancingReceivables60To89DaysPastDueMemberwrld:TaxAdvanceLoanMember2023-12-310000108385us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberwrld:TaxAdvanceLoanMember2023-12-310000108385wrld:TaxAdvanceLoanMember2023-12-310000108385us-gaap:ConsumerPortfolioSegmentMemberus-gaap:PerformingFinancingReceivableMember2023-03-310000108385us-gaap:ConsumerPortfolioSegmentMemberus-gaap:ConsumerLoanMemberus-gaap:PerformingFinancingReceivableMember2023-03-310000108385us-gaap:ConsumerPortfolioSegmentMemberus-gaap:FinancingReceivables30To59DaysPastDueMember2023-03-310000108385us-gaap:ConsumerPortfolioSegmentMemberus-gaap:FinancingReceivables60To89DaysPastDueMember2023-03-310000108385us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberus-gaap:ConsumerPortfolioSegmentMember2023-03-310000108385us-gaap:ConsumerPortfolioSegmentMember2023-03-310000108385us-gaap:ConsumerPortfolioSegmentMemberus-gaap:ConsumerLoanMember2023-03-310000108385wrld:TaxAdvanceLoanMemberus-gaap:PerformingFinancingReceivableMember2023-03-310000108385us-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:TaxAdvanceLoanMember2023-03-310000108385us-gaap:FinancingReceivables60To89DaysPastDueMemberwrld:TaxAdvanceLoanMember2023-03-310000108385us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberwrld:TaxAdvanceLoanMember2023-03-310000108385wrld:TaxAdvanceLoanMember2023-03-310000108385us-gaap:ConsumerPortfolioSegmentMemberwrld:ContractualBasisMemberus-gaap:PerformingFinancingReceivableMember2023-12-310000108385us-gaap:ConsumerPortfolioSegmentMemberus-gaap:ConsumerLoanMemberwrld:ContractualBasisMemberus-gaap:PerformingFinancingReceivableMember2023-12-310000108385us-gaap:ConsumerPortfolioSegmentMemberus-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:ContractualBasisMember2023-12-310000108385us-gaap:ConsumerPortfolioSegmentMemberus-gaap:FinancingReceivables60To89DaysPastDueMemberwrld:ContractualBasisMember2023-12-310000108385us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberus-gaap:ConsumerPortfolioSegmentMemberwrld:ContractualBasisMember2023-12-310000108385us-gaap:ConsumerPortfolioSegmentMemberwrld:ContractualBasisMember2023-12-310000108385us-gaap:ConsumerPortfolioSegmentMemberus-gaap:ConsumerLoanMemberwrld:ContractualBasisMember2023-12-310000108385wrld:TaxAdvanceLoanMemberwrld:ContractualBasisMemberus-gaap:PerformingFinancingReceivableMember2023-12-310000108385us-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:TaxAdvanceLoanMemberwrld:ContractualBasisMember2023-12-310000108385us-gaap:FinancingReceivables60To89DaysPastDueMemberwrld:TaxAdvanceLoanMemberwrld:ContractualBasisMember2023-12-310000108385us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberwrld:TaxAdvanceLoanMemberwrld:ContractualBasisMember2023-12-310000108385wrld:TaxAdvanceLoanMemberwrld:ContractualBasisMember2023-12-310000108385us-gaap:ConsumerPortfolioSegmentMemberwrld:ContractualBasisMemberus-gaap:PerformingFinancingReceivableMember2023-03-310000108385us-gaap:ConsumerPortfolioSegmentMemberus-gaap:ConsumerLoanMemberwrld:ContractualBasisMemberus-gaap:PerformingFinancingReceivableMember2023-03-310000108385us-gaap:ConsumerPortfolioSegmentMemberus-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:ContractualBasisMember2023-03-310000108385us-gaap:ConsumerPortfolioSegmentMemberus-gaap:FinancingReceivables60To89DaysPastDueMemberwrld:ContractualBasisMember2023-03-310000108385us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberus-gaap:ConsumerPortfolioSegmentMemberwrld:ContractualBasisMember2023-03-310000108385us-gaap:ConsumerPortfolioSegmentMemberwrld:ContractualBasisMember2023-03-310000108385us-gaap:ConsumerPortfolioSegmentMemberus-gaap:ConsumerLoanMemberwrld:ContractualBasisMember2023-03-310000108385wrld:TaxAdvanceLoanMemberwrld:ContractualBasisMemberus-gaap:PerformingFinancingReceivableMember2023-03-310000108385us-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:TaxAdvanceLoanMemberwrld:ContractualBasisMember2023-03-310000108385us-gaap:FinancingReceivables60To89DaysPastDueMemberwrld:TaxAdvanceLoanMemberwrld:ContractualBasisMember2023-03-310000108385us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberwrld:TaxAdvanceLoanMemberwrld:ContractualBasisMember2023-03-310000108385wrld:TaxAdvanceLoanMemberwrld:ContractualBasisMember2023-03-310000108385us-gaap:ConsumerPortfolioSegmentMember2023-10-012023-12-310000108385wrld:TaxAdvanceLoanMember2023-10-012023-12-310000108385us-gaap:ConsumerPortfolioSegmentMember2023-04-012023-12-310000108385wrld:TaxAdvanceLoanMember2023-04-012023-12-310000108385us-gaap:ConsumerPortfolioSegmentMember2022-10-012022-12-310000108385wrld:TaxAdvanceLoanMember2022-10-012022-12-310000108385us-gaap:ConsumerPortfolioSegmentMember2022-04-012022-12-310000108385wrld:TaxAdvanceLoanMember2022-04-012022-12-310000108385wrld:RecencyBasisMemberwrld:A0To5MonthsMemberus-gaap:FinancialAssetNotPastDueMember2023-12-310000108385wrld:RecencyBasisMemberus-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:A0To5MonthsMember2023-12-310000108385us-gaap:FinancingReceivables60To89DaysPastDueMemberwrld:RecencyBasisMemberwrld:A0To5MonthsMember2023-12-310000108385us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberwrld:RecencyBasisMemberwrld:A0To5MonthsMember2023-12-310000108385wrld:TotalPastDueMemberwrld:RecencyBasisMemberwrld:A0To5MonthsMember2023-12-310000108385wrld:RecencyBasisMemberwrld:A0To5MonthsMember2023-12-310000108385wrld:RecencyBasisMemberus-gaap:FinancialAssetNotPastDueMemberwrld:A6To17MonthsMember2023-12-310000108385wrld:RecencyBasisMemberus-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:A6To17MonthsMember2023-12-310000108385us-gaap:FinancingReceivables60To89DaysPastDueMemberwrld:RecencyBasisMemberwrld:A6To17MonthsMember2023-12-310000108385us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberwrld:RecencyBasisMemberwrld:A6To17MonthsMember2023-12-310000108385wrld:TotalPastDueMemberwrld:RecencyBasisMemberwrld:A6To17MonthsMember2023-12-310000108385wrld:RecencyBasisMemberwrld:A6To17MonthsMember2023-12-310000108385wrld:RecencyBasisMemberwrld:A18To35MonthsMemberus-gaap:FinancialAssetNotPastDueMember2023-12-310000108385wrld:RecencyBasisMemberus-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:A18To35MonthsMember2023-12-310000108385us-gaap:FinancingReceivables60To89DaysPastDueMemberwrld:RecencyBasisMemberwrld:A18To35MonthsMember2023-12-310000108385us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberwrld:RecencyBasisMemberwrld:A18To35MonthsMember2023-12-310000108385wrld:TotalPastDueMemberwrld:RecencyBasisMemberwrld:A18To35MonthsMember2023-12-310000108385wrld:RecencyBasisMemberwrld:A18To35MonthsMember2023-12-310000108385wrld:RecencyBasisMemberwrld:A36To59MonthsMemberus-gaap:FinancialAssetNotPastDueMember2023-12-310000108385wrld:RecencyBasisMemberus-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:A36To59MonthsMember2023-12-310000108385us-gaap:FinancingReceivables60To89DaysPastDueMemberwrld:RecencyBasisMemberwrld:A36To59MonthsMember2023-12-310000108385us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberwrld:RecencyBasisMemberwrld:A36To59MonthsMember2023-12-310000108385wrld:TotalPastDueMemberwrld:RecencyBasisMemberwrld:A36To59MonthsMember2023-12-310000108385wrld:RecencyBasisMemberwrld:A36To59MonthsMember2023-12-310000108385wrld:RecencyBasisMemberwrld:A60MonthsMemberus-gaap:FinancialAssetNotPastDueMember2023-12-310000108385wrld:RecencyBasisMemberus-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:A60MonthsMember2023-12-310000108385us-gaap:FinancingReceivables60To89DaysPastDueMemberwrld:RecencyBasisMemberwrld:A60MonthsMember2023-12-310000108385us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberwrld:RecencyBasisMemberwrld:A60MonthsMember2023-12-310000108385wrld:TotalPastDueMemberwrld:RecencyBasisMemberwrld:A60MonthsMember2023-12-310000108385wrld:RecencyBasisMemberwrld:A60MonthsMember2023-12-310000108385wrld:TaxAdvanceLoanMemberwrld:RecencyBasisMemberus-gaap:FinancialAssetNotPastDueMember2023-12-310000108385wrld:TaxAdvanceLoanMemberwrld:RecencyBasisMemberus-gaap:FinancingReceivables30To59DaysPastDueMember2023-12-310000108385wrld:TaxAdvanceLoanMemberus-gaap:FinancingReceivables60To89DaysPastDueMemberwrld:RecencyBasisMember2023-12-310000108385us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberwrld:TaxAdvanceLoanMemberwrld:RecencyBasisMember2023-12-310000108385wrld:TaxAdvanceLoanMemberwrld:TotalPastDueMemberwrld:RecencyBasisMember2023-12-310000108385wrld:TaxAdvanceLoanMemberwrld:RecencyBasisMember2023-12-310000108385wrld:RecencyBasisMemberus-gaap:FinancialAssetNotPastDueMember2023-12-310000108385wrld:RecencyBasisMemberus-gaap:FinancingReceivables30To59DaysPastDueMember2023-12-310000108385us-gaap:FinancingReceivables60To89DaysPastDueMemberwrld:RecencyBasisMember2023-12-310000108385us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberwrld:RecencyBasisMember2023-12-310000108385wrld:TotalPastDueMemberwrld:RecencyBasisMember2023-12-310000108385wrld:RecencyBasisMember2023-12-31xbrli:pure0000108385wrld:RecencyBasisMemberwrld:A0To5MonthsMemberus-gaap:FinancialAssetNotPastDueMember2023-03-310000108385wrld:RecencyBasisMemberus-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:A0To5MonthsMember2023-03-310000108385us-gaap:FinancingReceivables60To89DaysPastDueMemberwrld:RecencyBasisMemberwrld:A0To5MonthsMember2023-03-310000108385us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberwrld:RecencyBasisMemberwrld:A0To5MonthsMember2023-03-310000108385wrld:TotalPastDueMemberwrld:RecencyBasisMemberwrld:A0To5MonthsMember2023-03-310000108385wrld:RecencyBasisMemberwrld:A0To5MonthsMember2023-03-310000108385wrld:RecencyBasisMemberus-gaap:FinancialAssetNotPastDueMemberwrld:A6To17MonthsMember2023-03-310000108385wrld:RecencyBasisMemberus-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:A6To17MonthsMember2023-03-310000108385us-gaap:FinancingReceivables60To89DaysPastDueMemberwrld:RecencyBasisMemberwrld:A6To17MonthsMember2023-03-310000108385us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberwrld:RecencyBasisMemberwrld:A6To17MonthsMember2023-03-310000108385wrld:TotalPastDueMemberwrld:RecencyBasisMemberwrld:A6To17MonthsMember2023-03-310000108385wrld:RecencyBasisMemberwrld:A6To17MonthsMember2023-03-310000108385wrld:RecencyBasisMemberwrld:A18To35MonthsMemberus-gaap:FinancialAssetNotPastDueMember2023-03-310000108385wrld:RecencyBasisMemberus-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:A18To35MonthsMember2023-03-310000108385us-gaap:FinancingReceivables60To89DaysPastDueMemberwrld:RecencyBasisMemberwrld:A18To35MonthsMember2023-03-310000108385us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberwrld:RecencyBasisMemberwrld:A18To35MonthsMember2023-03-310000108385wrld:TotalPastDueMemberwrld:RecencyBasisMemberwrld:A18To35MonthsMember2023-03-310000108385wrld:RecencyBasisMemberwrld:A18To35MonthsMember2023-03-310000108385wrld:RecencyBasisMemberwrld:A36To59MonthsMemberus-gaap:FinancialAssetNotPastDueMember2023-03-310000108385wrld:RecencyBasisMemberus-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:A36To59MonthsMember2023-03-310000108385us-gaap:FinancingReceivables60To89DaysPastDueMemberwrld:RecencyBasisMemberwrld:A36To59MonthsMember2023-03-310000108385us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberwrld:RecencyBasisMemberwrld:A36To59MonthsMember2023-03-310000108385wrld:TotalPastDueMemberwrld:RecencyBasisMemberwrld:A36To59MonthsMember2023-03-310000108385wrld:RecencyBasisMemberwrld:A36To59MonthsMember2023-03-310000108385wrld:RecencyBasisMemberwrld:A60MonthsMemberus-gaap:FinancialAssetNotPastDueMember2023-03-310000108385wrld:RecencyBasisMemberus-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:A60MonthsMember2023-03-310000108385us-gaap:FinancingReceivables60To89DaysPastDueMemberwrld:RecencyBasisMemberwrld:A60MonthsMember2023-03-310000108385us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberwrld:RecencyBasisMemberwrld:A60MonthsMember2023-03-310000108385wrld:TotalPastDueMemberwrld:RecencyBasisMemberwrld:A60MonthsMember2023-03-310000108385wrld:RecencyBasisMemberwrld:A60MonthsMember2023-03-310000108385wrld:TaxAdvanceLoanMemberwrld:RecencyBasisMemberus-gaap:FinancialAssetNotPastDueMember2023-03-310000108385wrld:TaxAdvanceLoanMemberwrld:RecencyBasisMemberus-gaap:FinancingReceivables30To59DaysPastDueMember2023-03-310000108385wrld:TaxAdvanceLoanMemberus-gaap:FinancingReceivables60To89DaysPastDueMemberwrld:RecencyBasisMember2023-03-310000108385us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberwrld:TaxAdvanceLoanMemberwrld:RecencyBasisMember2023-03-310000108385wrld:TaxAdvanceLoanMemberwrld:TotalPastDueMemberwrld:RecencyBasisMember2023-03-310000108385wrld:TaxAdvanceLoanMemberwrld:RecencyBasisMember2023-03-310000108385wrld:RecencyBasisMemberus-gaap:FinancialAssetNotPastDueMember2023-03-310000108385wrld:RecencyBasisMemberus-gaap:FinancingReceivables30To59DaysPastDueMember2023-03-310000108385us-gaap:FinancingReceivables60To89DaysPastDueMemberwrld:RecencyBasisMember2023-03-310000108385us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberwrld:RecencyBasisMember2023-03-310000108385wrld:TotalPastDueMemberwrld:RecencyBasisMember2023-03-310000108385wrld:RecencyBasisMember2023-03-310000108385wrld:ContractualBasisMemberwrld:A0To5MonthsMemberus-gaap:FinancialAssetNotPastDueMember2023-12-310000108385us-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:ContractualBasisMemberwrld:A0To5MonthsMember2023-12-310000108385us-gaap:FinancingReceivables60To89DaysPastDueMemberwrld:ContractualBasisMemberwrld:A0To5MonthsMember2023-12-310000108385us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberwrld:ContractualBasisMemberwrld:A0To5MonthsMember2023-12-310000108385wrld:TotalPastDueMemberwrld:ContractualBasisMemberwrld:A0To5MonthsMember2023-12-310000108385wrld:A0To5MonthsMemberwrld:ContractualBasisMember2023-12-310000108385wrld:ContractualBasisMemberus-gaap:FinancialAssetNotPastDueMemberwrld:A6To17MonthsMember2023-12-310000108385us-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:ContractualBasisMemberwrld:A6To17MonthsMember2023-12-310000108385us-gaap:FinancingReceivables60To89DaysPastDueMemberwrld:ContractualBasisMemberwrld:A6To17MonthsMember2023-12-310000108385us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberwrld:ContractualBasisMemberwrld:A6To17MonthsMember2023-12-310000108385wrld:TotalPastDueMemberwrld:ContractualBasisMemberwrld:A6To17MonthsMember2023-12-310000108385wrld:ContractualBasisMemberwrld:A6To17MonthsMember2023-12-310000108385wrld:A18To35MonthsMemberwrld:ContractualBasisMemberus-gaap:FinancialAssetNotPastDueMember2023-12-310000108385us-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:A18To35MonthsMemberwrld:ContractualBasisMember2023-12-310000108385us-gaap:FinancingReceivables60To89DaysPastDueMemberwrld:A18To35MonthsMemberwrld:ContractualBasisMember2023-12-310000108385us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberwrld:A18To35MonthsMemberwrld:ContractualBasisMember2023-12-310000108385wrld:TotalPastDueMemberwrld:A18To35MonthsMemberwrld:ContractualBasisMember2023-12-310000108385wrld:A18To35MonthsMemberwrld:ContractualBasisMember2023-12-310000108385wrld:A36To59MonthsMemberwrld:ContractualBasisMemberus-gaap:FinancialAssetNotPastDueMember2023-12-310000108385us-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:A36To59MonthsMemberwrld:ContractualBasisMember2023-12-310000108385us-gaap:FinancingReceivables60To89DaysPastDueMemberwrld:A36To59MonthsMemberwrld:ContractualBasisMember2023-12-310000108385us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberwrld:A36To59MonthsMemberwrld:ContractualBasisMember2023-12-310000108385wrld:TotalPastDueMemberwrld:A36To59MonthsMemberwrld:ContractualBasisMember2023-12-310000108385wrld:A36To59MonthsMemberwrld:ContractualBasisMember2023-12-310000108385wrld:A60MonthsMemberwrld:ContractualBasisMemberus-gaap:FinancialAssetNotPastDueMember2023-12-310000108385us-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:A60MonthsMemberwrld:ContractualBasisMember2023-12-310000108385us-gaap:FinancingReceivables60To89DaysPastDueMemberwrld:A60MonthsMemberwrld:ContractualBasisMember2023-12-310000108385us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberwrld:A60MonthsMemberwrld:ContractualBasisMember2023-12-310000108385wrld:TotalPastDueMemberwrld:A60MonthsMemberwrld:ContractualBasisMember2023-12-310000108385wrld:A60MonthsMemberwrld:ContractualBasisMember2023-12-310000108385wrld:TaxAdvanceLoanMemberwrld:ContractualBasisMemberus-gaap:FinancialAssetNotPastDueMember2023-12-310000108385wrld:TaxAdvanceLoanMemberus-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:ContractualBasisMember2023-12-310000108385wrld:TaxAdvanceLoanMemberus-gaap:FinancingReceivables60To89DaysPastDueMemberwrld:ContractualBasisMember2023-12-310000108385us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberwrld:TaxAdvanceLoanMemberwrld:ContractualBasisMember2023-12-310000108385wrld:TaxAdvanceLoanMemberwrld:TotalPastDueMemberwrld:ContractualBasisMember2023-12-310000108385wrld:TaxAdvanceLoanMemberwrld:ContractualBasisMember2023-12-310000108385wrld:ContractualBasisMemberus-gaap:FinancialAssetNotPastDueMember2023-12-310000108385us-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:ContractualBasisMember2023-12-310000108385us-gaap:FinancingReceivables60To89DaysPastDueMemberwrld:ContractualBasisMember2023-12-310000108385us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberwrld:ContractualBasisMember2023-12-310000108385wrld:TotalPastDueMemberwrld:ContractualBasisMember2023-12-310000108385wrld:ContractualBasisMember2023-12-310000108385wrld:ContractualBasisMemberwrld:A0To5MonthsMemberus-gaap:FinancialAssetNotPastDueMember2023-03-310000108385us-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:ContractualBasisMemberwrld:A0To5MonthsMember2023-03-310000108385us-gaap:FinancingReceivables60To89DaysPastDueMemberwrld:ContractualBasisMemberwrld:A0To5MonthsMember2023-03-310000108385us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberwrld:ContractualBasisMemberwrld:A0To5MonthsMember2023-03-310000108385wrld:TotalPastDueMemberwrld:ContractualBasisMemberwrld:A0To5MonthsMember2023-03-310000108385wrld:A0To5MonthsMemberwrld:ContractualBasisMember2023-03-310000108385wrld:ContractualBasisMemberus-gaap:FinancialAssetNotPastDueMemberwrld:A6To17MonthsMember2023-03-310000108385us-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:ContractualBasisMemberwrld:A6To17MonthsMember2023-03-310000108385us-gaap:FinancingReceivables60To89DaysPastDueMemberwrld:ContractualBasisMemberwrld:A6To17MonthsMember2023-03-310000108385us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberwrld:ContractualBasisMemberwrld:A6To17MonthsMember2023-03-310000108385wrld:TotalPastDueMemberwrld:ContractualBasisMemberwrld:A6To17MonthsMember2023-03-310000108385wrld:ContractualBasisMemberwrld:A6To17MonthsMember2023-03-310000108385wrld:A18To35MonthsMemberwrld:ContractualBasisMemberus-gaap:FinancialAssetNotPastDueMember2023-03-310000108385us-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:A18To35MonthsMemberwrld:ContractualBasisMember2023-03-310000108385us-gaap:FinancingReceivables60To89DaysPastDueMemberwrld:A18To35MonthsMemberwrld:ContractualBasisMember2023-03-310000108385us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberwrld:A18To35MonthsMemberwrld:ContractualBasisMember2023-03-310000108385wrld:TotalPastDueMemberwrld:A18To35MonthsMemberwrld:ContractualBasisMember2023-03-310000108385wrld:A18To35MonthsMemberwrld:ContractualBasisMember2023-03-310000108385wrld:A36To59MonthsMemberwrld:ContractualBasisMemberus-gaap:FinancialAssetNotPastDueMember2023-03-310000108385us-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:A36To59MonthsMemberwrld:ContractualBasisMember2023-03-310000108385us-gaap:FinancingReceivables60To89DaysPastDueMemberwrld:A36To59MonthsMemberwrld:ContractualBasisMember2023-03-310000108385us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberwrld:A36To59MonthsMemberwrld:ContractualBasisMember2023-03-310000108385wrld:TotalPastDueMemberwrld:A36To59MonthsMemberwrld:ContractualBasisMember2023-03-310000108385wrld:A36To59MonthsMemberwrld:ContractualBasisMember2023-03-310000108385wrld:A60MonthsMemberwrld:ContractualBasisMemberus-gaap:FinancialAssetNotPastDueMember2023-03-310000108385us-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:A60MonthsMemberwrld:ContractualBasisMember2023-03-310000108385us-gaap:FinancingReceivables60To89DaysPastDueMemberwrld:A60MonthsMemberwrld:ContractualBasisMember2023-03-310000108385us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberwrld:A60MonthsMemberwrld:ContractualBasisMember2023-03-310000108385wrld:TotalPastDueMemberwrld:A60MonthsMemberwrld:ContractualBasisMember2023-03-310000108385wrld:A60MonthsMemberwrld:ContractualBasisMember2023-03-310000108385wrld:TaxAdvanceLoanMemberwrld:ContractualBasisMemberus-gaap:FinancialAssetNotPastDueMember2023-03-310000108385wrld:TaxAdvanceLoanMemberus-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:ContractualBasisMember2023-03-310000108385wrld:TaxAdvanceLoanMemberus-gaap:FinancingReceivables60To89DaysPastDueMemberwrld:ContractualBasisMember2023-03-310000108385us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberwrld:TaxAdvanceLoanMemberwrld:ContractualBasisMember2023-03-310000108385wrld:TaxAdvanceLoanMemberwrld:TotalPastDueMemberwrld:ContractualBasisMember2023-03-310000108385wrld:TaxAdvanceLoanMemberwrld:ContractualBasisMember2023-03-310000108385wrld:ContractualBasisMemberus-gaap:FinancialAssetNotPastDueMember2023-03-310000108385us-gaap:FinancingReceivables30To59DaysPastDueMemberwrld:ContractualBasisMember2023-03-310000108385us-gaap:FinancingReceivables60To89DaysPastDueMemberwrld:ContractualBasisMember2023-03-310000108385us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberwrld:ContractualBasisMember2023-03-310000108385wrld:TotalPastDueMemberwrld:ContractualBasisMember2023-03-310000108385wrld:ContractualBasisMember2023-03-310000108385wrld:A0To5MonthsMember2023-10-012023-12-310000108385wrld:A0To5MonthsMember2022-10-012022-12-310000108385wrld:A0To5MonthsMember2023-04-012023-12-310000108385wrld:A0To5MonthsMember2022-04-012022-12-310000108385wrld:A6To17MonthsMember2023-10-012023-12-310000108385wrld:A6To17MonthsMember2022-10-012022-12-310000108385wrld:A6To17MonthsMember2023-04-012023-12-310000108385wrld:A6To17MonthsMember2022-04-012022-12-310000108385wrld:A18To35MonthsMember2023-10-012023-12-310000108385wrld:A18To35MonthsMember2022-10-012022-12-310000108385wrld:A18To35MonthsMember2023-04-012023-12-310000108385wrld:A18To35MonthsMember2022-04-012022-12-310000108385wrld:A36To59MonthsMember2023-10-012023-12-310000108385wrld:A36To59MonthsMember2022-10-012022-12-310000108385wrld:A36To59MonthsMember2023-04-012023-12-310000108385wrld:A36To59MonthsMember2022-04-012022-12-310000108385wrld:A60MonthsMember2023-10-012023-12-310000108385wrld:A60MonthsMember2022-10-012022-12-310000108385wrld:A60MonthsMember2023-04-012023-12-310000108385wrld:A60MonthsMember2022-04-012022-12-310000108385wrld:A0To5MonthsMember2023-12-310000108385wrld:A0To5MonthsMember2023-03-310000108385wrld:A6To17MonthsMember2023-12-310000108385wrld:A6To17MonthsMember2023-03-310000108385wrld:A18To35MonthsMember2023-12-310000108385wrld:A18To35MonthsMember2023-03-310000108385wrld:A36To59MonthsMember2023-12-310000108385wrld:A36To59MonthsMember2023-03-310000108385wrld:A60MonthsMember2023-12-310000108385wrld:A60MonthsMember2023-03-310000108385wrld:TaxAdvanceLoanMember2023-10-012023-12-310000108385wrld:TaxAdvanceLoanMember2022-10-012022-12-310000108385wrld:TaxAdvanceLoanMember2023-04-012023-12-310000108385wrld:TaxAdvanceLoanMember2022-04-012022-12-310000108385wrld:NonaccrualStatusMember2023-12-310000108385wrld:NonaccrualStatusMember2023-03-310000108385srt:MinimumMember2023-12-310000108385srt:MaximumMember2023-12-310000108385us-gaap:EmployeeStockOptionMember2023-12-310000108385srt:MaximumMemberus-gaap:EmployeeStockOptionMember2023-04-012023-12-310000108385srt:MinimumMemberus-gaap:EmployeeStockOptionMember2023-04-012023-12-310000108385wrld:Target1Member2023-04-012023-12-310000108385wrld:Target2Member2023-04-012023-12-310000108385us-gaap:RestrictedStockMember2023-12-31wrld:installment0000108385wrld:ServiceOptionMember2023-04-012023-12-310000108385us-gaap:PerformanceSharesMember2023-04-012023-12-310000108385wrld:Target3Member2023-04-012023-12-310000108385us-gaap:EmployeeStockOptionMember2023-03-310000108385us-gaap:EmployeeStockOptionMember2023-04-012023-12-310000108385us-gaap:EmployeeStockOptionMemberwrld:Scenario1Member2023-12-310000108385wrld:Scenario2Memberus-gaap:EmployeeStockOptionMember2023-12-310000108385us-gaap:EmployeeStockOptionMember2023-10-012023-12-310000108385us-gaap:EmployeeStockOptionMember2022-10-012022-12-310000108385us-gaap:EmployeeStockOptionMember2022-04-012022-12-310000108385us-gaap:RestrictedStockMember2023-04-012023-12-310000108385us-gaap:RestrictedStockMember2023-04-012023-06-300000108385us-gaap:RestrictedStockMember2023-03-310000108385us-gaap:RestrictedStockMember2023-10-012023-12-310000108385us-gaap:RestrictedStockMember2022-10-012022-12-310000108385us-gaap:RestrictedStockMember2022-04-012022-12-310000108385us-gaap:EquitySecuritiesMember2023-10-012023-12-310000108385us-gaap:EquitySecuritiesMember2022-10-012022-12-310000108385us-gaap:EquitySecuritiesMember2023-04-012023-12-310000108385us-gaap:EquitySecuritiesMember2022-04-012022-12-310000108385us-gaap:PerformanceSharesMember2023-07-012023-09-30wrld:acquisition0000108385us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember2023-12-310000108385us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember2022-12-310000108385wrld:InsuranceAndOtherIncomeNetMember2023-04-012023-09-3000001083852023-04-012023-09-300000108385us-gaap:RevolvingCreditFacilityMemberwrld:RevolvingCreditFacilityEleventhAmendmentMember2023-11-090000108385us-gaap:RevolvingCreditFacilityMember2023-12-310000108385wrld:SubFacilityMemberus-gaap:RevolvingCreditFacilityMember2023-12-310000108385us-gaap:RevolvingCreditFacilityMember2023-04-012023-12-310000108385us-gaap:RevolvingCreditFacilityMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember2023-04-012023-12-310000108385srt:MinimumMemberus-gaap:RevolvingCreditFacilityMember2023-12-310000108385us-gaap:RevolvingCreditFacilityMember2022-04-012022-12-310000108385us-gaap:RevolvingCreditFacilityMember2023-03-310000108385wrld:SeniorNotesDue2026Memberus-gaap:SeniorNotesMember2021-09-270000108385wrld:SeniorNotesDue2026Memberus-gaap:SeniorNotesMemberus-gaap:DebtInstrumentRedemptionPeriodOneMember2021-09-272021-09-270000108385wrld:SeniorNotesDue2026Memberus-gaap:SeniorNotesMember2021-09-272021-09-270000108385wrld:SeniorNotesDue2026Memberus-gaap:DebtInstrumentRedemptionPeriodTwoMemberus-gaap:SeniorNotesMember2021-09-272021-09-270000108385wrld:SeniorNotesDue2026Memberus-gaap:SeniorNotesMember2022-04-012023-03-310000108385wrld:SeniorNotesDue2026Memberus-gaap:SeniorNotesMember2023-03-310000108385wrld:SeniorNotesDue2026Memberus-gaap:SeniorNotesMember2023-04-012023-12-310000108385wrld:SeniorNotesDue2026Memberus-gaap:SeniorNotesMember2023-12-310000108385wrld:SeniorNotesDue2026Memberus-gaap:SeniorNotesMember2023-10-012023-12-310000108385us-gaap:RevolvingCreditFacilityMemberwrld:Scenario1Member2023-04-012023-12-310000108385us-gaap:RevolvingCreditFacilityMemberwrld:Scenario2Member2023-04-012023-12-310000108385us-gaap:RevolvingCreditFacilityMemberwrld:Scenario3Member2023-04-012023-12-310000108385wrld:Scenario4Memberus-gaap:RevolvingCreditFacilityMember2023-04-012023-12-310000108385us-gaap:RevolvingCreditFacilityMemberwrld:Scenario5Member2023-04-012023-12-310000108385wrld:HistoricTaxCreditInvestmentMember2023-12-310000108385wrld:HistoricTaxCreditInvestmentMember2023-03-310000108385wrld:HistoricTaxCreditInvestmentMember2023-10-012023-12-310000108385wrld:HistoricTaxCreditInvestmentMember2022-10-012022-12-310000108385wrld:HistoricTaxCreditInvestmentMember2023-04-012023-12-310000108385wrld:HistoricTaxCreditInvestmentMember2022-04-012022-12-31


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

__________________________________
 Form 10-Q
__________________________________

(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended December 31, 2023
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT of 1934

For the transition period from ______________ to ______________
 
Commission File Number:  000-19599

WORLD ACCEPTANCE CORPORATION
(Exact name of registrant as specified in its charter.)
South Carolina
 57-0425114
(State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification Number)
104 S Main Street
Greenville,South Carolina29601
(Address of principal executive offices)
(Zip Code)
(864)298-9800
(registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
Common Stock, no par valueWRLD
The NASDAQ Stock Market LLC
(NASDAQ Global Select Market)
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for shorter period than the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x  No ¨

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No ¨
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.
1


Large Accelerated filerAccelerated filer
  
Non-accelerated filerSmaller reporting company
Emerging growth company

If an emerging growth company, indicate by check mark if registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  No x

The number of outstanding shares of the issuer’s common stock, no par value, as of February 1, 2024 was 6,080,276.

2


 WORLD ACCEPTANCE CORPORATION
FORM 10-Q

TABLE OF CONTENTS
Item No.ContentsPage
GLOSSARY OF DEFINED TERMS
PART I - FINANCIAL INFORMATION 
1.Consolidated Financial Statements (unaudited):
 Consolidated Balance Sheets as of December 31, 2023 and March 31, 2023
 Consolidated Statements of Operations for the three and nine months ended December 31, 2023 and December 31, 2022
 Consolidated Statements of Shareholders' Equity for the three and nine months ended December 31, 2023 and December 31, 2022
 Consolidated Statements of Cash Flows for the nine months ended December 31, 2023 and December 31, 2022
 Notes to Consolidated Financial Statements
2.Management's Discussion and Analysis of Financial Condition and Results of Operations
3.Quantitative and Qualitative Disclosures about Market Risk
4.Controls and Procedures
PART II - OTHER INFORMATION
1.Legal Proceedings
1A.Risk Factors
2.Unregistered Sales of Equity Securities and Use of Proceeds
3.Defaults Upon Senior Securities
4.Mine Safety Disclosures
5.Other Information
6.Exhibits
EXHIBIT INDEX
SIGNATURES

Introductory Note: As used herein, the "Company," "we," "our," "us," or similar formulations include World Acceptance Corporation and each of its subsidiaries, unless otherwise expressly noted or the context otherwise requires that it include only World Acceptance Corporation. All references in this report to "fiscal 2024" are to the Company’s fiscal year ending March 31, 2024; all references in this report to "fiscal 2023" are to the Company's fiscal year ended March 31, 2023; and all references to "fiscal 2019" are to the Company’s fiscal year ended March 31, 2019.


3

GLOSSARY OF DEFINED TERMS

The following terms may be used throughout this Report, including consolidated financial statements and related notes.
TermDefinition
2008 Plan
World Acceptance Corporation 2008 Stock Option Plan
2011 Plan
World Acceptance Corporation 2011 Stock Option Plan
2017 Plan
World Acceptance Corporation 2017 Stock Incentive Plan
ASCAccounting Standards Codification
ASUAccounting Standards Update
CECLCurrent Expected Credit Loss
CEOChief Executive Officer
CFOChief Financial Officer
CFPBU.S. Consumer Financial Protection Bureau
Compensation CommitteeCompensation and Stock Option Committee
Customer TenureThe number of years since a customer was first serviced by the Company
ERISAEmployee Retirement Income Security Act
Exchange ActSecurities Exchange Act of 1934, as amended
FASBFinancial Accounting Standards Board
FICOThe Fair Isaac Corporation
G&AGeneral and administrative
GAAPU.S. generally accepted accounting principles
HTCHistoric Tax Credit
IRSU.S. Internal Revenue Service
Notes$300 million in aggregate principal amount of 7.0% unsecured senior notes due 2026 issued on September 27, 2021
Option Measurement PeriodThe 6.5 year performance period beginning on September 30, 2018 and ending on March 31, 2025 over which the Performance Options are eligible to vest, following certification by the Compensation Committee of achievement
PCDPurchased Assets with Credit Deterioration
Performance OptionsPerformance-based stock options
Performance Share Measurement PeriodThe 6.5 year performance period beginning on September 30, 2018 and ending on March 31, 2025 over which the Performance Shares are eligible to vest, following certification by the Compensation Committee of achievement
Performance SharesService- and performance-based restricted stock awards
Rehab RatePercentage of 91 days or more delinquent that do not charge off
Restricted StockService-based restricted stock awards
SECU.S. Securities and Exchange Commission
Service OptionsService-based stock options
SOFRSecured Overnight Finance Rate
TALTax Advance Loan
4

PART I.  FINANCIAL INFORMATION

WORLD ACCEPTANCE CORPORATION
AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(Unaudited)
 December 31, 2023March 31, 2023
ASSETS  
Cash and cash equivalents$12,775,524 $16,508,935 
Gross loans receivable1,400,621,989 1,390,015,568 
Less:  
Unearned interest, insurance and fees(372,310,672)(376,674,349)
Allowance for credit losses(121,082,068)(125,552,733)
Loans receivable, net907,229,249 887,788,486 
Income taxes receivable1,716,789  
Operating lease right‐of‐use assets, net80,049,367 81,289,240 
Property and equipment, net23,195,803 23,926,080 
Deferred income taxes, net37,047,569 41,722,361 
Other assets, net38,046,804 43,422,669 
Goodwill7,370,791 7,370,791 
Intangible assets, net12,106,773 15,289,579 
Total assets$1,119,538,669 $1,117,318,141 
 
LIABILITIES & SHAREHOLDERS' EQUITY  
Liabilities:  
Senior notes payable$305,089,480 $307,910,824 
Senior unsecured notes payable, net279,915,756 287,352,892 
Income taxes payable 2,532,766 
Operating lease liability82,471,106 83,735,002 
Accounts payable and accrued expenses45,043,161 50,559,920 
Total liabilities712,519,503 732,091,404 
Commitments and contingencies
Shareholders' equity:  
Preferred stock, no par value Authorized 5,000,000, no shares issued or outstanding
  
Common stock, no par value Authorized 95,000,000 shares; issued and outstanding 6,073,299 and 6,231,082 shares at December 31, 2023 and March 31, 2023, respectively
  
Additional paid-in capital284,870,280 288,071,839 
Retained earnings122,148,886 97,154,898 
Total shareholders' equity407,019,166 385,226,737 
Total liabilities and shareholders' equity$1,119,538,669 $1,117,318,141 

See accompanying notes to consolidated financial statements.

5

WORLD ACCEPTANCE CORPORATION
AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
Three months ended December 31,Nine months ended December 31,
2023202220232022
Revenues:  
Interest and fee income$118,665,105 $126,201,028 $352,237,133 $386,867,966 
Insurance and other income, net19,084,282 20,331,122 61,711,366 68,840,650 
Total revenues137,749,387 146,532,150 413,948,499 455,708,616 
Expenses:   
Provision for credit losses40,631,994 59,608,655 127,697,072 214,051,068 
General and administrative expenses:  
Personnel39,890,187 40,700,713 120,119,638 131,173,726 
Occupancy and equipment12,090,198 12,932,456 37,138,444 39,658,067 
Advertising3,721,155 1,323,671 8,712,406 4,541,863 
Amortization of intangible assets1,050,926 1,114,540 3,182,805 3,352,694 
Other9,156,841 8,880,014 27,828,730 27,569,744 
Total general and administrative expenses65,909,307 64,951,394 196,982,023 206,296,094 
Interest expense11,689,924 14,070,458 36,475,411 38,277,223 
Total expenses118,231,225 138,630,507 361,154,506 458,624,385 
Income (loss) before income taxes19,518,162 7,901,643 52,793,993 (2,915,769)
Income tax expense2,853,344 2,097,057 10,508,008 483,696 
Net income (loss)$16,664,818 $5,804,586 $42,285,985 $(3,399,465)
Net income (loss) per common share:   
Basic$2.89 $1.01 $7.32 $(0.59)
Diluted$2.84 $0.99 $7.17 $(0.59)
Weighted average common shares outstanding:  
Basic5,772,503 5,761,954 5,775,108 5,743,094 
Diluted5,860,117 5,857,490 5,896,716 5,743,094 

See accompanying notes to consolidated financial statements.

6

WORLD ACCEPTANCE CORPORATION
AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY
(Unaudited)


Three months ended December 31, 2023
Common Stock
SharesAdditional Paid-in CapitalRetained EarningsTotal Shareholders' Equity
Balances at September 30, 20236,246,818 $287,246,730 $122,776,065 $410,022,795 
Proceeds from exercise of stock options11,104 948,441  948,441 
Common stock repurchases(148,765) (17,291,997)(17,291,997)
Stock-based compensation (reversal) related to restricted stock, net of cancellations ($2,823,774)
(35,858)(3,514,473) (3,514,473)
Stock-based compensation related to stock options 189,582  189,582 
Net income  16,664,818 16,664,818 
Balances at December 31, 20236,073,299 $284,870,280 $122,148,886 $407,019,166 

Three months ended December 31, 2022
Common Stock
SharesAdditional Paid-in CapitalRetained EarningsTotal Shareholders' Equity
Balances at September 30, 20226,281,721 $288,947,268 $66,718,858 $355,666,126 
Proceeds from exercise of stock options1,296 82,825 — 82,825 
Stock-based compensation (reversal) related to restricted stock, net of cancellations ($2,543,001)
(54,408)(3,222,444)— (3,222,444)
Stock-based compensation related to stock options— 425,120 — 425,120 
Net income— — 5,804,586 5,804,586 
Balances at December 31, 20226,228,609 $286,232,769 $72,523,444 $358,756,213 


7

Nine months ended December 31, 2023
Common Stock
SharesAdditional Paid-in CapitalRetained EarningsTotal Shareholders' Equity
Balances at March 31, 20236,231,082 $288,071,839 $97,154,898 $385,226,737 
Proceeds from exercise of stock options22,847 2,018,412  2,018,412 
Common stock repurchases(148,765)(17,291,997)(17,291,997)
Stock-based compensation (reversal) related to restricted stock, net of cancellations ($2,823,774)
(31,865)(1,348,623) (1,348,623)
Stock-based compensation (reversal) related to stock options (3,871,348) (3,871,348)
Net income  42,285,985 42,285,985 
Balances at December 31, 20236,073,299 $284,870,280 $122,148,886 $407,019,166 
Nine months ended December 31, 2022
Common Stock
SharesAdditional Paid-in CapitalRetained EarningsTotal Shareholders' Equity
Balances at March 31, 20226,348,314 $280,907,085 $92,117,343 $373,024,428 
Proceeds from exercise of stock options5,596 486,372 — 486,372 
Common stock repurchases(73,643)— (14,314,088)(14,314,088)
Stock-based compensation related to restricted stock, net of cancellations ($2,543,001)
(51,658)2,969,433 — 2,969,433 
Stock-based compensation related to stock options— 1,869,879 — 1,869,879 
Cumulative effect of adoption of ASU 2023-02— — (1,880,346)(1,880,346)
Net loss— — (3,399,465)(3,399,465)
Balances at December 31, 20226,228,609 $286,232,769 $72,523,444 $358,756,213 

See accompanying notes to consolidated financial statements.

8

WORLD ACCEPTANCE CORPORATION
AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
9

Nine months ended December 31,
 20232022
Cash flow from operating activities:  
Net income (loss)$42,285,985 $(3,399,465)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:  
Amortization of intangible assets3,182,805 3,352,694 
Accrued unearned interest(4,225,244)(2,253,757)
Amortization of deferred loan cost10,285,733 12,187,196 
Gain on extinguishment of senior unsecured notes payable(1,162,581) 
Amortization of debt issuance costs1,338,352 1,170,040 
Provision for credit losses127,697,072 214,051,068 
Depreciation4,937,169 4,648,277 
Amortization of finance leases 204,552 
Gain on asset acquisitions, net of income tax (3,708,344)
Loss (gain) on sale of property and equipment(95,621)21,261 
Deferred income tax expense (benefit)4,674,792 (3,665,493)
Stock-based compensation (reversal) related to equity classified awards(2,396,197)7,382,313 
Change in accounts:  
Other assets, net5,213,994 (6,579,852)
Income taxes payable(4,249,555)(8,295,947)
Accounts payable and accrued expenses(5,516,759)(9,241,015)
Net cash provided by operating activities181,969,945 205,873,528 
Cash flows from investing activities:  
Increase in loans receivable, net(153,198,324)(189,511,989)
Cash paid for acquisitions, primarily loans (22,314,902)
Purchases of property and equipment(4,419,445)(4,517,809)
Proceeds from the sale of property and equipment308,174 349,792 
Net cash used in investing activities(157,309,595)(215,994,908)
Cash flow from financing activities:  
Borrowings from senior notes payable215,066,622 251,431,701 
Payments on senior notes payable(217,887,966)(221,914,242)
Payments for extinguished senior unsecured notes payable(6,978,717) 
Debt issuance costs associated with senior unsecured notes payable (104,656)
Payments for debt extinguishment costs(20,625) 
Debt issuance costs associated with senior notes payable(475,716)(1,115,136)
Proceeds from exercise of stock options2,018,412 486,372 
Payments for taxes related to net share settlement of equity awards(2,823,774)(2,543,001)
Repayment of finance lease (80,067)
Repurchase of common stock(17,291,997)(14,314,088)
Net cash provided by (used in) financing activities(28,393,761)11,846,883 
Net change in cash and cash equivalents(3,733,411)1,725,503 
Cash and cash equivalents at beginning of period16,508,935 19,236,322 
Cash and cash equivalents at end of period$12,775,524 $20,961,825 
Supplemental Disclosures:
Interest paid during the period$41,233,947 $42,834,034 
Income taxes paid during the period$7,726,889 $10,772,869 
Finance lease right-of-use assets, net transferred to property and equipment, net$ $402,960 
10


See accompanying notes to consolidated financial statements.
11

WORLD ACCEPTANCE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
 (Unaudited)

NOTE 1 – BASIS OF PRESENTATION

The consolidated financial statements of the Company at December 31, 2023 and 2022 and for the three and nine months then ended were prepared in accordance with the instructions for Form 10-Q and are unaudited; however, in the opinion of management, all adjustments (consisting only of items of a normal, recurring nature) necessary for a fair presentation of the financial position at December 31, 2023, and the results of operations and cash flows for the periods ended December 31, 2023 and 2022, have been included. The results for the interim periods are not necessarily indicative of the results that may be expected for the full year or any other interim period.

The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent liabilities at the date of the consolidated financial statements and the reported amount of revenue and expenses during the reporting period. Actual results could differ from those estimates.

The consolidated financial statements do not include all disclosures required by GAAP and should be read in conjunction with the Company’s audited consolidated financial statements and related notes for the fiscal year ended March 31, 2023, included in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2023, as filed with the SEC. The Company applies the accounting policies contained in Note 1 to the Consolidated Financial Statements included in the Company's Annual Report on Form 10-K for the year ended March 31, 2023. The Company believes that the disclosures are adequate to make the information presented not misleading.

NOTE 2 – SUMMARY OF SIGNIFICANT POLICIES

Nature of Operations

The Company is a small-loan consumer finance company headquartered in Greenville, South Carolina that offers short-term small loans, medium-term larger loans, related credit insurance products and ancillary products and services to individuals who have limited access to other sources of consumer credit. The Company offers income tax return preparation services to its loan customers and other individuals.

Seasonality

The Company's loan volume and corresponding loans receivable follow seasonal trends. The Company's highest loan demand generally occurs from October through December, its third fiscal quarter. Loan demand is generally lowest and loan repayment highest from January to March, its fourth fiscal quarter. Loan volume and average balances remain relatively level during the remainder of the year. Consequently, the Company experiences significant seasonal fluctuations in its operating results and cash needs. Operating results for the Company's third fiscal quarter are generally lower than in other quarters, and operating results for its fourth fiscal quarter are generally higher than in other quarters.

Loans receivable, net

Loans receivable are carried at the gross amount outstanding, reduced by unearned interest and insurance income, net of deferred origination fees and direct costs, and an allowance for credit losses. Fees received and direct costs incurred for the origination of loans are deferred and amortized to interest income over the contractual lives of the loans using the interest method. Unamortized amounts are recognized in income at the time that loans are refinanced or paid in full except for those refinancings that do not constitute a more than minor modification. Net unamortized deferred origination costs were $5.6 million and $4.9 million as of December 31, 2023 and March 31, 2023, respectively.

From time to time, the Company may sell charged off loans receivable, which are accounted for as a sale in accordance with ASC 860, Transfers and Servicing.

Allowance for credit losses

Refer to Note 4, “Loans Receivable and Allowance for Credit Losses,” for information regarding the Company's CECL allowance model and a description of the methodology it utilizes.
12


Reclassification

Certain prior period amounts have been reclassified to conform to the current presentation. Such reclassifications had no impact on previously reported net income (loss) or shareholders' equity, with the exception of the following.

As a result of adopting ASU 2023-02, Investments- Equity Method and Joint Venture (Topic 323), in March 2023 with an effective date of April 1, 2022, previously reported net income for the three months ended December 31, 2022, net loss for the nine months ended December 31, 2022 and shareholders' equity as of December 31, 2022 were immaterially impacted to conform to the modified retrospective application of this newly adopted ASU.

Recently Adopted Accounting Standards

Troubled Debt Restructurings and Vintage Disclosures

In March 2022, the FASB issued ASU 2022-02, Troubled Debt Restructurings and Vintage Disclosures. The amendments in this update eliminated the accounting guidance for troubled debt restructurings by creditors in Subtopic 310-40, Receivables—Troubled Debt Restructurings by Creditors, while enhancing disclosure requirements for certain loan refinancings and restructurings by creditors when a borrower is experiencing financial difficulty. Additionally, for public business entities, the amendments in this update require that an entity disclose current-period gross write-offs by year of origination for financing receivables and net investments in leases within the scope of Subtopic 326-20, Financial Instruments—Credit Losses—Measured at Amortized Cost. The adoption of ASU 2022-02 on April 1, 2023 expanded our gross charge-off disclosures, but had no other impact on the Company’s Consolidated Financial Statements.

Recently Issued Accounting Standards Not Yet Adopted

Improvements to Reportable Segment Disclosures

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which improves reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendments are effective for fiscal years beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The amendments should be applied retrospectively to all prior periods presented in the financial statements. Management is currently evaluating this ASU to determine its impact on the Company's Consolidated Financial Statements and related disclosures.

Improvements to Income Tax Disclosures

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which modifies the rules on income tax disclosures to require entities to expand annual disclosures to 1) include specific categories in the rate reconciliation and additional information for reconciling items that meet a quantitative threshold and 2) disclose the amount of income taxes paid (net of refunds received) disaggregated by federal, state and foreign taxes. ASU 2023-09 also requires entities to disclose income (or loss) from continuing operations before income tax expense (or benefit) disaggregated between domestic and foreign, and income tax expense (or benefit) from continuing operations disaggregated by federal, state and foreign, among other changes. The amendments are effective for annual periods beginning after December 15, 2024. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. ASU 2023-09 should be applied on a prospective basis, but retrospective application is permitted. Management is currently evaluating this ASU to determine its impact on the Company's Consolidated Financial Statements and related disclosures.

We reviewed all other newly issued accounting pronouncements and concluded that they are either not applicable to our business or are not expected to have a material effect on the Consolidated Financial Statements and related disclosures as a result of future adoption.

13

NOTE 3 – FAIR VALUE

Fair Value Disclosures

The Company may carry certain financial instruments and derivative assets and liabilities at fair value measured on a recurring or nonrecurring basis. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants on the measurement date. The Company measures the fair values of its financial instruments based on the fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.

Fair value measurements are grouped in three levels. The levels prioritize the inputs used to measure the fair value of the assets or liabilities. These levels are:

Level 1 – Quoted prices (unadjusted) in active markets for identical assets or liabilities.
Level 2 – Inputs other than quoted prices that are observable for assets and liabilities, either directly or indirectly. These inputs include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are less active.
Level 3 – Unobservable inputs for assets or liabilities reflecting the reporting entity’s own assumptions.

The Company’s financial instruments consist of cash and cash equivalents, loans receivable, net, senior notes payable, and senior unsecured notes payable. Loans receivable are originated at prevailing market rates and have an average life of approximately less than twelve months. Given the short-term nature of these loans, they are continually repriced at current market rates. The Company’s senior notes payable, consisting of a senior revolving credit facility has a variable rate based on a margin over SOFR and reprices with any changes in SOFR. The fair value of the senior unsecured notes payable is estimated based on quoted prices in markets that are not active. The Company also considers its creditworthiness in its estimation of fair value.

The carrying amounts and estimated fair values of financial assets and liabilities disclosed but not carried at fair value and their level within the fair value hierarchy are summarized below.
December 31, 2023March 31, 2023
Input LevelCarrying ValueEstimated Fair ValueCarrying ValueEstimated Fair Value
ASSETS
Cash and cash equivalents1$12,775,524 $12,775,524 $16,508,935 $16,508,935 
Loans receivable, net3907,229,249 907,229,249 887,788,486 887,788,486 
LIABILITIES
Senior unsecured notes payable2282,610,000 257,517,058 290,860,000 218,127,548 
Senior notes payable3305,089,480 305,089,480 307,910,824 307,910,824 

There were no significant assets or liabilities measured at fair value on a non-recurring basis as of December 31, 2023 or March 31, 2023.

NOTE 4 – LOANS RECEIVABLE AND ALLOWANCE FOR CREDIT LOSSES

The following is a summary of gross loans receivable by Customer Tenure as of:
14

Customer TenureDecember 31, 2023March 31, 2023
0 to 5 months$88,474,205 $81,803,668 
6 to 17 months83,641,505 133,650,188 
18 to 35 months154,272,047 135,396,187 
36 to 59 months212,663,970 244,414,255 
60+ months861,562,368 792,189,216 
Tax advance loans7,894 2,562,054 
Total gross loans$1,400,621,989 $1,390,015,568 

Current payment performance is used to assess the capability of the borrower to repay contractual obligations of the loan agreements as scheduled, which is monitored by management on a daily basis. On an as needed basis, qualitative information may be taken into consideration if new information arises related to the customer’s ability to repay the loan. The Company’s payment performance buckets are as follows: current, 30-60 days past due, 61-90 days past due, 91 days or more past due.

The following table provides a breakdown of the Company’s gross loans receivable by current payment performance on a recency basis and year of origination at December 31, 2023:
Term Loans By Origination
LoansUp to
1
Year Ago
Between
1 and 2
Years Ago
Between
2 and 3
Years Ago
Between
3 and 4
Years Ago
Between
4 and 5
Years Ago
More than
5
Years Ago
Total
Current$1,199,541,510 $67,910,482 $4,917,687 $119,767 $36,259 $8,904 $1,272,534,609 
30 - 60 days past due39,988,200 5,754,817 604,508 28,282 15,556 3,633 46,394,996 
61 - 90 days past due25,958,915 3,677,614 285,870 14,542 18,404 1,843 29,957,188 
91 or more days past due43,659,995 7,522,539 512,369 21,530 5,091 5,778 51,727,302 
Total$1,309,148,620 $84,865,452 $6,320,434 $184,121 $75,310 $20,158 $1,400,614,095 
Term Loans By Origination
Tax advance loansUp to
1
Year Ago
Between
1 and 2
Years Ago
Between
2 and 3
Years Ago
Between
3 and 4
Years Ago
Between
4 and 5
Years Ago
More than
5
Years Ago
Total
Current$2,294 $ $ $ $ $ $2,294 
30 - 60 days past due2,508      2,508 
61 - 90 days past due3,092      3,092 
91 or more days past due       
Total$7,894 $ $ $ $ $ $7,894 
Total gross loans$1,400,621,989 

The following table provides a breakdown of the Company’s gross loans receivable by current payment performance on a recency basis and year of origination at March 31, 2023:
15

Term Loans By Origination
LoansUp to
1
Year Ago
Between
1 and 2
Years Ago
Between
2 and 3
Years Ago
Between
3 and 4
Years Ago
Between
4 and 5
Years Ago
More than
5
Years Ago
Total
Current$1,200,504,088 $62,076,656 $1,998,218 $148,662 $23,046 $6,863 $1,264,757,533 
30 - 60 days past due40,791,746 4,689,867 160,956 42,700 8,504 2,988 45,696,761 
61 - 90 days past due26,319,250 2,572,733 92,088 40,281 884  29,025,236 
91 or more days past due41,832,821 5,944,645 160,361 29,494 4,430 2,233 47,973,984 
Total$1,309,447,905 $75,283,901 $2,411,623 $261,137 $36,864 $12,084 $1,387,453,514 
Term Loans By Origination
Tax advance loansUp to
1
Year Ago
Between
1 and 2
Years Ago
Between
2 and 3
Years Ago
Between
3 and 4
Years Ago
Between
4 and 5
Years Ago
More than
5
Years Ago
Total
Current$1,932,607 $3,524 $ $ $ $ $1,936,131 
30 - 60 days past due609,844 736     610,580 
61 - 90 days past due 4,845     4,845 
91 or more days past due409 10,089     10,498 
Total$2,542,860 $19,194 $ $ $ $ $2,562,054 
Total gross loans$1,390,015,568 

The following table provides a breakdown of the Company’s gross loans receivable by current payment performance on a contractual basis and year of origination at December 31, 2023:

16

Term Loans By Origination
LoansUp to
1
Year Ago
Between
1 and 2
Years Ago
Between
2 and 3
Years Ago
Between
3 and 4
Years Ago
Between
4 and 5
Years Ago
More than
5
Years Ago
Total
Current$1,188,126,383 $60,651,793 $3,944,841 $52,853 $12,484 $652 $1,252,789,006 
30 - 60 days past due40,230,196 3,897,049 250,587 941 1,006  44,379,779 
61 - 90 days past due28,592,002 3,484,278 236,372 1,646  296 32,314,594 
91 or more days past due52,200,038 16,832,332 1,888,635 128,681 61,820 19,210 71,130,716 
Total$1,309,148,619 $84,865,452 $6,320,435 $184,121 $75,310 $20,158 $1,400,614,095 
Term Loans By Origination
Tax advance loansUp to
1
Year Ago
Between
1 and 2
Years Ago
Between
2 and 3
Years Ago
Between
3 and 4
Years Ago
Between
4 and 5
Years Ago
More than
5
Years Ago
Total
Current$ $ $ $ $ $ $ 
30 - 60 days past due439      439 
61 - 90 days past due1,714      1,714 
91 or more days past due5,741      5,741 
Total$7,894 $ $ $ $ $ $7,894 
Total gross loans$1,400,621,989 

The following table provides a breakdown of the Company’s gross loans receivable by current payment performance on a contractual basis and year of origination at March 31, 2023:
17

Term Loans By Origination
LoansUp to
1
Year Ago
Between
1 and 2
Years Ago
Between
2 and 3
Years Ago
Between
3 and 4
Years Ago
Between
4 and 5
Years Ago
More than
5
Years Ago
Total
Current$1,174,237,761 $53,652,011 $1,554,144 $64,233 $5,142 $1,491 $1,229,514,782 
30 - 60 days past due47,346,331 3,661,493 77,857 6,714   51,092,395 
61 - 90 days past due33,012,804 3,030,052 44,129 7,643   36,094,628 
91 or more days past due54,851,010 14,940,345 735,493 182,547 31,721 10,593 70,751,709 
Total$1,309,447,906 $75,283,901 $2,411,623 $261,137 $36,863 $12,084 $1,387,453,514 
Term Loans By Origination
Tax advance loansUp to
1
Year Ago
Between
1 and 2
Years Ago
Between
2 and 3
Years Ago
Between
3 and 4
Years Ago
Between
4 and 5
Years Ago
More than
5
Years Ago
Total
Current$1,932,607 $ $ $ $ $ $1,932,607 
30 - 60 days past due609,844      609,844 
61 - 90 days past due       
91 or more days past due409 19,194     19,603 
Total$2,542,860 $19,194 $ $ $ $ $2,562,054 
Total gross loans$1,390,015,568 

The following table provides a breakdown of the Company’s gross charge-offs by year of origination for the three and nine months ended December 31, 2023:

Three months ended December 31,Nine months ended December 31,
Gross Charge-offs by OriginationGross Charge-offs by Origination
Origination by Calendar YearLoansTax advance loansTotalLoansTax advance loansTotal
2018 and prior$1,958 $ $1,958 $9,686 $ $9,686 
20192,448  2,448 19,986  19,986 
202032,909  32,909 177,372  177,372 
2021943,234  943,234 5,589,791  5,589,791 
202215,175,088 188 15,175,276 95,994,906 5,436 96,000,342 
202338,460,870 118,287 38,579,157 54,171,402 1,260,035 55,431,437 
Total$54,616,507 $118,475 $54,734,982 $155,963,143 $1,265,471 $157,228,614 
The following table provides a breakdown of the Company’s gross charge-offs by year of origination for the three and nine months ended December 31, 2022:

18

Three months ended December 31,Nine months ended December 31,
Gross Charge-offs by OriginationGross Charge-offs by Origination
Origination by Calendar YearLoansTax advance loansTotalLoansTax advance loansTotal
2017 and prior$656 $ $656 $10,102 $ $10,102 
201819,203  19,203 39,797  39,797 
2019158,346  158,346 334,091  334,091 
2020441,199  441,199 2,591,494  2,591,494 
202119,276,965 263 19,277,228 125,968,883 19,885 125,988,768 
202266,102,716 383,534 66,486,250 97,354,602 2,413,550 99,768,152 
Total$85,999,085 $383,797 $86,382,882 $226,298,969 $2,433,435 $228,732,404 
The allowance for credit losses is applied to amortized cost, which is defined as the amount at which a financing receivable is originated, and net of deferred fees and costs, collection of cash, and charge-offs. Amortized cost also includes interest earned but not collected.

Credit Risk is inherent in the business of extending loans to borrowers and is continuously monitored by management and reflected within the allowance for credit losses for loans. The allowance for credit losses is an estimate of expected losses inherent within the Company’s gross loans receivable portfolio. In estimating the allowance for credit losses, loans with similar risk characteristics are aggregated into pools and collectively assessed. The Company’s loan products have generally the same terms therefore the Company looked to borrower characteristics as a way to disaggregate loans into pools sharing similar risks.

In determining the allowance for credit losses, the Company examined four borrower risk metrics as noted below.

1.Borrower type
2.Active months
3.Prior loan performance
4.Customer Tenure

To determine how well each metric predicts default risk the Company uses loss rate data over an observation period of twelve months at the loan level.

The information value was then calculated for each metric. From this analysis management determined the metric that had the strongest predictor of default risk was Customer Tenure. The Customer Tenure buckets used in the allowance for credit loss calculation are:

1.0 to 5 months
2.6 to 17 months
3.18 to 35     months
4.36 to 59 months
5.60+ months

Management will continue to monitor this credit metric on a quarterly basis.

Management estimates an allowance for each Customer Tenure bucket by performing a historical migration analysis of loans in that bucket for the twelve most recent historical twelve-month migration periods. All loans that are greater than 90 days past due on a recency basis and not written off as of the reporting date are reserved for at 100% of the outstanding balance, net of a calculated Rehab Rate. Loans are charged-off at the earlier of 120 days past due on a recency basis or when deemed uncollectible. Management considers whether current credit conditions might suggest a change is needed to the allowance for credit losses by monitoring trends in first pay success for new borrowers, 60-89 day delinquencies on a recency basis, FICO scores, percent of loan balances that are paying and percentage of gross loans that are acquired loans. From time to time, the Company will make changes, as deemed appropriate, to our new borrower underwriting guidance. As a result, management also considers whether a change in our new borrower underwriting might suggest a change is needed to the allowance for credit losses. If a change is determined necessary, then the Company has elected to immediately revert back to historical experience past the forecast period.

19

Due to the short term nature of the loan portfolio, forecasted changes in macroeconomic variables such as unemployment do not have a significant impact on loans outstanding at the end of a particular reporting period. Therefore, management develops a reasonable and supportable forecast of losses by comparing the most recent six-month loss curves as compared to historical loss curves to see if there are significant changes in borrower behavior that may indicate the historical migration rates should be adjusted. If management determines that historical migration rates should be adjusted to reflect expected credit losses, a qualitative adjustment is made to reflect management's judgment regarding observable changes in recent or expected economic trends and conditions, portfolio composition, or other significant events or conditions that affect the current estimate.

The following table presents a roll forward of the allowance for credit losses for the three and nine months ended December 31, 2023 and 2022:
Three months ended December 31,Nine months ended December 31,
2023202220232022
Beginning balance$128,892,192 $155,892,100 $125,552,733 $134,242,862 
Provision for credit losses40,631,994 59,608,655 127,697,072 214,051,068 
Charge-offs(54,734,982)(86,382,882)(157,228,614)(228,732,404)
Recoveries16,292,864 15,421,670 25,060,877 24,978,017 
Net charge-offs(48,442,118)(70,961,212)(132,167,737)(203,754,387)
Ending Balance$121,082,068 $144,539,543 $121,082,068 $144,539,543 

The following table is an aging analysis on a recency basis at amortized cost of the Company’s gross loans receivable at December 31, 2023:
Days Past Due - Recency Basis
Customer TenureCurrent30 - 6061 - 90Over 90Total Past DueTotal Loans
0 to 5 months$70,723,005 $5,258,173 $4,431,184 $8,061,843 $17,751,200 $88,474,205 
6 to 17 months70,403,444 4,322,410 2,974,763 5,940,888 13,238,061 83,641,505 
18 to 35 months136,529,566 6,306,026 4,251,454 7,185,001 17,742,481 154,272,047 
36 to 59 months191,171,843 7,712,458 5,057,386 8,722,283 21,492,127 212,663,970 
60+ months803,706,751 22,795,929 13,242,401 21,817,287 57,855,617 861,562,368 
Tax advance loans2,294 2,508 3,092  5,600 7,894 
Total gross loans1,272,536,903 46,397,504 29,960,280 51,727,302 128,085,086 1,400,621,989 
Unearned interest, insurance and fees(340,464,381)(9,305,045)(8,165,777)(14,375,469)(31,846,291)(372,310,672)
Total net loans$932,072,522 $37,092,459 $21,794,503 $37,351,833 $96,238,795 $1,028,311,317 
Percentage of period-end gross loans receivable3.3%2.1%3.7%9.1%

The following table is an aging analysis on a recency basis at amortized cost of the Company’s gross loans receivable at March 31, 2023:

1 Recoveries during the three and nine months ended December 31, 2023 include $3.7 million and $16.2 million, respectively, in proceeds from the sales of charge-offs. For the three months ended December 31, 2023, $0.8 million relates to bulk sales of charge-offs from prior periods and $2.9 million relates to recurring sales of charge-offs. For the nine months ended December 31, 2023, $5.7 million relates to bulk sales of charge-offs from prior periods and $10.5 million relates to recurring sales of charge-offs. Recoveries during the three and nine months ended December 31, 2022 include $11.4 million in proceeds related to the sale of charge-offs, for which $8.4 million relates to bulk sales of charge-offs from prior periods and $3.0 million relates to recurring sales of charge-offs The gain on sale is included as a component of Provision for credit losses in the Consolidated Statements of Operations.
20

Days Past Due - Recency Basis
Customer TenureCurrent30 - 6061 - 90Over 90Total Past DueTotal Loans
0 to 5 months$64,615,314 $5,451,276 $4,407,751 $7,329,327 $17,188,354 $81,803,668 
6 to 17 months113,946,833 6,527,355 4,655,441 8,520,559 19,703,355 133,650,188 
18 to 35 months120,125,821 5,336,994 3,727,331 6,206,041 15,270,366 135,396,187 
36 to 59 months223,734,062 8,070,011 4,839,000 7,771,182 20,680,193 244,414,255 
60+ months742,335,503 20,311,125 11,395,713 18,146,875 49,853,713 792,189,216 
Tax advance loans1,936,131 610,580 4,845 10,498 625,923 2,562,054 
Total gross loans1,266,693,664 46,307,341 29,030,081 47,984,482 123,321,904 1,390,015,568 
Unearned interest, insurance and fees(343,255,876)(12,548,627)(7,866,737)(13,003,109)(33,418,473)(376,674,349)
Total net loans$923,437,788 $33,758,714 $21,163,344 $34,981,373 $89,903,431 $1,013,341,219 
Percentage of period-end gross loans receivable3.3 %2.1 %3.5 %8.9 %

The following table is an aging analysis on a contractual basis at amortized cost of the Company’s gross loans receivable at December 31, 2023:
Days Past Due - Contractual Basis
Customer TenureCurrent30 - 6061 - 90Over 90Total Past DueTotal Loans
0 to 5 months$69,745,014 $5,057,373 $4,433,801 $9,238,017 $18,729,191 $88,474,205 
6 to 17 months68,600,697 3,932,710 3,077,743 8,030,355 15,040,808 83,641,505 
18 to 35 months134,132,918 5,933,072 4,509,138 9,696,919 20,139,129 154,272,047 
36 to 59 months187,676,345 7,282,389 5,443,963 12,261,273 24,987,625 212,663,970 
60+ months792,634,032 22,174,235 14,849,949 31,904,152 68,928,336 861,562,368 
Tax advance loans 439 1,714 5,741 7,894 7,894 
Total gross loans1,252,789,006 44,380,218 32,316,308 71,136,457 147,832,983 1,400,621,989 
Unearned interest, insurance and fees(336,138,470)(8,303,761)(8,796,156)(19,072,285)(36,172,202)(372,310,672)
Total net loans$916,650,536 $36,076,457 $23,520,152 $52,064,172 $111,660,781 $1,028,311,317 
Percentage of period-end gross loans receivable3.2%2.3%5.1%10.6 %

The following table is an aging analysis on a contractual basis at amortized cost of the Company’s gross loans receivable at March 31, 2023:
21

Days Past Due - Contractual Basis
Customer TenureCurrent30 - 6061 - 90Over 90Total Past DueTotal Loans
0 to 5 months$61,850,142 $5,320,659 $4,864,498 $9,768,369 $19,953,526 $81,803,668 
6 to 17 months109,694,389 6,892,610 5,613,468 11,449,721 23,955,799 133,650,188 
18 to 35 months115,711,782 5,721,694 4,499,010 9,463,701 19,684,405 135,396,187 
36 to 59 months217,821,239 8,991,995 6,078,488 11,522,533 26,593,016 244,414,255 
60+ months724,437,230 24,165,437 15,039,164 28,547,385 67,751,986 792,189,216 
Tax advance loans1,932,607 609,844  19,603 629,447 2,562,054 
Total gross loans1,231,447,389 51,702,239 36,094,628 70,771,312 158,568,179 1,390,015,568 
Unearned interest, insurance and fees(333,704,639)(14,010,568)(9,781,128)(19,178,014)(42,969,710)(376,674,349)
Total net loans$897,742,750 $37,691,671 $26,313,500 $51,593,298 $115,598,469 $1,013,341,219 
Percentage of period-end gross loans receivable3.7 %2.6 %5.1 %11.4 %

The Company elected not to record an allowance for credit losses for accrued interest as outlined in ASC 326-20-30-5A. Loans are placed on nonaccrual status when management determines that the full payment of principal and collection of interest according to contractual terms is no longer likely. The accrual of interest is discontinued when a loan is 61 days or more past the contractual due date. When the interest accrual is discontinued, all unpaid accrued interest is reversed against interest income. While a loan is on nonaccrual status, interest revenue is recognized only when a payment is received. Once a loan moves to nonaccrual status, it remains in nonaccrual status until it is paid out, charged off or refinanced.

The following table presents unpaid accrued interest reversed against interest income by Customer Tenure for the three and nine months ended December 31, 2023 and December 31, 2022:

Three months ended December 31,Nine months ended December 31,
2023202220232022
Customer Tenure
0 to 5 months$(1,358,755)$(1,813,804)$(3,904,031)$(8,117,103)
6 to 17 months(777,293)(1,627,586)(2,651,226)(4,605,102)
18 to 35 months(946,820)(1,285,309)(2,609,760)(3,862,834)
36 to 59 months(1,065,935)(1,365,428)(3,211,393)(3,543,651)
60+ months(2,822,515)(3,352,265)(7,972,048)(9,724,169)
Total$(6,971,318)$(9,444,392)$(20,348,458)$(29,852,859)

The following table presents the amortized cost basis of loans on nonaccrual status as of the beginning of the reporting period and the end of the reporting period, as well as interest income recognized on nonaccrual loans for the three and nine months ended December 31, 2023 and 2022:
22

Nonaccrual Loans Receivable
Customer TenureAs of December 31, 2023As of March 31, 2023
Interest Income
Recognized for the three months ended December 31, 2023
Interest Income
Recognized for the three months ended December 31, 2022
Interest Income
Recognized for the nine months ended December 31, 2023
Interest Income
Recognized for the nine months ended December 31, 2022
0 to 5 months$14,079,793 $15,781,494 $197,470 $480,947 $769,418 $1,522,535 
6 to 17 months11,853,469 18,288,714 319,474 450,877 1,168,253 1,216,091 
18 to 35 months15,380,814 15,551,806 396,720 544,689 1,249,102 1,741,780 
36 to 59 months19,379,244 19,745,397 547,608 555,085 1,728,965 1,606,466 
60+ months51,666,613 49,285,814 1,497,757 1,711,201 4,785,842 4,975,538 
Tax advance loans50,950 19,603     
Unearned interest, insurance and fees(29,880,847)(32,158,640) —  — 
Total$82,530,036 $86,514,188 $2,959,029 $3,742,799 $9,701,580 $11,062,410 

As of December 31, 2023 and March 31, 2023, there were no loans receivable 61 days or more past due, not on nonaccrual status, and no loans receivable on nonaccrual status with no related allowance for credit losses.

NOTE 5 – LEASES

Accounting Policies and Matters Requiring Management's Judgment

The Company uses its effective annual interest rate, adjusted for certain assumptions, as the discount rate when evaluating leases under Topic 842. Management applies the adjusted effective annual interest rate to leases entered for the entirety of the subsequent year.

Based on its historical practice, the Company believes it is reasonably certain to exercise a given option associated with a given office space lease. Therefore, the Company classifies all lease options for office space as “reasonably certain” unless it has specific knowledge to the contrary for a given lease. The Company generally does not believe it is reasonably certain to exercise any options associated with its office equipment leases.

Periodic Disclosures

The Company's operating leases consist of real estate leases for office space as well as office equipment. Both the branch real estate and office equipment lease terms generally range from three years to five years, and generally contain options to extend which mirror the original terms of the lease.

During the second quarter of fiscal 2023, the lease terms associated with the Company's finance leases expired and the Company exercised its purchase option to acquire the IT equipment. Because it was reasonably certain that the Company would obtain the assets at the end of their lease terms, the right-of-use assets have amortized over the useful life of the asset, rather than over the lease term. As of December 31, 2023, the Company had no finance leases.

23

The following table reports information about the Company's lease cost for the three and nine months ended December 31, 2023 and 2022:
Three months ended December 31,Nine months ended December 31,
 2023202220232022
Lease Cost
Finance lease cost$ $ $ $205,975 
Amortization of right-of-use assets   204,552 
Interest on lease liabilities   1,423 
Operating lease cost$6,163,762 $6,746,965 $19,000,163 $21,013,997 
Variable lease cost$888,119 $920,991 $2,808,845 $2,772,620 
Total lease cost$7,051,881 $7,667,956 $21,809,008 $23,992,592 

The following table reports other information about the Company's leases for the three and nine months ended December 31, 2023 and 2022:
Three months ended December 31,Nine months ended December 31,
 2023202220232022
Other Lease Information
Cash paid for amounts included in the measurement of lease liabilities$6,265,527 $6,550,184 $18,965,468 $19,998,398 
Operating cash flows from finance leases   1,423 
Operating cash flows from operating leases6,265,527 6,550,184 18,965,468 19,916,908 
Financing cash flows from finance leases   80,067 
Right-of-use assets obtained in exchange for new operating lease liabilities$4,568,169 $3,447,091 $13,560,648 $13,912,470 
Weighted-average remaining lease term — finance leases —  — 
Weighted average remaining lease term — operating leases6.9 years7.1 years6.9 years7.1 years
Weighted-average discount rate — finance leases % % % %
Weighted-average discount rate — operating leases6.3 %6.1 %6.3 %6.1 %

The aggregate annual lease obligations as of December 31, 2023 are as follows:
Operating Leases
Remainder of 2024$6,054,892 
202521,532,117 
202618,010,788 
202713,832,252 
202811,124,461 
Thereafter31,854,653 
Total undiscounted lease liability$102,409,163 
Imputed interest19,938,057 
Total discounted lease liability$82,471,106 

The Company had no leases with related parties at December 31, 2023 or March 31, 2023.

24

NOTE 6 – AVERAGE SHARE INFORMATION

The following is a summary of the basic and diluted average common shares outstanding:
Three months ended December 31,Nine months ended December 31,
2023202220232022
Basic:  
Weighted average common shares outstanding (denominator)5,772,503 5,761,954 5,775,108 5,743,094 
Diluted:  
Weighted average common shares outstanding5,772,503 5,761,954 5,775,108 5,743,094 
Dilutive potential common shares287,614 95,536 121,608  
Weighted average diluted shares outstanding (denominator)5,860,117 5,857,490 5,896,716 5,743,094 
 
Options to purchase 291,826 and 332,275 shares of common stock at various prices were outstanding during the three months ended December 31, 2023 and 2022, respectively, but were not included in diluted shares outstanding because the option exercise price exceeded the market value of the shares. 

Options to purchase 299,904 and 338,154 shares of common stock at various prices were outstanding during the nine months ended December 31, 2023 and 2022, respectively, but were not included in diluted shares outstanding because the option exercise price exceeded the market value of the shares. 
2 Dilutive potential common shares have been excluded from the weighted average diluted shares outstanding calculation for the nine months ended December 31, 2022. In accordance with ASC 260-10-45, shares which would otherwise be considered dilutive are deemed anti-dilutive when the entity incurs a loss from continuing operations in the period reported.
25

NOTE 7 – STOCK-BASED COMPENSATION

Stock Incentive Plans

The Company maintains the 2008 Plan, the 2011 Plan and the 2017 Plan for the benefit of certain non-employee directors, officers, and key employees. Under these plans, a total of 3,350,000 shares of authorized common stock have been reserved for issuance pursuant to grants approved by the Compensation Committee. Stock options granted under these plans have a maximum term of 10 years, may be subject to certain vesting requirements, which are generally three to six years for officers, non-employee directors, and key employees, and are priced at the market value of the Company's common stock on the option's grant date. At December 31, 2023, there were a total of 165,196 shares of common stock remaining available for grant under the 2017 Plan.

Stock-based compensation is recognized as provided under FASB ASC Topic 718-10 and FASB ASC Topic 505-50. FASB ASC Topic 718-10 requires all share-based payments to employees, including grants of employee stock options, to be recognized as compensation expense over the requisite service period (generally the vesting period) in the Consolidated Financial Statements based on their grant date fair values. Stock-based compensation related to restricted stock is based on the number of shares expected to vest and the fair market value of the common stock on the grant date. The Company has applied the Black-Scholes valuation model in determining the grant date fair value of stock option awards. Compensation expense is recognized only for those awards expected to vest.

Long-term Incentive Program and Non-Employee Director Awards

On October 15, 2018, the Compensation Committee and Board approved and adopted a long-term incentive program that seeks to motivate and reward certain employees and to align management’s interest with shareholders’ interest by focusing executives on the achievement of long-term results. The program is comprised of four components: Service Options, Performance Options, Restricted Stock, and Performance Shares.

Pursuant to this program, in fiscal 2019, the Compensation Committee approved certain grants of Service Options, Performance Options, Restricted Stock and Performance Shares under the 2011 Plan and the 2017 Plan to certain employee directors, vice presidents of operations, vice presidents, senior vice presidents, and executive officers. Separately, the Compensation Committee approved certain grants of Service Options and Restricted Stock to certain of the Company’s non-employee directors.

Under the long-term incentive program, up to 100% of the shares of restricted stock subject to the Performance Shares will vest, if at all, based on the achievement of two trailing earnings per share performance targets established by the Compensation Committee that are based on earnings per share (measured at the end of each calendar quarter, commencing with the calendar quarter ending September 30, 2019) for the previous four calendar quarters. The Performance Shares are eligible to vest over the Performance Share Measurement Period, subject to each respective employee’s continued employment at the Company through the last day of the Performance Share Measurement Period (or as otherwise provided under the terms of the applicable award agreement or applicable employment agreement).

The Performance Share performance targets are set forth below.
Trailing 4-Quarter EPS Targets for
September 30, 2018 through March 31, 2025
Restricted Stock Eligible for Vesting
(Percentage of Award)
$16.3540%
$20.4560%

The Restricted Stock awards typically vest in six equal annual installments, beginning on the first anniversary of the grant date, subject to each respective employee’s continued employment at the Company through each applicable vesting date or otherwise provided under the terms of the applicable award agreement or applicable employment agreement.

The Service Options typically vest in three equal annual installments, beginning on the first anniversary of the grant date, subject to each respective employee’s continued employment at the Company through each applicable vesting date or otherwise provided under the terms of the applicable award agreement or applicable employment agreement. The option price is equal to the fair market value of the common stock on the grant date and the Service Options have a 10-year term.

The Performance Options will fully vest if the Company attains the trailing earnings per share target over four consecutive calendar quarters occurring between September 30, 2018 and March 31, 2025 described below. Such performance target was
26

established by the Compensation Committee and will be measured at the end of each calendar quarter commencing on September 30, 2019. The Performance Options are eligible to vest over the Option Measurement Period, subject to each respective employee’s continued employment at the Company through the last day of the Option Measurement Period or as otherwise provided under the terms of the applicable award agreement or applicable employment agreement. The option price is equal to the fair market value of the common stock on the grant date and the Performance Options have a 10-year term. The Performance Option performance target is set forth below.

Trailing 4-Quarter EPS Targets for
September 30, 2018 through March 31, 2025
Options Eligible for Vesting
(Percentage of Award)
$25.30100%

Stock Options

The weighted-average fair value at the grant date for options issued during the three months ended December 31, 2023 and 2022 was $68.52 and $44.23, respectively. The weighted-average fair value at the grant date for options issued during the nine months ended December 31, 2023 and 2022 was $69.00 and $53.51, respectively.

Fair value was estimated at grant date using the weighted-average assumptions listed below:
Three months ended December 31,Nine months ended December 31,
2023202220232022
Dividend yield%%%%
Expected volatility62.54%57.46%62.55%57.09%
Average risk-free rate4.70%3.91%4.69%3.59%
Expected life4.6 years5.8 years4.6 years5.8 years

The expected stock price volatility is based on the historical volatility of the Company's common stock for a period approximating the expected life. The expected life represents the period of time that options are expected to be outstanding after the grant date. The risk-free rate reflects the interest rate at grant date on zero coupon U.S. governmental bonds having a remaining life similar to the expected option term.

Option activity for the nine months ended December 31, 2023 was as follows:
 SharesWeighted Average Exercise
Price
Weighted Average
Remaining
Contractual Term
Aggregate Intrinsic Value
Options outstanding, beginning of period314,742 $104.41   
Granted during period2,598 124.67   
Exercised during period(22,847)88.34   
Forfeited during period(11,027)122.25   
Expired during period(2,682)162.17   
Options outstanding, end of period280,784  3$104.66 5.2 years$8,250,477 
Options exercisable, end of period128,057 $105.11 5.1 years$3,919,056 
 
The aggregate intrinsic value reflected in the table above represents the total pre-tax intrinsic value (the difference between the closing stock price on December 31, 2023 and the exercise price, multiplied by the number of in-the-money options that are currently exercisable) that would have been received by option holders had all option holders exercised their options as of December 31, 2023. This amount will change as the market price of the common stock changes. The total intrinsic value of options exercised during the periods ended December 31, 2023 and 2022 was as follows:
3 Of the 280,784 options outstanding, 43,862 are not yet exercisable based solely on fulfilling a service condition and another 108,865 are not yet exercisable based solely on fulfilling the performance condition described further above.
27

December 31,
2023
December 31,
2022
Three months ended$369,543 $51,106 
Nine months ended$810,853 $481,572 
 
As of December 31, 2023, total unrecognized stock-based compensation expense related to non-vested stock options amounted to approximately $0.6 million, which is expected to be recognized over a weighted-average period of approximately 1.3 years.

Restricted Stock

During the first nine months of fiscal 2024, the Company granted 3,993 shares of restricted stock (which are equity classified) to certain vice presidents and senior vice presidents with a grant date weighted average fair value of $120.12 per share.

During fiscal 2023, the Company granted 3,250 shares of restricted stock (which are equity classified) to certain vice presidents with a grant date weighted average fair value of $129.85 per share.

As of December 31, 2023, there was approximately $1.9 million of unrecognized compensation cost related to unvested restricted stock awards, which is expected to be recognized over the next 0.9 years based on current estimates.

A summary of the status of the Company’s restricted stock as of December 31, 2023, and changes during the nine months ended December 31, 2023, are presented below:
 SharesWeighted Average Fair Value at Grant Date
Outstanding at March 31, 2023460,614 $101.82 
Granted during the period3,993 120.12 
Vested during the period(62,983)103.85 
Forfeited during the period(13,047)116.56 
Outstanding at December 31, 2023388,577 $101.18 
 
Total Stock-Based Compensation

Total stock-based compensation included as a component of personnel expenses in the Company's Consolidated Statements of Operations during the three and nine month periods ended December 31, 2023 and 2022 was as follows:
Three months ended December 31,Nine months ended December 31,
2023202220232022
Stock-based compensation related to equity classified awards:
Stock-based compensation (reversal) related to stock options4$189,582 $425,120 $(3,871,348)$1,869,879 
Stock-based compensation (reversal) related to restricted stock, net of adjustments and exclusive of cancellations5(690,699)(679,443)1,475,151 5,512,434 
Total stock-based compensation (reversal) related to equity classified awards$(501,117)$(254,323)$(2,396,197)$7,382,313 

4 During the second quarter of fiscal 2024, it was determined that the Performance Option performance target is no longer probable of being achieved. In accordance with ASC 718, the Company reversed $4.9 million in previously recognized stock-based compensation related to these Performance Options during the second quarter of fiscal 2024.
5 The $(690,699) for the three months ended December 31, 2023 represents $1.4 million in forfeiture credit, offset by $0.7 million in current period expense. The $(679,443) for the three months ended December 31, 2022 represents $2.8 million in forfeiture credit, offset by $2.1 million in current period expense.
28


NOTE 8 – ACQUISITIONS

The Company evaluates each set of assets and activities it acquires to determine if the set meets the definition of a business according to FASB ASC Topic 805-10-55. Acquisitions meeting the definition of a business are accounted for as a business combination while all other acquisitions are accounted for as asset purchases.

The following table sets forth the Company's acquisition activity for the nine months ended December 31, 2023 and 2022:
 Nine months ended December 31,
20232022
Acquisitions:
Number of loan portfolios acquired through asset purchases 43 
Total acquisitions 43 
Purchase price$ $22,314,902 
Tangible assets: 
Loans receivable, net 27,105,078 
Purchase price amount below carrying value of net tangible assets6$ $(4,790,176)

Acquisitions that are accounted for as business combinations typically result in one or more new branches. In such cases, the Company typically retains the existing employees and the branch location from the acquisition. The purchase price is allocated to the tangible assets and intangible assets acquired based upon their estimated fair market values at the acquisition date. The remainder is allocated to goodwill.

Acquisitions that are accounted for as asset purchases are typically limited to acquisitions of loan portfolios. The purchase price is allocated to the tangible assets and intangible assets acquired based upon their estimated fair market values at the acquisition date. In an asset purchase, no goodwill is recorded.

The Company’s acquisitions include tangible assets (generally loans and furniture and equipment) and intangible assets (generally non-compete agreements, customer lists, and goodwill), both of which are recorded at their fair values, which are estimated pursuant to the processes described below.

Acquired loans are valued at the net loan balance. Given the short-term nature of these loans, generally less than twelve months, and that these loans are priced at current rates, management believes the net loan balances approximate their fair value. Under CECL, acquired loans are included in the reserve calculations for all loan types (excluding TALs). Management includes recent acquisition activity compared to historical activity when considering reasonable and supportable forecasts as it relates to assessing the adequacy of the allowance for expected credit losses. The Company did not acquire any loans that would qualify as PCDs during the nine months ended December 31, 2023 and 2022.

Furniture and equipment are valued at the specific purchase price as agreed to by both parties at the time of acquisition, which management believes approximates their fair values.

Non-compete agreements are valued at the stated amount paid to the other party for these agreements, which the Company believes approximates their fair values.

6 As a result of asset purchases during the first six months of fiscal 2023, the Company recorded a $4.8 million gain, net of $1.1 million income tax, which is included as a component of Insurance and other income, net in the Consolidated Statements of Operations. The transaction resulted in a gain as the acquired loan portfolios were purchased at a discount. As an immediate gain would be recognized on the net loans acquired if the cost below fair value was allocated, it was not determined appropriate to reduce the basis of the net loans acquired.
29

Customer lists are valued with a valuation model that utilizes the Company’s historical data to estimate the value of any acquired customer lists. Customer lists are allocated at a branch level and are evaluated for impairment at a branch level when a triggering event occurs in accordance with FASB ASC Topic 360-10-05. If a triggering event occurs, the impairment loss to the customer list is generally the remaining unamortized customer list balance. In most acquisitions, the original fair value of the customer list allocated to a branch is less than $100,000, and management believes that in the event a triggering event were to occur, the impairment loss to an unamortized customer list would be immaterial.

The estimated results of all acquisitions have been included in the Company’s Consolidated Financial Statements since the respective acquisition date. The pro forma impact of these branches as though they had been acquired at the beginning of the periods presented would not have a material effect on the results of operations as reported.

NOTE 9 – DEBT

Senior Notes Payable; Revolving Credit Facility

On November 9, 2023, the Company amended its revolving credit agreement ("Eleventh Amendment") to (i) permit the Company to repurchase up to $20 million of Company securities in its fiscal quarter ending December 31, 2023 and (ii) not require the minimum fixed charges coverage ratio to be at least 2.0 to 1.0 for the fiscal quarter ending September 30, 2023 in order to make such repurchases.

At December 31, 2023, the Company's senior notes payable consisted of a $580.0 million senior revolving credit facility, which has an accordion feature permitting the maximum aggregate commitments to increase to $730.0 million provided that certain conditions are met.

At December 31, 2023, $305.1 million was outstanding under the Company's credit facility, not including a $524.0 thousand outstanding standby letter of credit related to workers compensation under a $1.5 million sub-facility. To the extent that the letter of credit is drawn upon, the disbursement will be funded by the credit facility. There are no amounts due related to the letter of credit as of December 31, 2023. The letter of credit expires on December 31, 2024 and automatically extends for one year on the expiration date. Subject to a borrowing base formula, the Company may borrow at the rate of one month SOFR plus 0.10% and an applicable margin of 3.5% with a minimum rate of 4.5%. The revolving credit facility has a commitment fee of 0.50% per annum on the unused portion of the commitment. Commitment fees on the unused portion of the borrowing totaled $1.3 million and $0.9 million for the nine months ended December 31, 2023 and 2022, respectively.

For the nine months ended December 31, 2023 and fiscal year ended March 31, 2023, the Company’s effective interest rate, including the commitment fee and amortization of debt issuance costs, was 9.8% annualized and 7.0%, respectively. At December 31, 2023, the unused amount available under the revolving credit facility was $274.4 million and borrowings under the revolving credit facility mature on June 7, 2026.

Substantially all of the Company’s assets are pledged as collateral for borrowings under the revolving credit agreement.

Senior Unsecured Notes Payable

On September 27, 2021, we issued $300 million in aggregate principal amount of 7.0% senior notes due 2026. The Notes were sold in a private placement in reliance on Rule 144A and Regulation S under the Securities Act of 1933, as amended. The Notes are unconditionally guaranteed, jointly and severally, on a senior unsecured basis by all of the Company’s existing and certain of its future subsidiaries that guarantee the revolving credit facility. Interest on the Notes is payable semi-annually in arrears on May 1 and November 1 of each year, commencing May 1, 2022. At any time prior to November 1, 2023, the Company could have redeemed the Notes, in whole or in part, at a redemption price equal to 100% of the principal amount plus a make-whole premium, as described in the indenture, plus accrued and unpaid interest, if any, to, but not including, the date of redemption. At any time on or after November 1, 2023, the Company may redeem the Notes at redemption prices set forth in the indenture, plus accrued and unpaid interest, if any, to, but not including, the date of redemption. In addition, at any time prior to November 1, 2023, the Company could have used the proceeds of certain equity offerings to redeem up to 40.0% of the aggregate principal amount of the Notes issued under the indenture at a redemption price equal to 107.0% of the principal amount of Notes redeemed, plus accrued and unpaid interest, if any, to, but not including, the date of redemption.

We used the net proceeds from this offering to repay a portion of the outstanding indebtedness under our revolving credit facility and for general corporate purposes.

30

During the fourth quarter of fiscal 2023, the Company repurchased and extinguished $9.1 million of its Notes, net of $0.1 million unamortized debt issuance costs related to the extinguished debt, on the open market for a reacquisition price of $7.2 million.

During the first nine months of fiscal 2024, the Company repurchased and extinguished $8.25 million of its Notes, net of $88.1 thousand unamortized debt issuance costs related to the extinguished debt, on the open market for a reacquisition price of $7.0 million. For the three and nine months ended December 31, 2023, the Company recognized a $0.6 million and $1.2 million gain on extinguishment, respectively. In accordance with ASC 470, the Company recognized the gain on extinguishment as a component of interest expense in the Company's Consolidated Statements of Operations.

Debt Covenants

The agreement governing the Company’s revolving credit facility contains affirmative and negative covenants, including covenants that generally restrict the ability of the Company and its subsidiaries to, among other things, incur or guarantee indebtedness, incur liens, pay dividends and repurchase or redeem capital stock, dispose of assets, engage in mergers and consolidations, make acquisitions or other investments, redeem or prepay subordinated debt, amend subordinated debt documents, make changes in the nature of its business, and engage in transactions with affiliates. The agreement allows the Company to incur subordinated debt that matures after the termination date for the revolving credit facility and that contains specified subordination terms, subject to limitations on amount imposed by the financial covenants under the agreement. The agreement's financial covenants include (i) a minimum consolidated net worth of $325.0 million on and after December 31, 2020; (ii) a maximum ratio of total debt to consolidated adjusted net worth of 2.5 to 1.0 (decreasing to 2.25 to 1.0 for the fiscal quarters ending March 31, 2023 and June 30, 2023, 2.0 to 1.0 for the fiscal quarter ending September 30, 2023, and 2.25 to 1.0 for the fiscal quarter ending December 31, 2023); (iii) a maximum collateral performance indicator of 26% as of the end of each calendar month (increasing to 28% for the calendar months ending October 31, 2022 through June 30, 2023); and (iv) a minimum fixed charges coverage ratio of 1.25 to 1.0 for the fiscal quarter ended December 31, 2022, 1.15 to 1.0 for the fiscal quarters ending March 31, 2023 and June 30, 2023, 1.50 to 1.0 for the fiscal quarter ending September 30, 2023, 2.0 to 1.0 for the fiscal quarter ending December 31, 2023, and 2.25 to 1.0 for each fiscal quarter thereafter, where the ratio for the most recent four consecutive fiscal quarters must be at least 2.0 to 1.0, other than for the fiscal quarter ending September 30, 2023, in order for the Company to declare dividends or purchase any class or series of its capital stock or other equity.

The collateral performance indicator is equal to the sum of (a) a three-month rolling average rate of receivables at least sixty days past due and (b) an eight-month rolling average net charge-off rate.

The Company was in compliance with these covenants at December 31, 2023 and does not believe that these covenants will materially limit its business and expansion strategy.

The agreement contains events of default including, without limitation, nonpayment of principal, interest or other obligations, violation of covenants, misrepresentation, cross-default to other debt, bankruptcy and other insolvency events, judgments, certain ERISA events, actual or asserted invalidity of loan documentation, invalidity of subordination provisions of subordinated debt, certain changes of control of the Company, and the occurrence of certain regulatory events, (including the entry of any stay, order, judgment, ruling or similar event related to the Company’s or any of its subsidiaries’ originating, holding, pledging, collecting or enforcing its eligible loans receivable that is material to the Company or any subsidiary) which remains unvacated, undischarged, unbonded or unstayed by appeal or otherwise for a period of 60 days from the date of its entry and is reasonably likely to cause a material adverse change.

The indenture governing the Notes contains certain covenants that, among other things, limit the Company’s ability and the ability of its restricted subsidiaries to (i) incur additional indebtedness or issue certain disqualified stock and preferred stock; (ii) pay dividends or distributions or redeem or purchase capital stock; (iii) prepay subordinated debt or make certain investments; (iv) transfer and sell assets; (v) create or permit to exist liens; (vi) enter into agreements that restrict dividends, loans and other distributions from their subsidiaries; (vii) engage in a merger, consolidation or sell, transfer or otherwise dispose of all or substantially all of their assets; and (viii) engage in transactions with affiliates. However, these covenants are subject to a number of important detailed qualifications and exceptions.

Debt Maturities

31

The aggregate annual maturities of the Company's debt arrangements as of December 31, 2023 are as follows:

Amount
Remainder of 2024$ 
2025 
2026 
2027587,699,480 
2028 
Total future debt payments$587,699,480 

NOTE 10 – INCOME TAXES

As of December 31, 2023 and March 31, 2023, the Company had $1.0 million and $1.1 million, respectively, of total gross unrecognized tax benefits including interest. Approximately $0.8 million and $0.9 million, respectively, represent the amount of net unrecognized tax benefits that are permanent in nature and, if recognized, would affect the annual effective tax rate. At December 31, 2023, approximately $0.4 million of gross unrecognized tax benefits are expected to be resolved during the next twelve months through the expiration of the statute of limitations and settlement with taxing authorities. The Company’s continuing practice is to recognize interest and penalties related to income tax matters in income tax expense. The Company had approximately $296.8 thousand accrued for gross interest as of December 31, 2023, and accrued $3.9 thousand during the nine months ended December 31, 2023.

Investment in HTC was $19.4 million and $23.0 million as of December 31, 2023 and March 31, 2023, respectively, which is included as a component of Other assets, net in the Consolidated Balance Sheets. The Company recognized net amortization from these investments of $1.2 million and $0.4 million during the three months ended December 31, 2023 and 2022, respectively, and $3.2 million and $1.7 million during the nine months ended December 31, 2023 and 2022, respectively, in income tax expense. The Company recognized tax benefits from these investments of $1.2 million and $0.5 million during the three months ended December 31, 2023 and 2022, respectively, and $3.6 million and $1.5 million during the nine months ended December 31, 2023 and 2022, respectively, in income tax expense and in Income taxes payable in the Consolidated Statements of Cash Flows. The Company did not recognize any non-tax related activity or have any significant modifications in the investments during the current period.
 
The Company is subject to U.S. income taxes, as well as taxes in various other state and local jurisdictions. With the exception of a few states, the Company is no longer subject to U.S. federal, state and local, or non-U.S. income tax examinations by tax authorities for years before 2019, although carryforward attributes that were generated prior to 2019 may still be adjusted upon examination by the taxing authorities if they either have been or will be used in a future period.

NOTE 11 – COMMITMENTS AND CONTINGENCIES

General

From time to time the Company is involved in litigation matters relating to claims arising out of its operations in the normal course of business.

Estimating an amount or range of possible losses resulting from litigation, government actions and other legal proceedings is inherently difficult and requires an extensive degree of judgment, particularly where the matters involve indeterminate claims for monetary damages, may involve fines, penalties or damages that are discretionary in amount, involve a large number of claimants or significant discretion by regulatory authorities, represent a change in regulatory policy or interpretation, present novel legal theories, are in the early stages of the proceedings, are subject to appeal or could result in a change in business practices. In addition, because most legal proceedings are resolved over extended periods of time, potential losses are subject to change due to, among other things, new developments, changes in legal strategy, the outcome of intermediate procedural and substantive rulings and other parties’ settlement posture and their evaluation of the strength or weakness of their case against us. However, in light of the inherent uncertainties involved, an adverse outcome in one or more of these matters could materially and adversely affect the Company’s financial condition, results of operations or cash flows in any particular reporting period.

NOTE 12 – SUBSEQUENT EVENTS

32

Management is not aware of any significant events occurring subsequent to the balance sheet date that would have a material effect on the financial statements thereby requiring adjustment or disclosure.
33

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

Cautionary Note Regarding Forward-Looking Information

This report on Form 10-Q, including "Management’s Discussion and Analysis of Financial Condition and Results of Operations," contains various "forward-looking statements," within the meaning of The Private Securities Litigation Reform Act of 1995, that are based on management’s beliefs and assumptions, as well as information currently available to management. Statements other than those of historical fact, including those identified by words such as “anticipate,” “estimate,” “intend,” “plan,” “expect,” "project," “believe,” “may,” “will,” “should,” "would," "could," "continue," "probable," "forecast," and any variation of the foregoing and similar expressions, are forward-looking statements. Although the Company believes that the expectations reflected in any such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to be correct. Any such statements are subject to certain risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company’s actual financial results, performance or financial condition may vary materially from those anticipated, estimated or expected. Therefore, you should not rely on any of these forward-looking statements.

Among the key factors that could cause our actual financial results, performance or condition to differ from the expectations expressed or implied in such forward-looking statements are the following: recently enacted, proposed or future legislation and the manner in which it is implemented; changes in the U.S. tax code; the nature and scope of regulatory authority, particularly discretionary authority, that is or may be exercised by regulators, including, but not limited to, the U.S. Consumer Financial Protection Bureau, and individual state regulators having jurisdiction over the Company; the unpredictable nature of regulatory proceedings and litigation; employee misconduct or misconduct by third parties; uncertainties associated with management turnover and the effective succession of senior management; media and public characterization of consumer installment loans; labor unrest; the impact of changes in accounting rules and regulations, or their interpretation or application, which could materially and adversely affect the Company’s reported consolidated financial statements or necessitate material delays or changes in the issuance of the Company’s audited consolidated financial statements; the Company's assessment of its internal control over financial reporting; changes in interest rates; the impact of inflation; risks relating to the acquisition or sale of assets or businesses or other strategic initiatives, including increased loan delinquencies or net charge-offs, the loss of key personnel, integration or migration issues, the failure to achieve anticipated synergies, increased costs of servicing, incomplete records, and retention of customers; risks inherent in making loans, including repayment risks and value of collateral; cybersecurity threats or incidents, including the potential or actual misappropriation of assets or sensitive information, corruption of data or operational disruption and the costs of the associated response thereto; our dependence on debt and the potential impact of limitations in the Company’s amended revolving credit facility or other impacts on the Company's ability to borrow money on favorable terms, or at all; the timing and amount of revenues that may be recognized by the Company; changes in current revenue and expense trends (including trends affecting delinquency and charge-offs); the impact of extreme weather events and natural disasters; changes in the Company’s markets and general changes in the economy (particularly in the markets served by the Company).

These and other risks are discussed in more detail in Part I, Item 1A “Risk Factors” in the Company's most recent annual report on Form 10-K for the fiscal year ended March 31, 2023 filed with the SEC, and in the Company’s other reports filed with, or furnished to, the SEC from time to time. The Company does not undertake any obligation to update any forward-looking statements it may make, except to the extent required by law.

Results of Operations

The following table sets forth certain information derived from the Company's Consolidated Statements of Operations and Consolidated Balance Sheets (unaudited), as well as operating data and ratios, for the periods indicated:
34

Three months ended December 31,Nine months ended December 31,
 2023202220232022
 (Dollars in thousands)
Gross loans receivable$1,400,622 $1,553,985 $1,400,622 $1,553,985 
Average gross loans receivable (1)
1,383,194 1,562,199 1,388,752 1,585,306 
Net loans receivable (2)
1,028,311 1,122,687 1,028,311 1,122,687 
Average net loans receivable (3)
1,014,113 1,131,636 1,015,237 1,153,443 
Expenses as a percentage of total revenue:
Provision for credit losses29.5 %40.7 %30.8 %47.0 %
General and administrative47.8 %44.3 %47.6 %45.3 %
Interest expense8.5 %9.6 %8.8 %8.4 %
Operating income as a % of total revenue (4)
22.7 %15.0 %21.6 %7.8 %
Loan volume (5)
744,193 787,775 2,133,642 2,476,631 
Net charge-offs as percent of average net loans receivable on an annualized basis19.1 %25.1 %17.4 %23.6 %
Return on average assets (trailing 12 months)6.0 %1.2 %6.0 %1.2 %
Return on average equity (trailing 12 months)17.3 %4.1 %17.3 %4.1 %
Branches opened or acquired (merged or closed), net(1)(20)(21)(83)
Branches open (at period end)1,052 1,084 1,052 1,084 
_______________________________________________________
(1) Average gross loans receivable has been determined by averaging month-end gross loans receivable over the indicated period, excluding tax advances.
(2) Net loans receivable is defined as gross loans receivable less unearned interest and deferred fees.
(3) Average net loans receivable has been determined by averaging month-end gross loans receivable less unearned interest and deferred fees over the indicated period, excluding tax advances.
(4) Operating income is computed as total revenue less provision for credit losses and general and administrative expenses.
(5) Loan volume includes all loan balances originated by the Company. It does not include loans purchased through acquisitions.

Comparison of three months ended December 31, 2023 versus three months ended December 31, 2022

Gross loans outstanding decreased to $1.40 billion as of December 31, 2023, a 9.9% decrease from the $1.55 billion of gross loans outstanding as of December 31, 2022. During the most recent quarter, gross loans outstanding increased sequentially 1.5%, or $21.1 million, from $1.38 billion as of September 30, 2023, compared to a decrease of 2.8%, or $44.4 million, in the comparable quarter of the prior year. Additionally, we saw an increase in borrowing from new, former, and refinance customers compared to the same quarter of fiscal 2023 as we took incremental steps to ease the historically stringent underwriting standards implemented in prior quarters. We also continued to improve the gross yield to expected loss ratio for all new, former, and refinance customer originations. During the three months ended December 31, 2023 our unique borrowers increased by 2.4% compared to a decrease of 4.9% during the three months ended December 31, 2022.

Net income for the three months ended December 31, 2023 increased to $16.7 million, a 187.1% increase from net income of $5.8 million for the same period of the prior year. Operating income, which is revenue less provision for credit losses and general and administrative expenses, increased by $9.2 million, or 42.0%, compared to the same period of the prior fiscal year.

35

Revenues for the three months ended December 31, 2023 decreased by $8.8 million, or 6.0%, to $137.7 million from $146.5 million for the same period of the prior year. Interest and fee income for the three months ended December 31, 2023 decreased by $7.5 million, or 6.0%, from the same period of the prior year due to a decrease in loans outstanding. The large loan portfolio decreased from 56.4% of the overall portfolio as of December 31, 2022, to 55.2% as of December 31, 2023.

Insurance and other income for the three months ended December 31, 2023 decreased by $1.2 million, or 6.1%, from the same period of the prior year. Insurance income decreased by approximately $2.7 million, or 15.9%, during the three months ended December 31, 2023 when compared to the three months ended December 31, 2022. Insurance commissions decreased primarily due to a decrease in loans where our insurance products are available to our customer. Other income increased by $1.5 million.

The provision for credit losses decreased $19.0 million, or 31.8%, to $40.6 million from $59.6 million when comparing the third quarter of fiscal 2024 to the third quarter of fiscal 2023. The table below itemizes the key components of the CECL allowance and provision impact during the quarter.

CECL Allowance and Provision (Dollars in millions)FY 2024FY 2023DifferenceReconciliation
Beginning Allowance - September 30$128.9$155.9$(27.0)
Change due to Growth$2.0$(4.3)$6.3$6.3
Change due to Expected Loss Rate on Performing Loans$(10.0)$(7.5)$(2.5)$(2.5)
Change due to 90 day past due$0.2$0.4$(0.2)$(0.2)
Ending Allowance - December 31$121.1$144.5$(23.4)$3.6
Net Charge-offs$48.4$71.0$(22.6)$(22.6)
Provision$40.6$59.6$(19.0)$(19.0)
Note: The change in allowance for the quarter plus net charge-offs for the quarter equals the provision for the quarter (see above reconciliation).
The provision benefited from substantially lower charge-offs and smaller increases in loans 90 days past due.

Net charge-offs for the quarter decreased 22.6 million, from $71.0 million in the third quarter of fiscal 2023 to $48.4 million in the third quarter of fiscal 2024. Net charge-offs as a percentage of average net loan receivables on an annualized basis decreased from 25.1% in the third quarter of fiscal 2023 to 19.1% in the third quarter of fiscal 2024. Net charge-offs during the period include $3.7 million in proceeds related to the sale of charge-offs, for which $0.8 million relates to bulk sales of charge-offs from prior periods and $2.9 million relates to recurring sales of charge-offs.

The Company's allowance for credit losses as a percentage of net loans was 11.8% at December 31, 2023 compared to 12.9% at December 31, 2022. Accounts that were 61 days or more past due on a recency basis were 5.8% of the portfolio at December 31, 2023 and 7.4% of the portfolio at December 31, 2022.

We experienced significant improvement in recency delinquency on accounts at least 90 days past due, improving from 4.9% at December 31, 2022, to 3.7% at December 31, 2023.

G&A expenses for the three months ended December 31, 2023 increased by $1.0 million, or 1.5%, from the corresponding period of the previous year. As a percentage of revenues, G&A expenses increased from 44.3% during the three months ended December 31, 2022 to 47.8% during the three months ended December 31, 2023. G&A expenses per average open branch increased by 5.4% when comparing the two three-month periods. The change in G&A expense is explained in greater detail below.

Personnel expense totaled $39.9 million for the three months ended December 31, 2023, a $0.8 million, or 2.0%, decrease over the three months ended December 31, 2022. Benefit expense increased approximately $0.6 million, or 8.1%, when comparing the quarterly periods ended December 31, 2023 and 2022. Incentive expense decreased $1.0 million, or 24.5%. Salary expense totaled $32.0 million staying relatively flat, when comparing the two quarterly periods ended December 31, 2023 and 2022. The decrease in incentive expense is mostly due to a decrease in bonuses paid.

Occupancy and equipment expense totaled $12.1 million for the three months ended December 31, 2023, a $0.8 million, or 6.5%, decrease over the three months ended December 31, 2022. Occupancy and equipment expense is generally a function of the number of branches the Company has open throughout the period. The prior year's third quarter includes $0.4 million in expense related to the merger of branches during the quarter. For the three months
36

ended December 31, 2023, the average open branches decreased 3.8% compared to the three months ended December 31, 2022.

Advertising expense increased $2.4 million, or 181.1%, in the third quarter of fiscal 2024 compared to the third quarter of fiscal 2023 due to increased spending on customer acquisition programs.

Amortization of intangible assets totaled $1.1 million for the three months ended December 31, 2023, a $63.6 thousand, or 5.7%, decrease over the three months ended December 31, 2022.

Other expense totaled $9.2 million for the three months ended December 31, 2023, a $0.3 million, or 3.1%, increase over the three months ended December 31, 2022.
Interest expense for the three months ended December 31, 2023 decreased by $2.4 million, or 16.9%, from the corresponding three months of the previous year. The decrease in interest expense was due to a 22.8% decrease in the average debt outstanding from $734.3 million to $567.1 million partially offset by a 12.5% increase in the effective interest rate from 7.6% to 8.6%. The Company’s debt-to-equity ratio decreased from 2.0:1 at December 31, 2022 to 1.4:1 at December 31, 2023. The Company repurchased and extinguished $4.75 million of its Notes, net of $48.0 thousand unamortized debt issuance costs related to the extinguished debt, on the open market for a reacquisition price of $4.1 million.

Other key return ratios for the three months ended December 31, 2023 included a 6.0% return on average assets and a return on average equity of 17.3% (both on a trailing 12-month basis), as compared to a 1.2% return on average assets and a return on average equity of 4.1% (both on a trailing 12-month basis) for the three months ended December 31, 2022.

The Company’s effective income tax rate decreased to 14.6% for the three months ended December 31, 2023 compared to 26.5% for the corresponding period of the previous year. The decrease is primarily due to the permanent tax benefit related to non-qualified stock option exercises and vesting of restricted stock along with provision to return adjustments as discrete items in the current quarter.

Comparison of nine months ended December 31, 2023 versus nine months ended December 31, 2022

Gross loans outstanding decreased to $1.40 billion as of December 31, 2023, a 9.9% decrease from the $1.55 billion of gross loans outstanding as of December 31, 2022. During the twelve months ended December 31, 2023 our number of unique borrowers in the portfolio decreased by 2.4% compared to a decrease of 13.7% during the twelve months ended December 31, 2022.

Net income for the nine months ended December 31, 2023 increased to $42.3 million from the $3.4 million loss reported for the same period of the prior year. Operating income (revenue less provision for credit losses and general and administrative expenses) increased by $53.9 million, or 152.4%.

Revenues decreased by $41.8 million, or 9.2%, to $413.9 million during the nine months ended December 31, 2023 from $455.7 million for the same period of the prior year. The decrease was primarily due to a decrease in average net loans outstanding.

Interest and fee income for the nine months ended December 31, 2023 decreased by $34.6 million, or 9.0%, from the same period of the prior year. Net loans outstanding at December 31, 2023 decreased by 8.4% over the balance at December 31, 2022. Average net loans outstanding decreased by 12.0% for the nine months ended December 31, 2023 compared to the nine-month period ended December 31, 2022.

37

Insurance commissions and other income for the nine months ended December 31, 2023 decreased by $7.1 million, or 10.4%, from the same period of the prior year. Insurance commissions decreased by approximately $5.1 million, or 9.9%, during the nine months ended December 31, 2023 when compared to the nine months ended December 31, 2022. Other income decreased by $2.1 million. Sales of our motor club product decreased by $1.5 million as sales opportunities decreased with lower originations.

The provision for credit losses decreased $86.4 million, or 40.3%, to $127.7 million from $214.1 million when comparing the first three quarters of fiscal 2024 to the first three quarters of fiscal 2023. This decrease was primarily driven by a $71.6 million decrease in net charge-offs. Net charge-offs as a percentage of average net loans receivable on an annualized basis decreased from 23.6% in the first three quarters of fiscal 2023 to 17.4% in the first three quarters of fiscal 2024. Net charge-offs during the period include $16.2 million in proceeds related to the sales of charge-offs, for which $5.7 million relates to bulk sales of charge-offs from prior periods and $10.5 million relates to recurring sales of charge-offs.

G&A expenses for the nine months ended December 31, 2023 decreased by $9.3 million, or 4.5%, from the corresponding period of the previous year. As a percentage of revenues, G&A expenses increased from 45.3% during the first nine months of fiscal 2023 to 47.6% during the first nine months of fiscal 2024. G&A expenses per average open branch increased by 1.8% when comparing the two nine-month periods. The change in G&A expense is explained in greater detail below.

Personnel expense totaled $120.1 million for the nine months ended December 31, 2023, a $11.1 million, or 8.4%, decrease over the nine months ended December 31, 2022. Salary expense increased approximately $0.4 million, or 0.4%, when comparing the two nine month periods ended December 31, 2023 and 2022. Our headcount as of December 31, 2023, decreased 6.9% compared to December 31, 2022. Benefit expense increased approximately $0.1 million, or 0.4%, when comparing the nine month periods ended December 31, 2023 and 2022. Incentive expense decreased $11.7 million, or 53.9%, mostly due to the reversal of the expense associated with the Performance Option performance target, and a decrease in stock-based compensation expense.

Occupancy and equipment expense totaled $37.1 million for the nine months ended December 31, 2023, a $2.5 million, or 6.4%, decrease over the nine months ended December 31, 2022. Occupancy and equipment expense is generally a function of the number of branches the Company has open throughout the period. For the nine months ended December 31, 2023, the average occupancy and equipment expense per branch totaled $35.2 thousand, staying relatively flat when compared to the nine months ended December 31, 2022. The prior year period includes $1.5 million in expense related to the merger of branches during the period.

Advertising expense totaled $8.7 million for the nine months ended December 31, 2023, a $4.2 million, or 91.8%, increase over the nine months ended December 31, 2022 due to increased spending on customer acquisition programs.

Amortization of intangible assets totaled $3.2 million for the nine months ended December 31, 2023, a $0.2 million, or 5.1%, decrease over the nine months ended December 31, 2022.

Other expense totaled $27.8 million for the nine months ended December 31, 2023, a $0.3 million, or 0.9% increase over the nine months ended December 31, 2022.
Interest expense for the nine months ended December 31, 2023 decreased by $1.8 million, or 4.7%, from the corresponding nine months of the previous year. The decrease in interest expense was due to a 22.3% decrease in the average debt outstanding, from $747.4 million to $581.0 million, partially offset by a 26.5% increase in the effective interest rate from 6.8% to 8.6%. The Company repurchased and extinguished $8.25 million of its Notes, net of $88.1 thousand unamortized debt issuance costs related to the extinguished debt, on the open market for a reacquisition price of $7.0 million.

Other key return ratios for the first nine months of fiscal 2024 included a 6.0% return on average assets and a return on average equity of 17.3% (both on a trailing 12-month basis), as compared to a 1.2% return on average assets and a return on average equity of 4.1% (both on a trailing 12-month basis) for the first nine months of fiscal 2023.

The Company’s effective income tax rate increased to 19.9% for the nine months ended December 31, 2023 compared to (16.6)% for the corresponding period of the previous year. The difference is primarily due to the tax benefit related to the bargain purchase recorded as a discrete item in the prior year. This was partially offset by the permanent tax benefit related to non-qualified stock option exercises and vesting of restricted stock along with provision to return adjustments as discrete items in the current year.

38

Regulatory Matters

CFPB Rulemaking Initiatives

On October 5, 2017, the CFPB issued a final rule (the "Rule") imposing limitations on (i) short-term consumer loans, (ii) longer-term consumer installment loans with balloon payments, and (iii) higher-rate consumer installment loans repayable by a payment authorization. The Rule originally required lenders originating short-term loans and longer-term balloon payment loans to evaluate whether each consumer has the ability to repay the loan along with current obligations and expenses (“ability to repay requirements”); however, the ability to repay requirements were rescinded in July 2020. The Rule also curtails repeated unsuccessful attempts to debit consumers’ accounts for short-term loans, balloon payment loans, and installment loans that involve a payment authorization and an annual percentage rate over 36% (“payment requirements”). However, on October 19, 2022, a three-judge panel of the Fifth Circuit Court of Appeals held in Cmty. Fin.l Servs. Ass’n of Am., Ltd. v. Consumer Fin. Prot. Bureau, ruled that the CFPB’s funding structure violated the U.S. Constitution’s Appropriations Clause, which requires that all expenditures of federal funds be approved by Congress. On this ground, it vacated the Rule. The decision will be binding in the Fifth Circuit’s jurisdiction, covering Louisiana, Texas and Mississippi, and persuasive in other circuits until there’s a competing case to contradict it. The CFPB has filed a certiorari petition asking the U.S. Supreme Court to review the Fifth Circuit’s panel decision. The Supreme Court heard oral arguments on October 3, 2023 and it is possible that a decision may not be issued until the end of the Court’s term in June 2024. Implementation of the Rule’s payment requirements is uncertain, but if it were to take effect it could require changes to the Company’s practices and procedures for such loans, which could materially and adversely affect the Company’s ability to make such loans, the cost of making such loans, the Company’s ability to, or frequency with which it could, refinance any such loans, and the profitability of such loans.

Unless rescinded or otherwise amended, the Company will have to comply with the Rule’s payment requirements if it continues to allow consumers to set up future recurring payments online for certain covered loans such that it meets the definition of having a “leveraged payment mechanism” under the Rule. If the payment provisions of the Rule apply, the Company will have to modify its loan payment procedures to comply with the required notices and mandated timeframes set forth in the final rule.

In its Fall 2015 rulemaking agenda, the CFPB stated that it expected to conduct a rulemaking to identify larger participants in the installment lending market for purposes of its supervision program. However, this initiative was classified as “inactive” on the CFPB’s Spring 2018 rulemaking, and its Fall 2023 rulemaking agenda showed no planned activity in this area. Though the likelihood and timing of any such rulemaking is uncertain, the Company believes that the implementation of such rules would likely bring the Company’s business under the CFPB’s supervisory authority which, among other things, would subject the Company to reporting obligations to, and on-site compliance examinations by, the CFPB. While the CFPB has not yet initiated rulemaking for defining larger participants in the installment lending market, its Fall 2023 rulemaking agenda indicates that the CFPB is considering rules to define larger participants in markets for consumer payments, suggesting that the CFPB has renewed its focus on further identifying larger participants for purposes of its supervision program. Even in the absence of a larger participant rule, the CFPB has the power to order individual nonbank financial institutions to submit to supervision where the CFPB has reasonable cause to determine that the institution is engaged in “conduct that poses risks to consumers” under 12 USC 5514(a)(1)(C). On April 25, 2022, the CFPB announced that it has begun using this “dormant authority” to examine nonbank entities that pose risks to consumers. The CFPB has determined under its dormant authority that the Company is subject to its supervisory authority, and therefore is subject to reporting obligations to, and on-site examinations by, the CFPB. In light of this, we expect a supervisory review by the CFPB in the near future.

See Part I, Item 1, “Business - Government Regulation - Federal legislation,” for a further discussion of these matters and the federal regulations to which the Company’s operations are subject and Part I, Item 1A, “Risk Factors,” in the Company’s Form 10-K for the year ended March 31, 2023 for more information regarding these regulatory and related risks.

Liquidity and Capital Resources

The Company has historically financed and continues to finance its operations, acquisitions and branch expansion primarily through a combination of cash flows from operations and borrowings from its institutional lenders. As discussed below, the Company has also issued debt securities to finance its operations and repay a portion of its outstanding indebtedness. The Company has generally applied its cash flows from operations to fund its loan volume, fund acquisitions, repay long-term indebtedness, and repurchase its common stock. Net cash provided by operating activities for the nine months ended December 31, 2023 was $182.0 million.

The Company believes that attractive opportunities to acquire new branches or receivables from its competitors or to acquire branches in communities not currently served by the Company will continue to become available as conditions in local economies and the financial circumstances of owners change.

39

On September 27, 2021, we issued a $300 million in aggregate principal amount of 7.0% senior notes due 2026. The Notes were sold in a private placement in reliance on Rule 144A and Regulation S under the Securities Act of 1933, as amended. The Notes are unconditionally guaranteed, jointly and severally, on a senior unsecured basis by all of the Company’s existing and certain of its future subsidiaries that guarantee the revolving credit facility. Interest on the Notes is payable semi-annually in arrears on May 1 and November 1 of each year, commencing May 1, 2022. At any time prior to November 1, 2023, the Company could have redeemed the Notes, in whole or in part, at a redemption price equal to 100% of the principal amount plus a make-whole premium, as described in the indenture, plus accrued and unpaid interest, if any, to, but not including, the date of redemption. At any time on or after November 1, 2023, the Company may redeem the Notes at redemption prices set forth in the indenture, plus accrued and unpaid interest, if any, to, but not including, the date of redemption. In addition, at any time prior to November 1, 2023, the Company could have used the proceeds of certain equity offerings to redeem up to 40% of the aggregate principal amount of the Notes issued under the indenture at a redemption price equal to 107.0% of the principal amount of Notes redeemed, plus accrued and unpaid interest, if any, to, but not including, the date of redemption.

We used the net proceeds from this offering to repay a portion of the outstanding indebtedness under our revolving credit facility and for general corporate purposes.

During the fourth quarter of fiscal 2023, the Company repurchased and extinguished $9.1 million of its Notes, net of $0.1 million unamortized debt issuance costs related to the extinguished debt, on the open market for a reacquisition price of $7.2 million.

During the first nine months of fiscal 2024, the Company repurchased and extinguished $8.25 million of its Notes, net of $88.1 thousand unamortized debt issuance costs related to the extinguished debt, on the open market for a reacquisition price of $7.0 million. For the three and nine months ended December 31, 2023, the Company recognized a $0.6 million and $1.2 million gain on extinguishment, respectively. In accordance with ASC 470, the Company recognized the gain on extinguishment as a component of interest expense in the Company's Consolidated Statements of Operations.

The indenture governing the Notes contains certain covenants that, among other things, limit the Company’s ability and the ability of its restricted subsidiaries to (i) incur additional indebtedness or issue certain disqualified stock and preferred stock; (ii) pay dividends or distributions or redeem or purchase capital stock; (iii) prepay subordinated debt or make certain investments; (iv) transfer and sell assets; (v) create or permit to exist liens; (vi) enter into agreements that restrict dividends, loans and other distributions from their subsidiaries; (vii) engage in a merger, consolidation or sell, transfer or otherwise dispose of all or substantially all of their assets; and (viii) engage in transactions with affiliates. However, these covenants are subject to a number of important detailed qualifications and exceptions.

The Company continues to believe stock repurchases are a viable component of the Company’s long-term financial strategy and an excellent use of excess cash when the opportunity arises. However, our revolving credit facility and the Notes limit share repurchases to up to 50% of consolidated adjusted net income for the period commencing January 1, 2019. As of December 31, 2023, subject to further approval from our Board of Directors, we could repurchase approximately $33.2 million of shares under the terms of our debt facilities. Additional share repurchases can be made subject to compliance with, among other things, applicable restricted payment covenants under the revolving credit facility and the Notes.

The Company has a revolving credit facility with a syndicate of banks. The revolving credit facility provides for revolving borrowings of up to the lesser of (a) the aggregate commitments under the facility and (b) a borrowing base, and it includes a $524.0 thousand letter of credit under a $1.5 million subfacility.

Subject to a borrowing base formula, the Company may borrow at the rate of one month SOFR plus 0.10% and an applicable margin of 3.5% with a minimum rate of 4.5%. At December 31, 2023, the aggregate commitments under the revolving credit facility were $580.0 million. The $524.0 thousand letter of credit outstanding under the subfacility expires on December 31, 2024 and automatically extends for one year on the expiration date. The borrowing base limitation is equal to the product of (a) the Company’s eligible finance receivables, less unearned finance charges, insurance premiums and insurance commissions applicable to such eligible finance receivables, and (b) an advance rate percentage that ranges from 70% to 80% based on a collateral performance indicator, as more completely described below. Further, under the amended and restated revolving credit agreement, the administrative agent has the right to set aside reasonable reserves against the available borrowing base in such amounts as it may deem appropriate, including, without limitation, reserves with respect to certain regulatory events or any increased operational, legal, or regulatory risk of the Company and its subsidiaries.

For the nine months ended December 31, 2023 and fiscal year ended March 31, 2023, the Company’s effective interest rate, including the commitment fee and amortization of debt issuance costs, as it relates to the revolving credit facility was 9.8% annualized and 7.0%, respectively. At December 31, 2023, the unused amount available under the revolving credit facility was $274.4 million and borrowings under the revolving credit facility mature on June 7, 2026.
40


The Company’s obligations under the revolving credit facility, together with treasury management and hedging obligations owing to any lender under the revolving credit facility or any affiliate of any such lender, are required to be guaranteed by each of the Company’s wholly-owned domestic subsidiaries. The obligations of the Company and the subsidiary guarantors under the revolving credit facility, together with such treasury management and hedging obligations, are secured by a first-priority security interest in substantially all assets of the Company and the subsidiary guarantors.

The agreement governing the Company’s revolving credit facility contains affirmative and negative covenants, including covenants that restrict the ability of the Company and its subsidiaries to, among other things, incur or guarantee indebtedness, incur liens, pay dividends and repurchase or redeem capital stock, dispose of assets, engage in mergers and consolidations, make acquisitions or other investments, redeem or prepay subordinated debt, amend subordinated debt documents, make changes in the nature of its business, and engage in transactions with affiliates. The agreement allows the Company to incur subordinated debt that matures after the termination date for the revolving credit facility and that contains specified subordination terms, subject to limitations on amount imposed by the financial covenants under the agreement. The agreement's financial covenants include (i) a minimum consolidated net worth of $325 million on and after December 31, 2020; (ii) a maximum ratio of total debt to consolidated adjusted net worth of 2.5 to 1.0 (decreasing to 2.25 to 1.0 for the fiscal quarters ending March 31, 2023 and June 30, 2023, 2.0 to 1.0 for the fiscal quarter ending September 30, 2023, and 2.25 to 1.0 for the fiscal quarter ending December 31, 2023); (iii) a maximum collateral performance indicator of 26.0% as of the end of each calendar month (increasing to 28.0% for the calendar months ending October 31, 2022 through June 30, 2023); and (iv) a minimum fixed charges coverage ratio of 1.25 to 1.0 for the fiscal quarter ended December 31, 2022, 1.15 to 1.0 for the fiscal quarters ending March 31, 2023 and June 30, 2023, 1.50 to 1.0 for the fiscal quarter ending September 30, 2023, 2.0 to 1.0 for the fiscal quarter ending December 31, 2023, and 2.25 to 1.0 for each fiscal quarter thereafter, where the ratio for the most recent four consecutive fiscal quarters must be at least 2.0 to 1.0, other than for the fiscal quarter ending September 30, 2023, in order for the Company to declare dividends or purchase any class or series of its capital stock or other equity.

The collateral performance indicator is equal to the sum of (a) a three-month rolling average rate of receivables at least sixty days past due and (b) an eight-month rolling average net charge-off rate.

The Company was in compliance with these covenants at December 31, 2023 and does not believe that these covenants will materially limit its business and expansion strategy.

The agreement contains events of default including, without limitation, nonpayment of principal, interest or other obligations, violation of covenants, misrepresentation, cross-default to other debt, bankruptcy and other insolvency events, judgments, certain ERISA events, actual or asserted invalidity of loan documentation, invalidity of subordination provisions of subordinated debt, certain changes of control of the Company, and the occurrence of certain regulatory events, (including the entry of any stay, order, judgment, ruling or similar event related to the Company’s or any of its subsidiaries’ originating, holding, pledging, collecting or enforcing its eligible loans receivable that is material to the Company or any subsidiary) which remains unvacated, undischarged, unbonded or unstayed by appeal or otherwise for a period of 60 days from the date of its entry and is reasonably likely to cause a material adverse change.

As of December 31, 2023, the Company's debt outstanding was $585.0 million, net of $2.7 million unamortized debt issuance costs related to the unsecured senior notes payable, and its shareholders' equity was $407.0 million resulting in a debt-to-equity ratio of 1.4:1.0. Management will continue to monitor the Company's debt-to-equity ratio and is committed to maintaining a debt level that will allow the Company to continue to execute its business objectives, while not putting undue stress on its consolidated balance sheet.

The Company believes that cash flow from operations and borrowings under its revolving credit facility or other sources will be adequate to fund the expected cost of opening or acquiring new branches, including funding initial operating losses of new branches and funding loans receivable originated by those branches and the Company's other branches (for the next 12 months and for the foreseeable future beyond that). Except as otherwise discussed in this report including, but not limited to, any discussions in Part 1, Item 1A, "Risk Factors" in this Quarterly Report on Form 10-Q and our Annual Report on Form 10-K (as supplemented by any subsequent disclosures in information the Company files with or furnishes to the SEC from time to time), management is not currently aware of any trends, demands, commitments, events or uncertainties that it believes will or could result in, or are or could be reasonably likely to result in, any material adverse effect on the Company’s liquidity.

41

Share Repurchase Program

On November 9, 2023, the Board of Directors authorized the Company to repurchase up to $20.0 million of the Company’s outstanding common stock, inclusive of the amount that remained available for repurchase under prior repurchase authorizations. As of December 31, 2023, the Company had $2.8 million in aggregate remaining repurchase capacity under its current share repurchase program. The timing and actual number of shares repurchased will depend on a variety of factors, including the stock price, corporate and regulatory requirements, available funds, alternative uses of capital, restrictions under the revolving credit agreement, and other market and economic conditions. The Company’s stock repurchase program may be suspended or discontinued at any time.

The Company continues to believe stock repurchases are a viable component of the Company’s long-term financial strategy and an excellent use of excess cash when the opportunity arises. Additional share repurchases can be made subject to compliance with, among other things, applicable restricted payment covenants under the revolving credit facility and the Notes. Our first priority is to ensure we have enough capital to fund loan growth. As of December 31, 2023, subject to further approval from our Board of Directors, we could repurchase approximately $33.2 million of shares under the terms of our debt facilities. To the extent we have excess capital, we may repurchase stock, if appropriate and as authorized by our Board of Directors.

Inflation

The Company does not believe that inflation, within reasonably anticipated rates, will have a material, adverse effect on its financial condition. Although inflation would increase the Company’s operating costs in absolute terms, the Company expects that the same decrease in the value of money would result in an increase in the size of loans demanded by its customer base. It is reasonable to anticipate that such a change in customer preference would result in an increase in total loans receivable and an increase in absolute revenue to be generated from that larger amount of loans receivable. The Company believes that this increase in absolute revenue should offset any increase in operating costs. In addition, because the Company’s loans have a relatively short contractual term and average life, it is unlikely that loans made at any given point in time will be repaid with significantly inflated dollars.

Quarterly Information and Seasonality

See Note 2 to the unaudited Consolidated Financial Statements.

Recently Adopted Accounting Pronouncements
 
See Note 2 to the unaudited Consolidated Financial Statements.

Critical Accounting Policies
 
The Company’s accounting and reporting policies are in accordance with GAAP and conform to general practices within the finance company industry. Certain accounting policies involve significant judgment by the Company’s management, including the use of estimates and assumptions which affect the reported amounts of assets, liabilities, revenue, and expenses. As a result, changes in these estimates and assumptions could significantly affect the Company’s financial position and results of operations. The Company considers its policies regarding the allowance for credit losses, share-based compensation and income taxes to be its most critical accounting policies due to the significant degree of management judgment involved.

Allowance for Credit Losses

Accounting policies related to the allowance for credit losses are considered to be critical as these policies involve considerable subjective judgement and estimation by management. In the case of loans, the allowance for credit losses is a contra-asset valuation account, calculated in accordance with ASC 326 that is deducted from the amortized cost basis of loans to present the net amount expected to be collected. The amount of the allowance account represents management’s best estimate of current expected credit losses on these financial instruments considering available information, from internal and external sources, relevant to assessing exposure to credit loss over the contractual term of the instrument. Relevant available information includes historical credit loss experience, current conditions, qualitative factors, and reasonable and supportable forecasts.
 
Share-Based Compensation

The Company measures compensation cost for share-based awards at fair value and recognizes compensation over the service period for awards expected to vest. The fair value of restricted stock is based on the number of shares granted and the quoted
42

price of the Company’s common stock at the time of grant, and the fair value of stock options is determined using the Black-Scholes valuation model. The Black-Scholes model requires the input of assumptions, including expected volatility, risk-free interest rate and expected life.

Income Taxes
 
Management uses certain assumptions and estimates in determining income taxes payable or refundable, deferred income tax liabilities and assets for events recognized differently in its financial statements and income tax returns, and income tax expense. Determining these amounts requires analysis of certain transactions and interpretation of tax laws and regulations. Management exercises considerable judgment in evaluating the amount and timing of recognition of the resulting income tax liabilities and assets. These judgments and estimates are re-evaluated on a periodic basis as regulatory and business factors change.

No assurance can be given that either the tax returns submitted by management or the income tax reported on the Consolidated Financial Statements will not be adjusted by either adverse rulings, changes in the tax code, or assessments made by the IRS, state, or foreign taxing authorities. The Company is subject to potential adverse adjustments, including but not limited to: an increase in the statutory federal or state income tax rates, the permanent non-deductibility of amounts currently considered deductible either now or in future periods, and the dependency on the generation of future taxable income in order to ultimately realize deferred income tax assets.
 
Under FASB ASC Topic 740, the Company will include the current and deferred tax impact of its tax positions in the financial statements when it is more likely than not (likelihood of greater than 50%) that such positions will be sustained by taxing authorities, with full knowledge of relevant information, based on the technical merits of the tax position. While the Company supports its tax positions by unambiguous tax law, prior experience with the taxing authority, and analysis of what it considers to be all relevant facts, circumstances and regulations, management must still rely on assumptions and estimates to determine the overall likelihood of success and proper quantification of a given tax position.

43

Item 3. Quantitative and Qualitative Disclosures about Market Risk

Interest Rate Risk

The Company’s outstanding debt under its revolving credit facility was $305.1 million at December 31, 2023. Interest on borrowing under this facility is based on the greater of 4.5% or one month SOFR plus 0.10% and an applicable margin of 3.5%. Based on the outstanding balance at December 31, 2023, a change of 1.0% in the interest rate would cause a change in interest expense of approximately $3.1 million on an annual basis.

Item 4. Controls and Procedures

Changes in Internal Control over Financial Reporting

There were no changes to our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Evaluation of Disclosure Controls and Procedures

Based on management’s evaluation, with the participation of our CEO and CFO, as of the end of the period covered by this report, our CEO and CFO have concluded that our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, are effective to provide reasonable assurance that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms, and is accumulated and communicated to management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.

Our management is responsible for establishing and maintaining adequate “internal control over financial reporting,” as defined in Exchange Act Rules 13a-15(f) and 15d-15(f). Our management, including the CEO and CFO do not expect that our internal controls will prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected.

44

PART II.  OTHER INFORMATION

Item 1. Legal Proceedings

See Note 11 to the unaudited Consolidated Financial Statements included in this report for information regarding legal proceedings.

Item 1A. Risk Factors

There have been no material changes to the risk factors disclosed in Part I, Item 1A of the Company's Annual Report on Form 10-K for the fiscal year ended March 31, 2023.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

The Company's credit agreements contain certain limits on share repurchases. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Liquidity and Capital Resources."

On November 9, 2023, the Board of Directors authorized the Company to repurchase up to $20.0 million of the Company’s outstanding common stock, inclusive of the amount that remained available for repurchase under prior repurchase authorizations. As of December 31, 2023 the Company had $2.8 million in aggregate remaining repurchase capacity under its current share repurchase program. The timing and actual number of shares repurchased will depend on a variety of factors, including the stock price, corporate and regulatory requirements, available funds, alternative uses of capital, restrictions under the revolving credit agreement, and other market and economic conditions. The Company’s stock repurchase program may be suspended or discontinued at any time.

The repurchase authorization does not have a stated expiration date. The following table details purchases of the Company's common stock, if any, made by the Company during the three months ended December 31, 2023:
(a)
Total number of
shares purchased
(b)
Average price paid
per share
(c)
Total number of shares purchased
as part of publicly announced
plans or programs
(d)
Approximate dollar value of shares
that may yet be purchased
under the plans or programs(1)
October 1 through October 31, 2023— $— — $1,123,544 
November 1 through November 30, 202364,062 110.18 64,062 12,941,576 
December 1 through December 31, 202384,703 119.38 84,703 2,829,485 
Total for the quarter148,765 $115.42 148,765 

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

None of our officers and directors entered into, modified or terminated any “Rule 10b5-1 trading arrangements” or “non-Rule 10b5-1 trading arrangements” (each as defined in in Item 408(c) of Regulation S-K) during the quarter ended December 31, 2023.


45

Item 6. Exhibits

The exhibits listed in the accompanying exhibit index are filed as part of the Quarterly Report on Form 10-Q.

46

EXHIBIT INDEX
Exhibit
Number
Exhibit DescriptionFiled
Herewith
Incorporated by Reference
Form or
Registration
Number
ExhibitFiling
Date
3.01S-83.107-29-03
3.0210-Q3.0111-08-18
10.018-K10.1
10.2
07-18-23
10.028-K10.1
10.2
11-09-23
31.01*
31.02*
32.01*
32.02*
101.01The following materials from the Company's Quarterly Report for the fiscal quarter ended December 31, 2023, formatted in Inline XBRL:*
 (i)Consolidated Balance Sheets as of December 31, 2023 and March 31, 2023;  
 (ii)Consolidated Statements of Operations for the three and nine months ended December 31, 2023 and December 31, 2022;  
 (iii)Consolidated Statements of Shareholders' Equity for the three and nine months ended December 31, 2023 and December 31, 2022;  
 (iv)Consolidated Statements of Cash Flows for the nine months ended December 31, 2023 and December 31, 2022; and  
 (v)Notes to the Consolidated Financial Statements.  
104.01Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)*
*Filed herewith.
+Management Contract or other compensatory plan required to be filed under Item 6 of this report and Item 601 of Regulation S-K of the Securities and Exchange Commission.

47

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
WORLD ACCEPTANCE CORPORATION
 
By: /s/ Scott McIntyre
Scott McIntyre
Senior Vice President of Accounting
Signing on behalf of the registrant and as principal accounting officer
Date:February 7, 2024

48

EXHIBIT 31.01

CERTIFICATION

I, R. Chad Prashad, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of World Acceptance Corporation;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):
a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.




Dated: February 7, 2024/s/  R. Chad Prashad
 R. Chad Prashad
 President and Chief Executive Officer



EXHIBIT 31.02

CERTIFICATION

I, John L. Calmes, Jr., certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of World Acceptance Corporation;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):
a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.




Dated: February 7, 2024/s/  John L. Calmes, Jr.
 John L. Calmes, Jr.
 Executive Vice President and Chief Financial and Strategy Officer



EXHIBIT 32.01

CERTIFICATION OF PERIODIC REPORT

I, R. Chad Prashad, President and Chief Executive Officer of World Acceptance Corporation (the “Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that to my knowledge:
(1)the Quarterly Report on Form 10-Q of the Company for the quarter ended December 31, 2023, (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



Dated: February 7, 2024/s/  R. Chad Prashad
 R. Chad Prashad
 President and Chief Executive Officer





EXHIBIT 32.02

CERTIFICATION OF PERIODIC REPORT

I, John L. Calmes, Jr., Executive Vice President and Chief Financial and Strategy Officer of World Acceptance Corporation (the “Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that to my knowledge:
(1)the Quarterly Report on Form 10-Q of the Company for the quarter ended December 31, 2023, (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



Dated: February 7, 2024/s/  John L. Calmes, Jr.
 John L. Calmes, Jr.
 Executive Vice President and Chief Financial and Strategy Officer


v3.24.0.1
COVER - shares
9 Months Ended
Dec. 31, 2023
Feb. 01, 2024
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Dec. 31, 2023  
Document Transition Report false  
Entity File Number 000-19599  
Entity Registrant Name WORLD ACCEPTANCE CORP  
Entity Incorporation, State or Country Code SC  
Entity Tax Identification Number 57-0425114  
Entity Address, Address Line One 104 S Main Street  
Entity Address, City or Town Greenville,  
Entity Address, State or Province SC  
Entity Address, Postal Zip Code 29601  
City Area Code (864)  
Local Phone Number 298-9800  
Title of 12(b) Security Common Stock, no par value  
Trading Symbol WRLD  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   6,080,276
Entity Central Index Key 0000108385  
Current Fiscal Year End Date --03-31  
Document Fiscal Year Focus 2024  
Document Fiscal Period Focus Q3  
Amendment Flag false  
v3.24.0.1
CONSOLIDATED BALANCE SHEETS - USD ($)
Dec. 31, 2023
Mar. 31, 2023
ASSETS    
Cash and cash equivalents $ 12,775,524 $ 16,508,935
Gross loans receivable 1,400,621,989 1,390,015,568
Less:    
Unearned interest, insurance and fees (372,310,672) (376,674,349)
Allowance for credit losses (121,082,068) (125,552,733)
Loans receivable, net 907,229,249 887,788,486
Income taxes receivable 1,716,789 0
Operating lease right‐of‐use assets, net 80,049,367 81,289,240
Property and equipment, net 23,195,803 23,926,080
Deferred income taxes, net 37,047,569 41,722,361
Other assets, net 38,046,804 43,422,669
Goodwill 7,370,791 7,370,791
Intangible assets, net 12,106,773 15,289,579
Total assets 1,119,538,669 1,117,318,141
Liabilities:    
Senior notes payable 305,089,480 307,910,824
Senior unsecured notes payable, net 279,915,756 287,352,892
Income taxes payable 0 2,532,766
Operating lease liability 82,471,106 83,735,002
Accounts payable and accrued expenses 45,043,161 50,559,920
Total liabilities 712,519,503 732,091,404
Commitments and contingencies
Shareholders' equity:    
Preferred stock, no par value Authorized 5,000,000, no shares issued or outstanding 0 0
Common stock, no par value Authorized 95,000,000 shares; issued and outstanding 6,073,299 and 6,231,082 shares at December 31, 2023 and March 31, 2023, respectively 0 0
Additional paid-in capital 284,870,280 288,071,839
Retained earnings 122,148,886 97,154,898
Total shareholders' equity 407,019,166 385,226,737
Total liabilities and shareholders' equity $ 1,119,538,669 $ 1,117,318,141
v3.24.0.1
CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares
Dec. 31, 2023
Mar. 31, 2023
Statement of Financial Position [Abstract]    
Preferred stock, par value (in dollars per share) $ 0 $ 0
Preferred stock, shares authorized (in shares) 5,000,000 5,000,000
Preferred stock, shares issued (in shares) 0 0
Preferred stock, shares outstanding (in shares) 0 0
Common stock, par value (in dollars per share) $ 0 $ 0
Common stock, shares authorized (in shares) 95,000,000 95,000,000
Common stock, shares issued (in shares) 6,073,299 6,231,082
Common stock, shares outstanding (in shares) 6,073,299 6,231,082
v3.24.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended 9 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Revenues:        
Interest and fee income $ 118,665,105 $ 126,201,028 $ 352,237,133 $ 386,867,966
Insurance and other income, net 19,084,282 20,331,122 61,711,366 68,840,650
Total revenues 137,749,387 146,532,150 413,948,499 455,708,616
Expenses:        
Provision for credit losses 40,631,994 59,608,655 127,697,072 214,051,068
General and administrative expenses:        
Personnel 39,890,187 40,700,713 120,119,638 131,173,726
Occupancy and equipment 12,090,198 12,932,456 37,138,444 39,658,067
Advertising 3,721,155 1,323,671 8,712,406 4,541,863
Amortization of intangible assets 1,050,926 1,114,540 3,182,805 3,352,694
Other 9,156,841 8,880,014 27,828,730 27,569,744
Total general and administrative expenses 65,909,307 64,951,394 196,982,023 206,296,094
Interest expense 11,689,924 14,070,458 36,475,411 38,277,223
Total expenses 118,231,225 138,630,507 361,154,506 458,624,385
Income (loss) before income taxes 19,518,162 7,901,643 52,793,993 (2,915,769)
Income tax expense 2,853,344 2,097,057 10,508,008 483,696
Net income (loss) $ 16,664,818 $ 5,804,586 $ 42,285,985 $ (3,399,465)
Net income (loss) per common share:        
Basic (in dollars per share) $ 2.89 $ 1.01 $ 7.32 $ (0.59)
Diluted (in dollars per share) $ 2.84 $ 0.99 $ 7.17 $ (0.59)
Weighted average common shares outstanding:        
Basic (in shares) 5,772,503 5,761,954 5,775,108 5,743,094
Diluted (in shares) 5,860,117 5,857,490 5,896,716 5,743,094
v3.24.0.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-in Capital
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Mar. 31, 2022     6,348,314      
Beginning balances at Mar. 31, 2022 $ 373,024,428 $ (1,880,346)   $ 280,907,085 $ 92,117,343 $ (1,880,346)
Increase (Decrease) in Shareholders' Equity [Roll Forward]            
Proceeds from exercise of stock options (in shares)     5,596      
Proceeds from exercise of stock options 486,372     486,372    
Common stock repurchases (in shares)     (73,643)      
Common stock repurchases (14,314,088)       (14,314,088)  
Stock-based compensation (reversal) related to restricted stock, net of cancellations (in shares)     (51,658)      
Stock-based compensation (reversal) related to restricted stock, net of cancellations 2,969,433     2,969,433    
Stock-based compensation related to stock options 1,869,879     1,869,879    
Net income (loss) (3,399,465)       (3,399,465)  
Ending balance (in shares) at Dec. 31, 2022     6,228,609      
Ending balances at Dec. 31, 2022 358,756,213     286,232,769 72,523,444  
Beginning balance (in shares) at Sep. 30, 2022     6,281,721      
Beginning balances at Sep. 30, 2022 355,666,126     288,947,268 66,718,858  
Increase (Decrease) in Shareholders' Equity [Roll Forward]            
Proceeds from exercise of stock options (in shares)     1,296      
Proceeds from exercise of stock options 82,825     82,825    
Stock-based compensation (reversal) related to restricted stock, net of cancellations (in shares)     (54,408)      
Stock-based compensation (reversal) related to restricted stock, net of cancellations (3,222,444)     (3,222,444)    
Stock-based compensation related to stock options 425,120     425,120    
Net income (loss) 5,804,586       5,804,586  
Ending balance (in shares) at Dec. 31, 2022     6,228,609      
Ending balances at Dec. 31, 2022 $ 358,756,213     286,232,769 72,523,444  
Beginning balance (in shares) at Mar. 31, 2023 6,231,082   6,231,082      
Beginning balances at Mar. 31, 2023 $ 385,226,737     288,071,839 97,154,898  
Increase (Decrease) in Shareholders' Equity [Roll Forward]            
Proceeds from exercise of stock options (in shares)     22,847      
Proceeds from exercise of stock options 2,018,412     2,018,412    
Common stock repurchases (in shares)     (148,765)      
Common stock repurchases (17,291,997)       (17,291,997)  
Stock-based compensation (reversal) related to restricted stock, net of cancellations (in shares)     (31,865)      
Stock-based compensation (reversal) related to restricted stock, net of cancellations (1,348,623)     (1,348,623)    
Stock-based compensation related to stock options (3,871,348)     (3,871,348)    
Net income (loss) $ 42,285,985       42,285,985  
Ending balance (in shares) at Dec. 31, 2023 6,073,299   6,073,299      
Ending balances at Dec. 31, 2023 $ 407,019,166     284,870,280 122,148,886  
Beginning balance (in shares) at Sep. 30, 2023     6,246,818      
Beginning balances at Sep. 30, 2023 410,022,795     287,246,730 122,776,065  
Increase (Decrease) in Shareholders' Equity [Roll Forward]            
Proceeds from exercise of stock options (in shares)     11,104      
Proceeds from exercise of stock options 948,441     948,441    
Common stock repurchases (in shares)     (148,765)      
Common stock repurchases (17,291,997)       (17,291,997)  
Stock-based compensation (reversal) related to restricted stock, net of cancellations (in shares)     (35,858)      
Stock-based compensation (reversal) related to restricted stock, net of cancellations (3,514,473)     (3,514,473)    
Stock-based compensation related to stock options 189,582     189,582    
Net income (loss) $ 16,664,818       16,664,818  
Ending balance (in shares) at Dec. 31, 2023 6,073,299   6,073,299      
Ending balances at Dec. 31, 2023 $ 407,019,166     $ 284,870,280 $ 122,148,886  
v3.24.0.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Parenthetical) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Mar. 31, 2022
Statement of Stockholders' Equity [Abstract]          
Accounting Standards Update [Extensible List]         Accounting Standards Update 2023-02 [Member]
Issuance of restricted common stock under stock option plan $ 2,823,774 $ 2,543,001 $ 2,823,774 $ 2,543,001  
v3.24.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
9 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Cash flow from operating activities:    
Net income (loss) $ 42,285,985 $ (3,399,465)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Amortization of intangible assets 3,182,805 3,352,694
Accrued unearned interest (4,225,244) (2,253,757)
Amortization of deferred loan cost 10,285,733 12,187,196
Gain on extinguishment of senior unsecured notes payable (1,162,581) 0
Amortization of debt issuance costs 1,338,352 1,170,040
Provision for credit losses 127,697,072 214,051,068
Depreciation 4,937,169 4,648,277
Amortization of finance leases 0 204,552
Gain on asset acquisitions, net of income tax 0 (3,708,344)
Loss (gain) on sale of property and equipment (95,621) 21,261
Deferred income tax expense (benefit) 4,674,792 (3,665,493)
Stock-based compensation (reversal) related to equity classified awards (2,396,197) 7,382,313
Change in accounts:    
Other assets, net 5,213,994 (6,579,852)
Income taxes payable (4,249,555) (8,295,947)
Accounts payable and accrued expenses (5,516,759) (9,241,015)
Net cash provided by operating activities 181,969,945 205,873,528
Cash flows from investing activities:    
Increase in loans receivable, net (153,198,324) (189,511,989)
Cash paid for acquisitions, primarily loans 0 (22,314,902)
Purchases of property and equipment (4,419,445) (4,517,809)
Proceeds from the sale of property and equipment 308,174 349,792
Net cash used in investing activities (157,309,595) (215,994,908)
Cash flow from financing activities:    
Borrowings from senior notes payable 215,066,622 251,431,701
Payments on senior notes payable (217,887,966) (221,914,242)
Payments for extinguished senior unsecured notes payable (6,978,717) 0
Debt issuance costs associated with senior unsecured notes payable 0 (104,656)
Payments for debt extinguishment costs (20,625) 0
Debt issuance costs associated with senior notes payable (475,716) (1,115,136)
Proceeds from exercise of stock options 2,018,412 486,372
Payments for taxes related to net share settlement of equity awards (2,823,774) (2,543,001)
Repayment of finance lease 0 (80,067)
Repurchase of common stock (17,291,997) (14,314,088)
Net cash provided by (used in) financing activities (28,393,761) 11,846,883
Net change in cash and cash equivalents (3,733,411) 1,725,503
Cash and cash equivalents at beginning of period 16,508,935 19,236,322
Cash and cash equivalents at end of period 12,775,524 20,961,825
Supplemental Disclosures:    
Interest paid during the period 41,233,947 42,834,034
Income taxes paid during the period 7,726,889 10,772,869
Finance lease right-of-use assets, net transferred to property and equipment, net $ 0 $ 402,960
v3.24.0.1
BASIS OF PRESENTATION
9 Months Ended
Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
BASIS OF PRESENTATION BASIS OF PRESENTATION
The consolidated financial statements of the Company at December 31, 2023 and 2022 and for the three and nine months then ended were prepared in accordance with the instructions for Form 10-Q and are unaudited; however, in the opinion of management, all adjustments (consisting only of items of a normal, recurring nature) necessary for a fair presentation of the financial position at December 31, 2023, and the results of operations and cash flows for the periods ended December 31, 2023 and 2022, have been included. The results for the interim periods are not necessarily indicative of the results that may be expected for the full year or any other interim period.

The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent liabilities at the date of the consolidated financial statements and the reported amount of revenue and expenses during the reporting period. Actual results could differ from those estimates.
The consolidated financial statements do not include all disclosures required by GAAP and should be read in conjunction with the Company’s audited consolidated financial statements and related notes for the fiscal year ended March 31, 2023, included in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2023, as filed with the SEC. The Company applies the accounting policies contained in Note 1 to the Consolidated Financial Statements included in the Company's Annual Report on Form 10-K for the year ended March 31, 2023. The Company believes that the disclosures are adequate to make the information presented not misleading.
v3.24.0.1
SUMMARY OF SIGNIFICANT POLICIES
9 Months Ended
Dec. 31, 2023
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT POLICIES SUMMARY OF SIGNIFICANT POLICIES
Nature of Operations

The Company is a small-loan consumer finance company headquartered in Greenville, South Carolina that offers short-term small loans, medium-term larger loans, related credit insurance products and ancillary products and services to individuals who have limited access to other sources of consumer credit. The Company offers income tax return preparation services to its loan customers and other individuals.

Seasonality

The Company's loan volume and corresponding loans receivable follow seasonal trends. The Company's highest loan demand generally occurs from October through December, its third fiscal quarter. Loan demand is generally lowest and loan repayment highest from January to March, its fourth fiscal quarter. Loan volume and average balances remain relatively level during the remainder of the year. Consequently, the Company experiences significant seasonal fluctuations in its operating results and cash needs. Operating results for the Company's third fiscal quarter are generally lower than in other quarters, and operating results for its fourth fiscal quarter are generally higher than in other quarters.

Loans receivable, net

Loans receivable are carried at the gross amount outstanding, reduced by unearned interest and insurance income, net of deferred origination fees and direct costs, and an allowance for credit losses. Fees received and direct costs incurred for the origination of loans are deferred and amortized to interest income over the contractual lives of the loans using the interest method. Unamortized amounts are recognized in income at the time that loans are refinanced or paid in full except for those refinancings that do not constitute a more than minor modification. Net unamortized deferred origination costs were $5.6 million and $4.9 million as of December 31, 2023 and March 31, 2023, respectively.

From time to time, the Company may sell charged off loans receivable, which are accounted for as a sale in accordance with ASC 860, Transfers and Servicing.

Allowance for credit losses

Refer to Note 4, “Loans Receivable and Allowance for Credit Losses,” for information regarding the Company's CECL allowance model and a description of the methodology it utilizes.
Reclassification

Certain prior period amounts have been reclassified to conform to the current presentation. Such reclassifications had no impact on previously reported net income (loss) or shareholders' equity, with the exception of the following.

As a result of adopting ASU 2023-02, Investments- Equity Method and Joint Venture (Topic 323), in March 2023 with an effective date of April 1, 2022, previously reported net income for the three months ended December 31, 2022, net loss for the nine months ended December 31, 2022 and shareholders' equity as of December 31, 2022 were immaterially impacted to conform to the modified retrospective application of this newly adopted ASU.

Recently Adopted Accounting Standards

Troubled Debt Restructurings and Vintage Disclosures

In March 2022, the FASB issued ASU 2022-02, Troubled Debt Restructurings and Vintage Disclosures. The amendments in this update eliminated the accounting guidance for troubled debt restructurings by creditors in Subtopic 310-40, Receivables—Troubled Debt Restructurings by Creditors, while enhancing disclosure requirements for certain loan refinancings and restructurings by creditors when a borrower is experiencing financial difficulty. Additionally, for public business entities, the amendments in this update require that an entity disclose current-period gross write-offs by year of origination for financing receivables and net investments in leases within the scope of Subtopic 326-20, Financial Instruments—Credit Losses—Measured at Amortized Cost. The adoption of ASU 2022-02 on April 1, 2023 expanded our gross charge-off disclosures, but had no other impact on the Company’s Consolidated Financial Statements.

Recently Issued Accounting Standards Not Yet Adopted

Improvements to Reportable Segment Disclosures

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which improves reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendments are effective for fiscal years beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The amendments should be applied retrospectively to all prior periods presented in the financial statements. Management is currently evaluating this ASU to determine its impact on the Company's Consolidated Financial Statements and related disclosures.

Improvements to Income Tax Disclosures

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which modifies the rules on income tax disclosures to require entities to expand annual disclosures to 1) include specific categories in the rate reconciliation and additional information for reconciling items that meet a quantitative threshold and 2) disclose the amount of income taxes paid (net of refunds received) disaggregated by federal, state and foreign taxes. ASU 2023-09 also requires entities to disclose income (or loss) from continuing operations before income tax expense (or benefit) disaggregated between domestic and foreign, and income tax expense (or benefit) from continuing operations disaggregated by federal, state and foreign, among other changes. The amendments are effective for annual periods beginning after December 15, 2024. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. ASU 2023-09 should be applied on a prospective basis, but retrospective application is permitted. Management is currently evaluating this ASU to determine its impact on the Company's Consolidated Financial Statements and related disclosures.

We reviewed all other newly issued accounting pronouncements and concluded that they are either not applicable to our business or are not expected to have a material effect on the Consolidated Financial Statements and related disclosures as a result of future adoption.
v3.24.0.1
FAIR VALUE
9 Months Ended
Dec. 31, 2023
Fair Value Disclosures [Abstract]  
FAIR VALUE FAIR VALUE
Fair Value Disclosures

The Company may carry certain financial instruments and derivative assets and liabilities at fair value measured on a recurring or nonrecurring basis. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants on the measurement date. The Company measures the fair values of its financial instruments based on the fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.

Fair value measurements are grouped in three levels. The levels prioritize the inputs used to measure the fair value of the assets or liabilities. These levels are:

Level 1 – Quoted prices (unadjusted) in active markets for identical assets or liabilities.
Level 2 – Inputs other than quoted prices that are observable for assets and liabilities, either directly or indirectly. These inputs include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are less active.
Level 3 – Unobservable inputs for assets or liabilities reflecting the reporting entity’s own assumptions.

The Company’s financial instruments consist of cash and cash equivalents, loans receivable, net, senior notes payable, and senior unsecured notes payable. Loans receivable are originated at prevailing market rates and have an average life of approximately less than twelve months. Given the short-term nature of these loans, they are continually repriced at current market rates. The Company’s senior notes payable, consisting of a senior revolving credit facility has a variable rate based on a margin over SOFR and reprices with any changes in SOFR. The fair value of the senior unsecured notes payable is estimated based on quoted prices in markets that are not active. The Company also considers its creditworthiness in its estimation of fair value.

The carrying amounts and estimated fair values of financial assets and liabilities disclosed but not carried at fair value and their level within the fair value hierarchy are summarized below.
December 31, 2023March 31, 2023
Input LevelCarrying ValueEstimated Fair ValueCarrying ValueEstimated Fair Value
ASSETS
Cash and cash equivalents1$12,775,524 $12,775,524 $16,508,935 $16,508,935 
Loans receivable, net3907,229,249 907,229,249 887,788,486 887,788,486 
LIABILITIES
Senior unsecured notes payable2282,610,000 257,517,058 290,860,000 218,127,548 
Senior notes payable3305,089,480 305,089,480 307,910,824 307,910,824 

There were no significant assets or liabilities measured at fair value on a non-recurring basis as of December 31, 2023 or March 31, 2023.
v3.24.0.1
LOANS RECEIVABLE AND ALLOWANCE FOR CREDIT LOSSES
9 Months Ended
Dec. 31, 2023
Receivables [Abstract]  
LOANS RECEIVABLE AND ALLOWANCE FOR CREDIT LOSSES LOANS RECEIVABLE AND ALLOWANCE FOR CREDIT LOSSES
The following is a summary of gross loans receivable by Customer Tenure as of:
Customer TenureDecember 31, 2023March 31, 2023
0 to 5 months$88,474,205 $81,803,668 
6 to 17 months83,641,505 133,650,188 
18 to 35 months154,272,047 135,396,187 
36 to 59 months212,663,970 244,414,255 
60+ months861,562,368 792,189,216 
Tax advance loans7,894 2,562,054 
Total gross loans$1,400,621,989 $1,390,015,568 

Current payment performance is used to assess the capability of the borrower to repay contractual obligations of the loan agreements as scheduled, which is monitored by management on a daily basis. On an as needed basis, qualitative information may be taken into consideration if new information arises related to the customer’s ability to repay the loan. The Company’s payment performance buckets are as follows: current, 30-60 days past due, 61-90 days past due, 91 days or more past due.

The following table provides a breakdown of the Company’s gross loans receivable by current payment performance on a recency basis and year of origination at December 31, 2023:
Term Loans By Origination
LoansUp to
1
Year Ago
Between
1 and 2
Years Ago
Between
2 and 3
Years Ago
Between
3 and 4
Years Ago
Between
4 and 5
Years Ago
More than
5
Years Ago
Total
Current$1,199,541,510 $67,910,482 $4,917,687 $119,767 $36,259 $8,904 $1,272,534,609 
30 - 60 days past due39,988,200 5,754,817 604,508 28,282 15,556 3,633 46,394,996 
61 - 90 days past due25,958,915 3,677,614 285,870 14,542 18,404 1,843 29,957,188 
91 or more days past due43,659,995 7,522,539 512,369 21,530 5,091 5,778 51,727,302 
Total$1,309,148,620 $84,865,452 $6,320,434 $184,121 $75,310 $20,158 $1,400,614,095 
Term Loans By Origination
Tax advance loansUp to
1
Year Ago
Between
1 and 2
Years Ago
Between
2 and 3
Years Ago
Between
3 and 4
Years Ago
Between
4 and 5
Years Ago
More than
5
Years Ago
Total
Current$2,294 $— $— $— $— $— $2,294 
30 - 60 days past due2,508 — — — — — 2,508 
61 - 90 days past due3,092 — — — — — 3,092 
91 or more days past due— — — — — — — 
Total$7,894 $— $— $— $— $— $7,894 
Total gross loans$1,400,621,989 

The following table provides a breakdown of the Company’s gross loans receivable by current payment performance on a recency basis and year of origination at March 31, 2023:
Term Loans By Origination
LoansUp to
1
Year Ago
Between
1 and 2
Years Ago
Between
2 and 3
Years Ago
Between
3 and 4
Years Ago
Between
4 and 5
Years Ago
More than
5
Years Ago
Total
Current$1,200,504,088 $62,076,656 $1,998,218 $148,662 $23,046 $6,863 $1,264,757,533 
30 - 60 days past due40,791,746 4,689,867 160,956 42,700 8,504 2,988 45,696,761 
61 - 90 days past due26,319,250 2,572,733 92,088 40,281 884 — 29,025,236 
91 or more days past due41,832,821 5,944,645 160,361 29,494 4,430 2,233 47,973,984 
Total$1,309,447,905 $75,283,901 $2,411,623 $261,137 $36,864 $12,084 $1,387,453,514 
Term Loans By Origination
Tax advance loansUp to
1
Year Ago
Between
1 and 2
Years Ago
Between
2 and 3
Years Ago
Between
3 and 4
Years Ago
Between
4 and 5
Years Ago
More than
5
Years Ago
Total
Current$1,932,607 $3,524 $— $— $— $— $1,936,131 
30 - 60 days past due609,844 736 — — — — 610,580 
61 - 90 days past due— 4,845 — — — — 4,845 
91 or more days past due409 10,089 — — — — 10,498 
Total$2,542,860 $19,194 $— $— $— $— $2,562,054 
Total gross loans$1,390,015,568 

The following table provides a breakdown of the Company’s gross loans receivable by current payment performance on a contractual basis and year of origination at December 31, 2023:
Term Loans By Origination
LoansUp to
1
Year Ago
Between
1 and 2
Years Ago
Between
2 and 3
Years Ago
Between
3 and 4
Years Ago
Between
4 and 5
Years Ago
More than
5
Years Ago
Total
Current$1,188,126,383 $60,651,793 $3,944,841 $52,853 $12,484 $652 $1,252,789,006 
30 - 60 days past due40,230,196 3,897,049 250,587 941 1,006 — 44,379,779 
61 - 90 days past due28,592,002 3,484,278 236,372 1,646 — 296 32,314,594 
91 or more days past due52,200,038 16,832,332 1,888,635 128,681 61,820 19,210 71,130,716 
Total$1,309,148,619 $84,865,452 $6,320,435 $184,121 $75,310 $20,158 $1,400,614,095 
Term Loans By Origination
Tax advance loansUp to
1
Year Ago
Between
1 and 2
Years Ago
Between
2 and 3
Years Ago
Between
3 and 4
Years Ago
Between
4 and 5
Years Ago
More than
5
Years Ago
Total
Current$— $— $— $— $— $— $— 
30 - 60 days past due439 — — — — — 439 
61 - 90 days past due1,714 — — — — — 1,714 
91 or more days past due5,741 — — — — — 5,741 
Total$7,894 $— $— $— $— $— $7,894 
Total gross loans$1,400,621,989 

The following table provides a breakdown of the Company’s gross loans receivable by current payment performance on a contractual basis and year of origination at March 31, 2023:
Term Loans By Origination
LoansUp to
1
Year Ago
Between
1 and 2
Years Ago
Between
2 and 3
Years Ago
Between
3 and 4
Years Ago
Between
4 and 5
Years Ago
More than
5
Years Ago
Total
Current$1,174,237,761 $53,652,011 $1,554,144 $64,233 $5,142 $1,491 $1,229,514,782 
30 - 60 days past due47,346,331 3,661,493 77,857 6,714 — — 51,092,395 
61 - 90 days past due33,012,804 3,030,052 44,129 7,643 — — 36,094,628 
91 or more days past due54,851,010 14,940,345 735,493 182,547 31,721 10,593 70,751,709 
Total$1,309,447,906 $75,283,901 $2,411,623 $261,137 $36,863 $12,084 $1,387,453,514 
Term Loans By Origination
Tax advance loansUp to
1
Year Ago
Between
1 and 2
Years Ago
Between
2 and 3
Years Ago
Between
3 and 4
Years Ago
Between
4 and 5
Years Ago
More than
5
Years Ago
Total
Current$1,932,607 $— $— $— $— $— $1,932,607 
30 - 60 days past due609,844 — — — — — 609,844 
61 - 90 days past due— — — — — — — 
91 or more days past due409 19,194 — — — — 19,603 
Total$2,542,860 $19,194 $— $— $— $— $2,562,054 
Total gross loans$1,390,015,568 

The following table provides a breakdown of the Company’s gross charge-offs by year of origination for the three and nine months ended December 31, 2023:

Three months ended December 31,Nine months ended December 31,
Gross Charge-offs by OriginationGross Charge-offs by Origination
Origination by Calendar YearLoansTax advance loansTotalLoansTax advance loansTotal
2018 and prior$1,958 $— $1,958 $9,686 $— $9,686 
20192,448 — 2,448 19,986 — 19,986 
202032,909 — 32,909 177,372 — 177,372 
2021943,234 — 943,234 5,589,791 — 5,589,791 
202215,175,088 188 15,175,276 95,994,906 5,436 96,000,342 
202338,460,870 118,287 38,579,157 54,171,402 1,260,035 55,431,437 
Total$54,616,507 $118,475 $54,734,982 $155,963,143 $1,265,471 $157,228,614 
The following table provides a breakdown of the Company’s gross charge-offs by year of origination for the three and nine months ended December 31, 2022:
Three months ended December 31,Nine months ended December 31,
Gross Charge-offs by OriginationGross Charge-offs by Origination
Origination by Calendar YearLoansTax advance loansTotalLoansTax advance loansTotal
2017 and prior$656 $— $656 $10,102 $— $10,102 
201819,203 — 19,203 39,797 — 39,797 
2019158,346 — 158,346 334,091 — 334,091 
2020441,199 — 441,199 2,591,494 — 2,591,494 
202119,276,965 263 19,277,228 125,968,883 19,885 125,988,768 
202266,102,716 383,534 66,486,250 97,354,602 2,413,550 99,768,152 
Total$85,999,085 $383,797 $86,382,882 $226,298,969 $2,433,435 $228,732,404 
The allowance for credit losses is applied to amortized cost, which is defined as the amount at which a financing receivable is originated, and net of deferred fees and costs, collection of cash, and charge-offs. Amortized cost also includes interest earned but not collected.

Credit Risk is inherent in the business of extending loans to borrowers and is continuously monitored by management and reflected within the allowance for credit losses for loans. The allowance for credit losses is an estimate of expected losses inherent within the Company’s gross loans receivable portfolio. In estimating the allowance for credit losses, loans with similar risk characteristics are aggregated into pools and collectively assessed. The Company’s loan products have generally the same terms therefore the Company looked to borrower characteristics as a way to disaggregate loans into pools sharing similar risks.

In determining the allowance for credit losses, the Company examined four borrower risk metrics as noted below.

1.Borrower type
2.Active months
3.Prior loan performance
4.Customer Tenure

To determine how well each metric predicts default risk the Company uses loss rate data over an observation period of twelve months at the loan level.

The information value was then calculated for each metric. From this analysis management determined the metric that had the strongest predictor of default risk was Customer Tenure. The Customer Tenure buckets used in the allowance for credit loss calculation are:

1.0 to 5 months
2.6 to 17 months
3.18 to 35     months
4.36 to 59 months
5.60+ months

Management will continue to monitor this credit metric on a quarterly basis.

Management estimates an allowance for each Customer Tenure bucket by performing a historical migration analysis of loans in that bucket for the twelve most recent historical twelve-month migration periods. All loans that are greater than 90 days past due on a recency basis and not written off as of the reporting date are reserved for at 100% of the outstanding balance, net of a calculated Rehab Rate. Loans are charged-off at the earlier of 120 days past due on a recency basis or when deemed uncollectible. Management considers whether current credit conditions might suggest a change is needed to the allowance for credit losses by monitoring trends in first pay success for new borrowers, 60-89 day delinquencies on a recency basis, FICO scores, percent of loan balances that are paying and percentage of gross loans that are acquired loans. From time to time, the Company will make changes, as deemed appropriate, to our new borrower underwriting guidance. As a result, management also considers whether a change in our new borrower underwriting might suggest a change is needed to the allowance for credit losses. If a change is determined necessary, then the Company has elected to immediately revert back to historical experience past the forecast period.
Due to the short term nature of the loan portfolio, forecasted changes in macroeconomic variables such as unemployment do not have a significant impact on loans outstanding at the end of a particular reporting period. Therefore, management develops a reasonable and supportable forecast of losses by comparing the most recent six-month loss curves as compared to historical loss curves to see if there are significant changes in borrower behavior that may indicate the historical migration rates should be adjusted. If management determines that historical migration rates should be adjusted to reflect expected credit losses, a qualitative adjustment is made to reflect management's judgment regarding observable changes in recent or expected economic trends and conditions, portfolio composition, or other significant events or conditions that affect the current estimate.

The following table presents a roll forward of the allowance for credit losses for the three and nine months ended December 31, 2023 and 2022:
Three months ended December 31,Nine months ended December 31,
2023202220232022
Beginning balance$128,892,192 $155,892,100 $125,552,733 $134,242,862 
Provision for credit losses40,631,994 59,608,655 127,697,072 214,051,068 
Charge-offs(54,734,982)(86,382,882)(157,228,614)(228,732,404)
Recoveries16,292,864 15,421,670 25,060,877 24,978,017 
Net charge-offs(48,442,118)(70,961,212)(132,167,737)(203,754,387)
Ending Balance$121,082,068 $144,539,543 $121,082,068 $144,539,543 

The following table is an aging analysis on a recency basis at amortized cost of the Company’s gross loans receivable at December 31, 2023:
Days Past Due - Recency Basis
Customer TenureCurrent30 - 6061 - 90Over 90Total Past DueTotal Loans
0 to 5 months$70,723,005 $5,258,173 $4,431,184 $8,061,843 $17,751,200 $88,474,205 
6 to 17 months70,403,444 4,322,410 2,974,763 5,940,888 13,238,061 83,641,505 
18 to 35 months136,529,566 6,306,026 4,251,454 7,185,001 17,742,481 154,272,047 
36 to 59 months191,171,843 7,712,458 5,057,386 8,722,283 21,492,127 212,663,970 
60+ months803,706,751 22,795,929 13,242,401 21,817,287 57,855,617 861,562,368 
Tax advance loans2,294 2,508 3,092 — 5,600 7,894 
Total gross loans1,272,536,903 46,397,504 29,960,280 51,727,302 128,085,086 1,400,621,989 
Unearned interest, insurance and fees(340,464,381)(9,305,045)(8,165,777)(14,375,469)(31,846,291)(372,310,672)
Total net loans$932,072,522 $37,092,459 $21,794,503 $37,351,833 $96,238,795 $1,028,311,317 
Percentage of period-end gross loans receivable3.3%2.1%3.7%9.1%

The following table is an aging analysis on a recency basis at amortized cost of the Company’s gross loans receivable at March 31, 2023:
Days Past Due - Recency Basis
Customer TenureCurrent30 - 6061 - 90Over 90Total Past DueTotal Loans
0 to 5 months$64,615,314 $5,451,276 $4,407,751 $7,329,327 $17,188,354 $81,803,668 
6 to 17 months113,946,833 6,527,355 4,655,441 8,520,559 19,703,355 133,650,188 
18 to 35 months120,125,821 5,336,994 3,727,331 6,206,041 15,270,366 135,396,187 
36 to 59 months223,734,062 8,070,011 4,839,000 7,771,182 20,680,193 244,414,255 
60+ months742,335,503 20,311,125 11,395,713 18,146,875 49,853,713 792,189,216 
Tax advance loans1,936,131 610,580 4,845 10,498 625,923 2,562,054 
Total gross loans1,266,693,664 46,307,341 29,030,081 47,984,482 123,321,904 1,390,015,568 
Unearned interest, insurance and fees(343,255,876)(12,548,627)(7,866,737)(13,003,109)(33,418,473)(376,674,349)
Total net loans$923,437,788 $33,758,714 $21,163,344 $34,981,373 $89,903,431 $1,013,341,219 
Percentage of period-end gross loans receivable3.3 %2.1 %3.5 %8.9 %

The following table is an aging analysis on a contractual basis at amortized cost of the Company’s gross loans receivable at December 31, 2023:
Days Past Due - Contractual Basis
Customer TenureCurrent30 - 6061 - 90Over 90Total Past DueTotal Loans
0 to 5 months$69,745,014 $5,057,373 $4,433,801 $9,238,017 $18,729,191 $88,474,205 
6 to 17 months68,600,697 3,932,710 3,077,743 8,030,355 15,040,808 83,641,505 
18 to 35 months134,132,918 5,933,072 4,509,138 9,696,919 20,139,129 154,272,047 
36 to 59 months187,676,345 7,282,389 5,443,963 12,261,273 24,987,625 212,663,970 
60+ months792,634,032 22,174,235 14,849,949 31,904,152 68,928,336 861,562,368 
Tax advance loans— 439 1,714 5,741 7,894 7,894 
Total gross loans1,252,789,006 44,380,218 32,316,308 71,136,457 147,832,983 1,400,621,989 
Unearned interest, insurance and fees(336,138,470)(8,303,761)(8,796,156)(19,072,285)(36,172,202)(372,310,672)
Total net loans$916,650,536 $36,076,457 $23,520,152 $52,064,172 $111,660,781 $1,028,311,317 
Percentage of period-end gross loans receivable3.2%2.3%5.1%10.6 %

The following table is an aging analysis on a contractual basis at amortized cost of the Company’s gross loans receivable at March 31, 2023:
Days Past Due - Contractual Basis
Customer TenureCurrent30 - 6061 - 90Over 90Total Past DueTotal Loans
0 to 5 months$61,850,142 $5,320,659 $4,864,498 $9,768,369 $19,953,526 $81,803,668 
6 to 17 months109,694,389 6,892,610 5,613,468 11,449,721 23,955,799 133,650,188 
18 to 35 months115,711,782 5,721,694 4,499,010 9,463,701 19,684,405 135,396,187 
36 to 59 months217,821,239 8,991,995 6,078,488 11,522,533 26,593,016 244,414,255 
60+ months724,437,230 24,165,437 15,039,164 28,547,385 67,751,986 792,189,216 
Tax advance loans1,932,607 609,844 — 19,603 629,447 2,562,054 
Total gross loans1,231,447,389 51,702,239 36,094,628 70,771,312 158,568,179 1,390,015,568 
Unearned interest, insurance and fees(333,704,639)(14,010,568)(9,781,128)(19,178,014)(42,969,710)(376,674,349)
Total net loans$897,742,750 $37,691,671 $26,313,500 $51,593,298 $115,598,469 $1,013,341,219 
Percentage of period-end gross loans receivable3.7 %2.6 %5.1 %11.4 %

The Company elected not to record an allowance for credit losses for accrued interest as outlined in ASC 326-20-30-5A. Loans are placed on nonaccrual status when management determines that the full payment of principal and collection of interest according to contractual terms is no longer likely. The accrual of interest is discontinued when a loan is 61 days or more past the contractual due date. When the interest accrual is discontinued, all unpaid accrued interest is reversed against interest income. While a loan is on nonaccrual status, interest revenue is recognized only when a payment is received. Once a loan moves to nonaccrual status, it remains in nonaccrual status until it is paid out, charged off or refinanced.

The following table presents unpaid accrued interest reversed against interest income by Customer Tenure for the three and nine months ended December 31, 2023 and December 31, 2022:

Three months ended December 31,Nine months ended December 31,
2023202220232022
Customer Tenure
0 to 5 months$(1,358,755)$(1,813,804)$(3,904,031)$(8,117,103)
6 to 17 months(777,293)(1,627,586)(2,651,226)(4,605,102)
18 to 35 months(946,820)(1,285,309)(2,609,760)(3,862,834)
36 to 59 months(1,065,935)(1,365,428)(3,211,393)(3,543,651)
60+ months(2,822,515)(3,352,265)(7,972,048)(9,724,169)
Total$(6,971,318)$(9,444,392)$(20,348,458)$(29,852,859)

The following table presents the amortized cost basis of loans on nonaccrual status as of the beginning of the reporting period and the end of the reporting period, as well as interest income recognized on nonaccrual loans for the three and nine months ended December 31, 2023 and 2022:
Nonaccrual Loans Receivable
Customer TenureAs of December 31, 2023As of March 31, 2023
Interest Income
Recognized for the three months ended December 31, 2023
Interest Income
Recognized for the three months ended December 31, 2022
Interest Income
Recognized for the nine months ended December 31, 2023
Interest Income
Recognized for the nine months ended December 31, 2022
0 to 5 months$14,079,793 $15,781,494 $197,470 $480,947 $769,418 $1,522,535 
6 to 17 months11,853,469 18,288,714 319,474 450,877 1,168,253 1,216,091 
18 to 35 months15,380,814 15,551,806 396,720 544,689 1,249,102 1,741,780 
36 to 59 months19,379,244 19,745,397 547,608 555,085 1,728,965 1,606,466 
60+ months51,666,613 49,285,814 1,497,757 1,711,201 4,785,842 4,975,538 
Tax advance loans50,950 19,603  —  — 
Unearned interest, insurance and fees(29,880,847)(32,158,640) —  — 
Total$82,530,036 $86,514,188 $2,959,029 $3,742,799 $9,701,580 $11,062,410 

As of December 31, 2023 and March 31, 2023, there were no loans receivable 61 days or more past due, not on nonaccrual status, and no loans receivable on nonaccrual status with no related allowance for credit losses.
v3.24.0.1
LEASES
9 Months Ended
Dec. 31, 2023
Leases [Abstract]  
LEASES LEASES
Accounting Policies and Matters Requiring Management's Judgment

The Company uses its effective annual interest rate, adjusted for certain assumptions, as the discount rate when evaluating leases under Topic 842. Management applies the adjusted effective annual interest rate to leases entered for the entirety of the subsequent year.

Based on its historical practice, the Company believes it is reasonably certain to exercise a given option associated with a given office space lease. Therefore, the Company classifies all lease options for office space as “reasonably certain” unless it has specific knowledge to the contrary for a given lease. The Company generally does not believe it is reasonably certain to exercise any options associated with its office equipment leases.

Periodic Disclosures

The Company's operating leases consist of real estate leases for office space as well as office equipment. Both the branch real estate and office equipment lease terms generally range from three years to five years, and generally contain options to extend which mirror the original terms of the lease.

During the second quarter of fiscal 2023, the lease terms associated with the Company's finance leases expired and the Company exercised its purchase option to acquire the IT equipment. Because it was reasonably certain that the Company would obtain the assets at the end of their lease terms, the right-of-use assets have amortized over the useful life of the asset, rather than over the lease term. As of December 31, 2023, the Company had no finance leases.
The following table reports information about the Company's lease cost for the three and nine months ended December 31, 2023 and 2022:
Three months ended December 31,Nine months ended December 31,
 2023202220232022
Lease Cost
Finance lease cost$ $— $ $205,975 
Amortization of right-of-use assets —  204,552 
Interest on lease liabilities —  1,423 
Operating lease cost$6,163,762 $6,746,965 $19,000,163 $21,013,997 
Variable lease cost$888,119 $920,991 $2,808,845 $2,772,620 
Total lease cost$7,051,881 $7,667,956 $21,809,008 $23,992,592 

The following table reports other information about the Company's leases for the three and nine months ended December 31, 2023 and 2022:
Three months ended December 31,Nine months ended December 31,
 2023202220232022
Other Lease Information
Cash paid for amounts included in the measurement of lease liabilities$6,265,527 $6,550,184 $18,965,468 $19,998,398 
Operating cash flows from finance leases —  1,423 
Operating cash flows from operating leases6,265,527 6,550,184 18,965,468 19,916,908 
Financing cash flows from finance leases —  80,067 
Right-of-use assets obtained in exchange for new operating lease liabilities$4,568,169 $3,447,091 $13,560,648 $13,912,470 
Weighted-average remaining lease term — finance leases —  — 
Weighted average remaining lease term — operating leases6.9 years7.1 years6.9 years7.1 years
Weighted-average discount rate — finance leases %— % %— %
Weighted-average discount rate — operating leases6.3 %6.1 %6.3 %6.1 %

The aggregate annual lease obligations as of December 31, 2023 are as follows:
Operating Leases
Remainder of 2024$6,054,892 
202521,532,117 
202618,010,788 
202713,832,252 
202811,124,461 
Thereafter31,854,653 
Total undiscounted lease liability$102,409,163 
Imputed interest19,938,057 
Total discounted lease liability$82,471,106 

The Company had no leases with related parties at December 31, 2023 or March 31, 2023.
v3.24.0.1
AVERAGE SHARE INFORMATION
9 Months Ended
Dec. 31, 2023
Earnings Per Share [Abstract]  
AVERAGE SHARE INFORMATION AVERAGE SHARE INFORMATION
The following is a summary of the basic and diluted average common shares outstanding:
Three months ended December 31,Nine months ended December 31,
2023202220232022
Basic:  
Weighted average common shares outstanding (denominator)5,772,503 5,761,954 5,775,108 5,743,094 
Diluted:  
Weighted average common shares outstanding5,772,503 5,761,954 5,775,108 5,743,094 
Dilutive potential common shares287,614 95,536 121,608 — 
Weighted average diluted shares outstanding (denominator)5,860,117 5,857,490 5,896,716 5,743,094 
 
Options to purchase 291,826 and 332,275 shares of common stock at various prices were outstanding during the three months ended December 31, 2023 and 2022, respectively, but were not included in diluted shares outstanding because the option exercise price exceeded the market value of the shares. 
Options to purchase 299,904 and 338,154 shares of common stock at various prices were outstanding during the nine months ended December 31, 2023 and 2022, respectively, but were not included in diluted shares outstanding because the option exercise price exceeded the market value of the shares.
v3.24.0.1
STOCK-BASED COMPENSATION
9 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
STOCK-BASED COMPENSATION STOCK-BASED COMPENSATION
Stock Incentive Plans

The Company maintains the 2008 Plan, the 2011 Plan and the 2017 Plan for the benefit of certain non-employee directors, officers, and key employees. Under these plans, a total of 3,350,000 shares of authorized common stock have been reserved for issuance pursuant to grants approved by the Compensation Committee. Stock options granted under these plans have a maximum term of 10 years, may be subject to certain vesting requirements, which are generally three to six years for officers, non-employee directors, and key employees, and are priced at the market value of the Company's common stock on the option's grant date. At December 31, 2023, there were a total of 165,196 shares of common stock remaining available for grant under the 2017 Plan.

Stock-based compensation is recognized as provided under FASB ASC Topic 718-10 and FASB ASC Topic 505-50. FASB ASC Topic 718-10 requires all share-based payments to employees, including grants of employee stock options, to be recognized as compensation expense over the requisite service period (generally the vesting period) in the Consolidated Financial Statements based on their grant date fair values. Stock-based compensation related to restricted stock is based on the number of shares expected to vest and the fair market value of the common stock on the grant date. The Company has applied the Black-Scholes valuation model in determining the grant date fair value of stock option awards. Compensation expense is recognized only for those awards expected to vest.

Long-term Incentive Program and Non-Employee Director Awards

On October 15, 2018, the Compensation Committee and Board approved and adopted a long-term incentive program that seeks to motivate and reward certain employees and to align management’s interest with shareholders’ interest by focusing executives on the achievement of long-term results. The program is comprised of four components: Service Options, Performance Options, Restricted Stock, and Performance Shares.

Pursuant to this program, in fiscal 2019, the Compensation Committee approved certain grants of Service Options, Performance Options, Restricted Stock and Performance Shares under the 2011 Plan and the 2017 Plan to certain employee directors, vice presidents of operations, vice presidents, senior vice presidents, and executive officers. Separately, the Compensation Committee approved certain grants of Service Options and Restricted Stock to certain of the Company’s non-employee directors.

Under the long-term incentive program, up to 100% of the shares of restricted stock subject to the Performance Shares will vest, if at all, based on the achievement of two trailing earnings per share performance targets established by the Compensation Committee that are based on earnings per share (measured at the end of each calendar quarter, commencing with the calendar quarter ending September 30, 2019) for the previous four calendar quarters. The Performance Shares are eligible to vest over the Performance Share Measurement Period, subject to each respective employee’s continued employment at the Company through the last day of the Performance Share Measurement Period (or as otherwise provided under the terms of the applicable award agreement or applicable employment agreement).

The Performance Share performance targets are set forth below.
Trailing 4-Quarter EPS Targets for
September 30, 2018 through March 31, 2025
Restricted Stock Eligible for Vesting
(Percentage of Award)
$16.3540%
$20.4560%

The Restricted Stock awards typically vest in six equal annual installments, beginning on the first anniversary of the grant date, subject to each respective employee’s continued employment at the Company through each applicable vesting date or otherwise provided under the terms of the applicable award agreement or applicable employment agreement.

The Service Options typically vest in three equal annual installments, beginning on the first anniversary of the grant date, subject to each respective employee’s continued employment at the Company through each applicable vesting date or otherwise provided under the terms of the applicable award agreement or applicable employment agreement. The option price is equal to the fair market value of the common stock on the grant date and the Service Options have a 10-year term.

The Performance Options will fully vest if the Company attains the trailing earnings per share target over four consecutive calendar quarters occurring between September 30, 2018 and March 31, 2025 described below. Such performance target was
established by the Compensation Committee and will be measured at the end of each calendar quarter commencing on September 30, 2019. The Performance Options are eligible to vest over the Option Measurement Period, subject to each respective employee’s continued employment at the Company through the last day of the Option Measurement Period or as otherwise provided under the terms of the applicable award agreement or applicable employment agreement. The option price is equal to the fair market value of the common stock on the grant date and the Performance Options have a 10-year term. The Performance Option performance target is set forth below.

Trailing 4-Quarter EPS Targets for
September 30, 2018 through March 31, 2025
Options Eligible for Vesting
(Percentage of Award)
$25.30100%

Stock Options

The weighted-average fair value at the grant date for options issued during the three months ended December 31, 2023 and 2022 was $68.52 and $44.23, respectively. The weighted-average fair value at the grant date for options issued during the nine months ended December 31, 2023 and 2022 was $69.00 and $53.51, respectively.

Fair value was estimated at grant date using the weighted-average assumptions listed below:
Three months ended December 31,Nine months ended December 31,
2023202220232022
Dividend yield—%—%—%—%
Expected volatility62.54%57.46%62.55%57.09%
Average risk-free rate4.70%3.91%4.69%3.59%
Expected life4.6 years5.8 years4.6 years5.8 years

The expected stock price volatility is based on the historical volatility of the Company's common stock for a period approximating the expected life. The expected life represents the period of time that options are expected to be outstanding after the grant date. The risk-free rate reflects the interest rate at grant date on zero coupon U.S. governmental bonds having a remaining life similar to the expected option term.

Option activity for the nine months ended December 31, 2023 was as follows:
 SharesWeighted Average Exercise
Price
Weighted Average
Remaining
Contractual Term
Aggregate Intrinsic Value
Options outstanding, beginning of period314,742 $104.41   
Granted during period2,598 124.67   
Exercised during period(22,847)88.34   
Forfeited during period(11,027)122.25   
Expired during period(2,682)162.17   
Options outstanding, end of period280,784  3$104.66 5.2 years$8,250,477 
Options exercisable, end of period128,057 $105.11 5.1 years$3,919,056 
 
The aggregate intrinsic value reflected in the table above represents the total pre-tax intrinsic value (the difference between the closing stock price on December 31, 2023 and the exercise price, multiplied by the number of in-the-money options that are currently exercisable) that would have been received by option holders had all option holders exercised their options as of December 31, 2023. This amount will change as the market price of the common stock changes. The total intrinsic value of options exercised during the periods ended December 31, 2023 and 2022 was as follows:
December 31,
2023
December 31,
2022
Three months ended$369,543 $51,106 
Nine months ended$810,853 $481,572 
 
As of December 31, 2023, total unrecognized stock-based compensation expense related to non-vested stock options amounted to approximately $0.6 million, which is expected to be recognized over a weighted-average period of approximately 1.3 years.

Restricted Stock

During the first nine months of fiscal 2024, the Company granted 3,993 shares of restricted stock (which are equity classified) to certain vice presidents and senior vice presidents with a grant date weighted average fair value of $120.12 per share.

During fiscal 2023, the Company granted 3,250 shares of restricted stock (which are equity classified) to certain vice presidents with a grant date weighted average fair value of $129.85 per share.

As of December 31, 2023, there was approximately $1.9 million of unrecognized compensation cost related to unvested restricted stock awards, which is expected to be recognized over the next 0.9 years based on current estimates.

A summary of the status of the Company’s restricted stock as of December 31, 2023, and changes during the nine months ended December 31, 2023, are presented below:
 SharesWeighted Average Fair Value at Grant Date
Outstanding at March 31, 2023460,614 $101.82 
Granted during the period3,993 120.12 
Vested during the period(62,983)103.85 
Forfeited during the period(13,047)116.56 
Outstanding at December 31, 2023388,577 $101.18 
 
Total Stock-Based Compensation

Total stock-based compensation included as a component of personnel expenses in the Company's Consolidated Statements of Operations during the three and nine month periods ended December 31, 2023 and 2022 was as follows:
Three months ended December 31,Nine months ended December 31,
2023202220232022
Stock-based compensation related to equity classified awards:
Stock-based compensation (reversal) related to stock options4$189,582 $425,120 $(3,871,348)$1,869,879 
Stock-based compensation (reversal) related to restricted stock, net of adjustments and exclusive of cancellations5(690,699)(679,443)1,475,151 5,512,434 
Total stock-based compensation (reversal) related to equity classified awards$(501,117)$(254,323)$(2,396,197)$7,382,313 
v3.24.0.1
ACQUISITIONS
9 Months Ended
Dec. 31, 2023
Business Combination and Asset Acquisition [Abstract]  
ACQUISITIONS ACQUISITIONS
The Company evaluates each set of assets and activities it acquires to determine if the set meets the definition of a business according to FASB ASC Topic 805-10-55. Acquisitions meeting the definition of a business are accounted for as a business combination while all other acquisitions are accounted for as asset purchases.

The following table sets forth the Company's acquisition activity for the nine months ended December 31, 2023 and 2022:
 Nine months ended December 31,
20232022
Acquisitions:
Number of loan portfolios acquired through asset purchases 43 
Total acquisitions 43 
Purchase price$ $22,314,902 
Tangible assets: 
Loans receivable, net 27,105,078 
Purchase price amount below carrying value of net tangible assets6$ $(4,790,176)

Acquisitions that are accounted for as business combinations typically result in one or more new branches. In such cases, the Company typically retains the existing employees and the branch location from the acquisition. The purchase price is allocated to the tangible assets and intangible assets acquired based upon their estimated fair market values at the acquisition date. The remainder is allocated to goodwill.

Acquisitions that are accounted for as asset purchases are typically limited to acquisitions of loan portfolios. The purchase price is allocated to the tangible assets and intangible assets acquired based upon their estimated fair market values at the acquisition date. In an asset purchase, no goodwill is recorded.

The Company’s acquisitions include tangible assets (generally loans and furniture and equipment) and intangible assets (generally non-compete agreements, customer lists, and goodwill), both of which are recorded at their fair values, which are estimated pursuant to the processes described below.

Acquired loans are valued at the net loan balance. Given the short-term nature of these loans, generally less than twelve months, and that these loans are priced at current rates, management believes the net loan balances approximate their fair value. Under CECL, acquired loans are included in the reserve calculations for all loan types (excluding TALs). Management includes recent acquisition activity compared to historical activity when considering reasonable and supportable forecasts as it relates to assessing the adequacy of the allowance for expected credit losses. The Company did not acquire any loans that would qualify as PCDs during the nine months ended December 31, 2023 and 2022.

Furniture and equipment are valued at the specific purchase price as agreed to by both parties at the time of acquisition, which management believes approximates their fair values.

Non-compete agreements are valued at the stated amount paid to the other party for these agreements, which the Company believes approximates their fair values.
Customer lists are valued with a valuation model that utilizes the Company’s historical data to estimate the value of any acquired customer lists. Customer lists are allocated at a branch level and are evaluated for impairment at a branch level when a triggering event occurs in accordance with FASB ASC Topic 360-10-05. If a triggering event occurs, the impairment loss to the customer list is generally the remaining unamortized customer list balance. In most acquisitions, the original fair value of the customer list allocated to a branch is less than $100,000, and management believes that in the event a triggering event were to occur, the impairment loss to an unamortized customer list would be immaterial.

The estimated results of all acquisitions have been included in the Company’s Consolidated Financial Statements since the respective acquisition date. The pro forma impact of these branches as though they had been acquired at the beginning of the periods presented would not have a material effect on the results of operations as reported.
v3.24.0.1
DEBT
9 Months Ended
Dec. 31, 2023
Debt Disclosure [Abstract]  
DEBT DEBT
Senior Notes Payable; Revolving Credit Facility

On November 9, 2023, the Company amended its revolving credit agreement ("Eleventh Amendment") to (i) permit the Company to repurchase up to $20 million of Company securities in its fiscal quarter ending December 31, 2023 and (ii) not require the minimum fixed charges coverage ratio to be at least 2.0 to 1.0 for the fiscal quarter ending September 30, 2023 in order to make such repurchases.

At December 31, 2023, the Company's senior notes payable consisted of a $580.0 million senior revolving credit facility, which has an accordion feature permitting the maximum aggregate commitments to increase to $730.0 million provided that certain conditions are met.

At December 31, 2023, $305.1 million was outstanding under the Company's credit facility, not including a $524.0 thousand outstanding standby letter of credit related to workers compensation under a $1.5 million sub-facility. To the extent that the letter of credit is drawn upon, the disbursement will be funded by the credit facility. There are no amounts due related to the letter of credit as of December 31, 2023. The letter of credit expires on December 31, 2024 and automatically extends for one year on the expiration date. Subject to a borrowing base formula, the Company may borrow at the rate of one month SOFR plus 0.10% and an applicable margin of 3.5% with a minimum rate of 4.5%. The revolving credit facility has a commitment fee of 0.50% per annum on the unused portion of the commitment. Commitment fees on the unused portion of the borrowing totaled $1.3 million and $0.9 million for the nine months ended December 31, 2023 and 2022, respectively.

For the nine months ended December 31, 2023 and fiscal year ended March 31, 2023, the Company’s effective interest rate, including the commitment fee and amortization of debt issuance costs, was 9.8% annualized and 7.0%, respectively. At December 31, 2023, the unused amount available under the revolving credit facility was $274.4 million and borrowings under the revolving credit facility mature on June 7, 2026.

Substantially all of the Company’s assets are pledged as collateral for borrowings under the revolving credit agreement.

Senior Unsecured Notes Payable

On September 27, 2021, we issued $300 million in aggregate principal amount of 7.0% senior notes due 2026. The Notes were sold in a private placement in reliance on Rule 144A and Regulation S under the Securities Act of 1933, as amended. The Notes are unconditionally guaranteed, jointly and severally, on a senior unsecured basis by all of the Company’s existing and certain of its future subsidiaries that guarantee the revolving credit facility. Interest on the Notes is payable semi-annually in arrears on May 1 and November 1 of each year, commencing May 1, 2022. At any time prior to November 1, 2023, the Company could have redeemed the Notes, in whole or in part, at a redemption price equal to 100% of the principal amount plus a make-whole premium, as described in the indenture, plus accrued and unpaid interest, if any, to, but not including, the date of redemption. At any time on or after November 1, 2023, the Company may redeem the Notes at redemption prices set forth in the indenture, plus accrued and unpaid interest, if any, to, but not including, the date of redemption. In addition, at any time prior to November 1, 2023, the Company could have used the proceeds of certain equity offerings to redeem up to 40.0% of the aggregate principal amount of the Notes issued under the indenture at a redemption price equal to 107.0% of the principal amount of Notes redeemed, plus accrued and unpaid interest, if any, to, but not including, the date of redemption.

We used the net proceeds from this offering to repay a portion of the outstanding indebtedness under our revolving credit facility and for general corporate purposes.
During the fourth quarter of fiscal 2023, the Company repurchased and extinguished $9.1 million of its Notes, net of $0.1 million unamortized debt issuance costs related to the extinguished debt, on the open market for a reacquisition price of $7.2 million.

During the first nine months of fiscal 2024, the Company repurchased and extinguished $8.25 million of its Notes, net of $88.1 thousand unamortized debt issuance costs related to the extinguished debt, on the open market for a reacquisition price of $7.0 million. For the three and nine months ended December 31, 2023, the Company recognized a $0.6 million and $1.2 million gain on extinguishment, respectively. In accordance with ASC 470, the Company recognized the gain on extinguishment as a component of interest expense in the Company's Consolidated Statements of Operations.

Debt Covenants

The agreement governing the Company’s revolving credit facility contains affirmative and negative covenants, including covenants that generally restrict the ability of the Company and its subsidiaries to, among other things, incur or guarantee indebtedness, incur liens, pay dividends and repurchase or redeem capital stock, dispose of assets, engage in mergers and consolidations, make acquisitions or other investments, redeem or prepay subordinated debt, amend subordinated debt documents, make changes in the nature of its business, and engage in transactions with affiliates. The agreement allows the Company to incur subordinated debt that matures after the termination date for the revolving credit facility and that contains specified subordination terms, subject to limitations on amount imposed by the financial covenants under the agreement. The agreement's financial covenants include (i) a minimum consolidated net worth of $325.0 million on and after December 31, 2020; (ii) a maximum ratio of total debt to consolidated adjusted net worth of 2.5 to 1.0 (decreasing to 2.25 to 1.0 for the fiscal quarters ending March 31, 2023 and June 30, 2023, 2.0 to 1.0 for the fiscal quarter ending September 30, 2023, and 2.25 to 1.0 for the fiscal quarter ending December 31, 2023); (iii) a maximum collateral performance indicator of 26% as of the end of each calendar month (increasing to 28% for the calendar months ending October 31, 2022 through June 30, 2023); and (iv) a minimum fixed charges coverage ratio of 1.25 to 1.0 for the fiscal quarter ended December 31, 2022, 1.15 to 1.0 for the fiscal quarters ending March 31, 2023 and June 30, 2023, 1.50 to 1.0 for the fiscal quarter ending September 30, 2023, 2.0 to 1.0 for the fiscal quarter ending December 31, 2023, and 2.25 to 1.0 for each fiscal quarter thereafter, where the ratio for the most recent four consecutive fiscal quarters must be at least 2.0 to 1.0, other than for the fiscal quarter ending September 30, 2023, in order for the Company to declare dividends or purchase any class or series of its capital stock or other equity.

The collateral performance indicator is equal to the sum of (a) a three-month rolling average rate of receivables at least sixty days past due and (b) an eight-month rolling average net charge-off rate.

The Company was in compliance with these covenants at December 31, 2023 and does not believe that these covenants will materially limit its business and expansion strategy.

The agreement contains events of default including, without limitation, nonpayment of principal, interest or other obligations, violation of covenants, misrepresentation, cross-default to other debt, bankruptcy and other insolvency events, judgments, certain ERISA events, actual or asserted invalidity of loan documentation, invalidity of subordination provisions of subordinated debt, certain changes of control of the Company, and the occurrence of certain regulatory events, (including the entry of any stay, order, judgment, ruling or similar event related to the Company’s or any of its subsidiaries’ originating, holding, pledging, collecting or enforcing its eligible loans receivable that is material to the Company or any subsidiary) which remains unvacated, undischarged, unbonded or unstayed by appeal or otherwise for a period of 60 days from the date of its entry and is reasonably likely to cause a material adverse change.

The indenture governing the Notes contains certain covenants that, among other things, limit the Company’s ability and the ability of its restricted subsidiaries to (i) incur additional indebtedness or issue certain disqualified stock and preferred stock; (ii) pay dividends or distributions or redeem or purchase capital stock; (iii) prepay subordinated debt or make certain investments; (iv) transfer and sell assets; (v) create or permit to exist liens; (vi) enter into agreements that restrict dividends, loans and other distributions from their subsidiaries; (vii) engage in a merger, consolidation or sell, transfer or otherwise dispose of all or substantially all of their assets; and (viii) engage in transactions with affiliates. However, these covenants are subject to a number of important detailed qualifications and exceptions.

Debt Maturities
The aggregate annual maturities of the Company's debt arrangements as of December 31, 2023 are as follows:

Amount
Remainder of 2024$— 
2025— 
2026— 
2027587,699,480 
2028— 
Total future debt payments$587,699,480 
v3.24.0.1
INCOME TAXES
9 Months Ended
Dec. 31, 2023
Income Tax Disclosure [Abstract]  
INCOME TAXES INCOME TAXES
As of December 31, 2023 and March 31, 2023, the Company had $1.0 million and $1.1 million, respectively, of total gross unrecognized tax benefits including interest. Approximately $0.8 million and $0.9 million, respectively, represent the amount of net unrecognized tax benefits that are permanent in nature and, if recognized, would affect the annual effective tax rate. At December 31, 2023, approximately $0.4 million of gross unrecognized tax benefits are expected to be resolved during the next twelve months through the expiration of the statute of limitations and settlement with taxing authorities. The Company’s continuing practice is to recognize interest and penalties related to income tax matters in income tax expense. The Company had approximately $296.8 thousand accrued for gross interest as of December 31, 2023, and accrued $3.9 thousand during the nine months ended December 31, 2023.

Investment in HTC was $19.4 million and $23.0 million as of December 31, 2023 and March 31, 2023, respectively, which is included as a component of Other assets, net in the Consolidated Balance Sheets. The Company recognized net amortization from these investments of $1.2 million and $0.4 million during the three months ended December 31, 2023 and 2022, respectively, and $3.2 million and $1.7 million during the nine months ended December 31, 2023 and 2022, respectively, in income tax expense. The Company recognized tax benefits from these investments of $1.2 million and $0.5 million during the three months ended December 31, 2023 and 2022, respectively, and $3.6 million and $1.5 million during the nine months ended December 31, 2023 and 2022, respectively, in income tax expense and in Income taxes payable in the Consolidated Statements of Cash Flows. The Company did not recognize any non-tax related activity or have any significant modifications in the investments during the current period.
 
The Company is subject to U.S. income taxes, as well as taxes in various other state and local jurisdictions. With the exception of a few states, the Company is no longer subject to U.S. federal, state and local, or non-U.S. income tax examinations by tax authorities for years before 2019, although carryforward attributes that were generated prior to 2019 may still be adjusted upon examination by the taxing authorities if they either have been or will be used in a future period.
v3.24.0.1
COMMITMENTS AND CONTINGENCIES
9 Months Ended
Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES COMMITMENTS AND CONTINGENCIES
General

From time to time the Company is involved in litigation matters relating to claims arising out of its operations in the normal course of business.

Estimating an amount or range of possible losses resulting from litigation, government actions and other legal proceedings is inherently difficult and requires an extensive degree of judgment, particularly where the matters involve indeterminate claims for monetary damages, may involve fines, penalties or damages that are discretionary in amount, involve a large number of claimants or significant discretion by regulatory authorities, represent a change in regulatory policy or interpretation, present novel legal theories, are in the early stages of the proceedings, are subject to appeal or could result in a change in business practices. In addition, because most legal proceedings are resolved over extended periods of time, potential losses are subject to change due to, among other things, new developments, changes in legal strategy, the outcome of intermediate procedural and substantive rulings and other parties’ settlement posture and their evaluation of the strength or weakness of their case against us. However, in light of the inherent uncertainties involved, an adverse outcome in one or more of these matters could materially and adversely affect the Company’s financial condition, results of operations or cash flows in any particular reporting period.
v3.24.0.1
SUBSEQUENT EVENTS
9 Months Ended
Dec. 31, 2023
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS SUBSEQUENT EVENTS
Management is not aware of any significant events occurring subsequent to the balance sheet date that would have a material effect on the financial statements thereby requiring adjustment or disclosure.
v3.24.0.1
Pay vs Performance Disclosure - USD ($)
3 Months Ended 9 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Pay vs Performance Disclosure        
Net income (loss) $ 16,664,818 $ 5,804,586 $ 42,285,985 $ (3,399,465)
v3.24.0.1
Insider Trading Arrangements
3 Months Ended
Dec. 31, 2023
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.24.0.1
SUMMARY OF SIGNIFICANT POLICIES (Policies)
9 Months Ended
Dec. 31, 2023
Accounting Policies [Abstract]  
Nature of Operations
Nature of Operations

The Company is a small-loan consumer finance company headquartered in Greenville, South Carolina that offers short-term small loans, medium-term larger loans, related credit insurance products and ancillary products and services to individuals who have limited access to other sources of consumer credit. The Company offers income tax return preparation services to its loan customers and other individuals.
Seasonality
Seasonality

The Company's loan volume and corresponding loans receivable follow seasonal trends. The Company's highest loan demand generally occurs from October through December, its third fiscal quarter. Loan demand is generally lowest and loan repayment highest from January to March, its fourth fiscal quarter. Loan volume and average balances remain relatively level during the remainder of the year. Consequently, the Company experiences significant seasonal fluctuations in its operating results and cash needs. Operating results for the Company's third fiscal quarter are generally lower than in other quarters, and operating results for its fourth fiscal quarter are generally higher than in other quarters.
Loans receivable, net
Loans receivable, net

Loans receivable are carried at the gross amount outstanding, reduced by unearned interest and insurance income, net of deferred origination fees and direct costs, and an allowance for credit losses. Fees received and direct costs incurred for the origination of loans are deferred and amortized to interest income over the contractual lives of the loans using the interest method. Unamortized amounts are recognized in income at the time that loans are refinanced or paid in full except for those refinancings that do not constitute a more than minor modification. Net unamortized deferred origination costs were $5.6 million and $4.9 million as of December 31, 2023 and March 31, 2023, respectively.

From time to time, the Company may sell charged off loans receivable, which are accounted for as a sale in accordance with ASC 860, Transfers and Servicing.
Allowance for credit losses
Allowance for credit losses

Refer to Note 4, “Loans Receivable and Allowance for Credit Losses,” for information regarding the Company's CECL allowance model and a description of the methodology it utilizes.
Reclassification
Reclassification

Certain prior period amounts have been reclassified to conform to the current presentation. Such reclassifications had no impact on previously reported net income (loss) or shareholders' equity, with the exception of the following.
As a result of adopting ASU 2023-02, Investments- Equity Method and Joint Venture (Topic 323), in March 2023 with an effective date of April 1, 2022, previously reported net income for the three months ended December 31, 2022, net loss for the nine months ended December 31, 2022 and shareholders' equity as of December 31, 2022 were immaterially impacted to conform to the modified retrospective application of this newly adopted ASU
Recently Adopted Accounting Standards and Recently Issued Accounting Standards Not Yet Adopted
Recently Adopted Accounting Standards

Troubled Debt Restructurings and Vintage Disclosures

In March 2022, the FASB issued ASU 2022-02, Troubled Debt Restructurings and Vintage Disclosures. The amendments in this update eliminated the accounting guidance for troubled debt restructurings by creditors in Subtopic 310-40, Receivables—Troubled Debt Restructurings by Creditors, while enhancing disclosure requirements for certain loan refinancings and restructurings by creditors when a borrower is experiencing financial difficulty. Additionally, for public business entities, the amendments in this update require that an entity disclose current-period gross write-offs by year of origination for financing receivables and net investments in leases within the scope of Subtopic 326-20, Financial Instruments—Credit Losses—Measured at Amortized Cost. The adoption of ASU 2022-02 on April 1, 2023 expanded our gross charge-off disclosures, but had no other impact on the Company’s Consolidated Financial Statements.

Recently Issued Accounting Standards Not Yet Adopted

Improvements to Reportable Segment Disclosures

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which improves reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendments are effective for fiscal years beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The amendments should be applied retrospectively to all prior periods presented in the financial statements. Management is currently evaluating this ASU to determine its impact on the Company's Consolidated Financial Statements and related disclosures.

Improvements to Income Tax Disclosures

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which modifies the rules on income tax disclosures to require entities to expand annual disclosures to 1) include specific categories in the rate reconciliation and additional information for reconciling items that meet a quantitative threshold and 2) disclose the amount of income taxes paid (net of refunds received) disaggregated by federal, state and foreign taxes. ASU 2023-09 also requires entities to disclose income (or loss) from continuing operations before income tax expense (or benefit) disaggregated between domestic and foreign, and income tax expense (or benefit) from continuing operations disaggregated by federal, state and foreign, among other changes. The amendments are effective for annual periods beginning after December 15, 2024. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. ASU 2023-09 should be applied on a prospective basis, but retrospective application is permitted. Management is currently evaluating this ASU to determine its impact on the Company's Consolidated Financial Statements and related disclosures.

We reviewed all other newly issued accounting pronouncements and concluded that they are either not applicable to our business or are not expected to have a material effect on the Consolidated Financial Statements and related disclosures as a result of future adoption.
v3.24.0.1
FAIR VALUE (Tables)
9 Months Ended
Dec. 31, 2023
Fair Value Disclosures [Abstract]  
Schedule of Fair Values of Financial Assets and Liabilities
The carrying amounts and estimated fair values of financial assets and liabilities disclosed but not carried at fair value and their level within the fair value hierarchy are summarized below.
December 31, 2023March 31, 2023
Input LevelCarrying ValueEstimated Fair ValueCarrying ValueEstimated Fair Value
ASSETS
Cash and cash equivalents1$12,775,524 $12,775,524 $16,508,935 $16,508,935 
Loans receivable, net3907,229,249 907,229,249 887,788,486 887,788,486 
LIABILITIES
Senior unsecured notes payable2282,610,000 257,517,058 290,860,000 218,127,548 
Senior notes payable3305,089,480 305,089,480 307,910,824 307,910,824 
v3.24.0.1
LOANS RECEIVABLE AND ALLOWANCE FOR CREDIT LOSSES (Tables)
9 Months Ended
Dec. 31, 2023
Receivables [Abstract]  
Schedule of Gross Loans Receivable by Customer Tenure
The following is a summary of gross loans receivable by Customer Tenure as of:
Customer TenureDecember 31, 2023March 31, 2023
0 to 5 months$88,474,205 $81,803,668 
6 to 17 months83,641,505 133,650,188 
18 to 35 months154,272,047 135,396,187 
36 to 59 months212,663,970 244,414,255 
60+ months861,562,368 792,189,216 
Tax advance loans7,894 2,562,054 
Total gross loans$1,400,621,989 $1,390,015,568 
The following table presents unpaid accrued interest reversed against interest income by Customer Tenure for the three and nine months ended December 31, 2023 and December 31, 2022:

Three months ended December 31,Nine months ended December 31,
2023202220232022
Customer Tenure
0 to 5 months$(1,358,755)$(1,813,804)$(3,904,031)$(8,117,103)
6 to 17 months(777,293)(1,627,586)(2,651,226)(4,605,102)
18 to 35 months(946,820)(1,285,309)(2,609,760)(3,862,834)
36 to 59 months(1,065,935)(1,365,428)(3,211,393)(3,543,651)
60+ months(2,822,515)(3,352,265)(7,972,048)(9,724,169)
Total$(6,971,318)$(9,444,392)$(20,348,458)$(29,852,859)
Schedule of Payment Performance on a Recency Basis
The following table provides a breakdown of the Company’s gross loans receivable by current payment performance on a recency basis and year of origination at December 31, 2023:
Term Loans By Origination
LoansUp to
1
Year Ago
Between
1 and 2
Years Ago
Between
2 and 3
Years Ago
Between
3 and 4
Years Ago
Between
4 and 5
Years Ago
More than
5
Years Ago
Total
Current$1,199,541,510 $67,910,482 $4,917,687 $119,767 $36,259 $8,904 $1,272,534,609 
30 - 60 days past due39,988,200 5,754,817 604,508 28,282 15,556 3,633 46,394,996 
61 - 90 days past due25,958,915 3,677,614 285,870 14,542 18,404 1,843 29,957,188 
91 or more days past due43,659,995 7,522,539 512,369 21,530 5,091 5,778 51,727,302 
Total$1,309,148,620 $84,865,452 $6,320,434 $184,121 $75,310 $20,158 $1,400,614,095 
Term Loans By Origination
Tax advance loansUp to
1
Year Ago
Between
1 and 2
Years Ago
Between
2 and 3
Years Ago
Between
3 and 4
Years Ago
Between
4 and 5
Years Ago
More than
5
Years Ago
Total
Current$2,294 $— $— $— $— $— $2,294 
30 - 60 days past due2,508 — — — — — 2,508 
61 - 90 days past due3,092 — — — — — 3,092 
91 or more days past due— — — — — — — 
Total$7,894 $— $— $— $— $— $7,894 
Total gross loans$1,400,621,989 

The following table provides a breakdown of the Company’s gross loans receivable by current payment performance on a recency basis and year of origination at March 31, 2023:
Term Loans By Origination
LoansUp to
1
Year Ago
Between
1 and 2
Years Ago
Between
2 and 3
Years Ago
Between
3 and 4
Years Ago
Between
4 and 5
Years Ago
More than
5
Years Ago
Total
Current$1,200,504,088 $62,076,656 $1,998,218 $148,662 $23,046 $6,863 $1,264,757,533 
30 - 60 days past due40,791,746 4,689,867 160,956 42,700 8,504 2,988 45,696,761 
61 - 90 days past due26,319,250 2,572,733 92,088 40,281 884 — 29,025,236 
91 or more days past due41,832,821 5,944,645 160,361 29,494 4,430 2,233 47,973,984 
Total$1,309,447,905 $75,283,901 $2,411,623 $261,137 $36,864 $12,084 $1,387,453,514 
Term Loans By Origination
Tax advance loansUp to
1
Year Ago
Between
1 and 2
Years Ago
Between
2 and 3
Years Ago
Between
3 and 4
Years Ago
Between
4 and 5
Years Ago
More than
5
Years Ago
Total
Current$1,932,607 $3,524 $— $— $— $— $1,936,131 
30 - 60 days past due609,844 736 — — — — 610,580 
61 - 90 days past due— 4,845 — — — — 4,845 
91 or more days past due409 10,089 — — — — 10,498 
Total$2,542,860 $19,194 $— $— $— $— $2,562,054 
Total gross loans$1,390,015,568 

The following table provides a breakdown of the Company’s gross loans receivable by current payment performance on a contractual basis and year of origination at December 31, 2023:
Term Loans By Origination
LoansUp to
1
Year Ago
Between
1 and 2
Years Ago
Between
2 and 3
Years Ago
Between
3 and 4
Years Ago
Between
4 and 5
Years Ago
More than
5
Years Ago
Total
Current$1,188,126,383 $60,651,793 $3,944,841 $52,853 $12,484 $652 $1,252,789,006 
30 - 60 days past due40,230,196 3,897,049 250,587 941 1,006 — 44,379,779 
61 - 90 days past due28,592,002 3,484,278 236,372 1,646 — 296 32,314,594 
91 or more days past due52,200,038 16,832,332 1,888,635 128,681 61,820 19,210 71,130,716 
Total$1,309,148,619 $84,865,452 $6,320,435 $184,121 $75,310 $20,158 $1,400,614,095 
Term Loans By Origination
Tax advance loansUp to
1
Year Ago
Between
1 and 2
Years Ago
Between
2 and 3
Years Ago
Between
3 and 4
Years Ago
Between
4 and 5
Years Ago
More than
5
Years Ago
Total
Current$— $— $— $— $— $— $— 
30 - 60 days past due439 — — — — — 439 
61 - 90 days past due1,714 — — — — — 1,714 
91 or more days past due5,741 — — — — — 5,741 
Total$7,894 $— $— $— $— $— $7,894 
Total gross loans$1,400,621,989 

The following table provides a breakdown of the Company’s gross loans receivable by current payment performance on a contractual basis and year of origination at March 31, 2023:
Term Loans By Origination
LoansUp to
1
Year Ago
Between
1 and 2
Years Ago
Between
2 and 3
Years Ago
Between
3 and 4
Years Ago
Between
4 and 5
Years Ago
More than
5
Years Ago
Total
Current$1,174,237,761 $53,652,011 $1,554,144 $64,233 $5,142 $1,491 $1,229,514,782 
30 - 60 days past due47,346,331 3,661,493 77,857 6,714 — — 51,092,395 
61 - 90 days past due33,012,804 3,030,052 44,129 7,643 — — 36,094,628 
91 or more days past due54,851,010 14,940,345 735,493 182,547 31,721 10,593 70,751,709 
Total$1,309,447,906 $75,283,901 $2,411,623 $261,137 $36,863 $12,084 $1,387,453,514 
Term Loans By Origination
Tax advance loansUp to
1
Year Ago
Between
1 and 2
Years Ago
Between
2 and 3
Years Ago
Between
3 and 4
Years Ago
Between
4 and 5
Years Ago
More than
5
Years Ago
Total
Current$1,932,607 $— $— $— $— $— $1,932,607 
30 - 60 days past due609,844 — — — — — 609,844 
61 - 90 days past due— — — — — — — 
91 or more days past due409 19,194 — — — — 19,603 
Total$2,542,860 $19,194 $— $— $— $— $2,562,054 
Total gross loans$1,390,015,568 

The following table provides a breakdown of the Company’s gross charge-offs by year of origination for the three and nine months ended December 31, 2023:

Three months ended December 31,Nine months ended December 31,
Gross Charge-offs by OriginationGross Charge-offs by Origination
Origination by Calendar YearLoansTax advance loansTotalLoansTax advance loansTotal
2018 and prior$1,958 $— $1,958 $9,686 $— $9,686 
20192,448 — 2,448 19,986 — 19,986 
202032,909 — 32,909 177,372 — 177,372 
2021943,234 — 943,234 5,589,791 — 5,589,791 
202215,175,088 188 15,175,276 95,994,906 5,436 96,000,342 
202338,460,870 118,287 38,579,157 54,171,402 1,260,035 55,431,437 
Total$54,616,507 $118,475 $54,734,982 $155,963,143 $1,265,471 $157,228,614 
The following table provides a breakdown of the Company’s gross charge-offs by year of origination for the three and nine months ended December 31, 2022:
Three months ended December 31,Nine months ended December 31,
Gross Charge-offs by OriginationGross Charge-offs by Origination
Origination by Calendar YearLoansTax advance loansTotalLoansTax advance loansTotal
2017 and prior$656 $— $656 $10,102 $— $10,102 
201819,203 — 19,203 39,797 — 39,797 
2019158,346 — 158,346 334,091 — 334,091 
2020441,199 — 441,199 2,591,494 — 2,591,494 
202119,276,965 263 19,277,228 125,968,883 19,885 125,988,768 
202266,102,716 383,534 66,486,250 97,354,602 2,413,550 99,768,152 
Total$85,999,085 $383,797 $86,382,882 $226,298,969 $2,433,435 $228,732,404 
Summary of Changes in the Allowance for Loan Losses
The following table presents a roll forward of the allowance for credit losses for the three and nine months ended December 31, 2023 and 2022:
Three months ended December 31,Nine months ended December 31,
2023202220232022
Beginning balance$128,892,192 $155,892,100 $125,552,733 $134,242,862 
Provision for credit losses40,631,994 59,608,655 127,697,072 214,051,068 
Charge-offs(54,734,982)(86,382,882)(157,228,614)(228,732,404)
Recoveries16,292,864 15,421,670 25,060,877 24,978,017 
Net charge-offs(48,442,118)(70,961,212)(132,167,737)(203,754,387)
Ending Balance$121,082,068 $144,539,543 $121,082,068 $144,539,543 
Summary of the Past Due Receivables
The following table is an aging analysis on a recency basis at amortized cost of the Company’s gross loans receivable at December 31, 2023:
Days Past Due - Recency Basis
Customer TenureCurrent30 - 6061 - 90Over 90Total Past DueTotal Loans
0 to 5 months$70,723,005 $5,258,173 $4,431,184 $8,061,843 $17,751,200 $88,474,205 
6 to 17 months70,403,444 4,322,410 2,974,763 5,940,888 13,238,061 83,641,505 
18 to 35 months136,529,566 6,306,026 4,251,454 7,185,001 17,742,481 154,272,047 
36 to 59 months191,171,843 7,712,458 5,057,386 8,722,283 21,492,127 212,663,970 
60+ months803,706,751 22,795,929 13,242,401 21,817,287 57,855,617 861,562,368 
Tax advance loans2,294 2,508 3,092 — 5,600 7,894 
Total gross loans1,272,536,903 46,397,504 29,960,280 51,727,302 128,085,086 1,400,621,989 
Unearned interest, insurance and fees(340,464,381)(9,305,045)(8,165,777)(14,375,469)(31,846,291)(372,310,672)
Total net loans$932,072,522 $37,092,459 $21,794,503 $37,351,833 $96,238,795 $1,028,311,317 
Percentage of period-end gross loans receivable3.3%2.1%3.7%9.1%

The following table is an aging analysis on a recency basis at amortized cost of the Company’s gross loans receivable at March 31, 2023:
Days Past Due - Recency Basis
Customer TenureCurrent30 - 6061 - 90Over 90Total Past DueTotal Loans
0 to 5 months$64,615,314 $5,451,276 $4,407,751 $7,329,327 $17,188,354 $81,803,668 
6 to 17 months113,946,833 6,527,355 4,655,441 8,520,559 19,703,355 133,650,188 
18 to 35 months120,125,821 5,336,994 3,727,331 6,206,041 15,270,366 135,396,187 
36 to 59 months223,734,062 8,070,011 4,839,000 7,771,182 20,680,193 244,414,255 
60+ months742,335,503 20,311,125 11,395,713 18,146,875 49,853,713 792,189,216 
Tax advance loans1,936,131 610,580 4,845 10,498 625,923 2,562,054 
Total gross loans1,266,693,664 46,307,341 29,030,081 47,984,482 123,321,904 1,390,015,568 
Unearned interest, insurance and fees(343,255,876)(12,548,627)(7,866,737)(13,003,109)(33,418,473)(376,674,349)
Total net loans$923,437,788 $33,758,714 $21,163,344 $34,981,373 $89,903,431 $1,013,341,219 
Percentage of period-end gross loans receivable3.3 %2.1 %3.5 %8.9 %

The following table is an aging analysis on a contractual basis at amortized cost of the Company’s gross loans receivable at December 31, 2023:
Days Past Due - Contractual Basis
Customer TenureCurrent30 - 6061 - 90Over 90Total Past DueTotal Loans
0 to 5 months$69,745,014 $5,057,373 $4,433,801 $9,238,017 $18,729,191 $88,474,205 
6 to 17 months68,600,697 3,932,710 3,077,743 8,030,355 15,040,808 83,641,505 
18 to 35 months134,132,918 5,933,072 4,509,138 9,696,919 20,139,129 154,272,047 
36 to 59 months187,676,345 7,282,389 5,443,963 12,261,273 24,987,625 212,663,970 
60+ months792,634,032 22,174,235 14,849,949 31,904,152 68,928,336 861,562,368 
Tax advance loans— 439 1,714 5,741 7,894 7,894 
Total gross loans1,252,789,006 44,380,218 32,316,308 71,136,457 147,832,983 1,400,621,989 
Unearned interest, insurance and fees(336,138,470)(8,303,761)(8,796,156)(19,072,285)(36,172,202)(372,310,672)
Total net loans$916,650,536 $36,076,457 $23,520,152 $52,064,172 $111,660,781 $1,028,311,317 
Percentage of period-end gross loans receivable3.2%2.3%5.1%10.6 %

The following table is an aging analysis on a contractual basis at amortized cost of the Company’s gross loans receivable at March 31, 2023:
Days Past Due - Contractual Basis
Customer TenureCurrent30 - 6061 - 90Over 90Total Past DueTotal Loans
0 to 5 months$61,850,142 $5,320,659 $4,864,498 $9,768,369 $19,953,526 $81,803,668 
6 to 17 months109,694,389 6,892,610 5,613,468 11,449,721 23,955,799 133,650,188 
18 to 35 months115,711,782 5,721,694 4,499,010 9,463,701 19,684,405 135,396,187 
36 to 59 months217,821,239 8,991,995 6,078,488 11,522,533 26,593,016 244,414,255 
60+ months724,437,230 24,165,437 15,039,164 28,547,385 67,751,986 792,189,216 
Tax advance loans1,932,607 609,844 — 19,603 629,447 2,562,054 
Total gross loans1,231,447,389 51,702,239 36,094,628 70,771,312 158,568,179 1,390,015,568 
Unearned interest, insurance and fees(333,704,639)(14,010,568)(9,781,128)(19,178,014)(42,969,710)(376,674,349)
Total net loans$897,742,750 $37,691,671 $26,313,500 $51,593,298 $115,598,469 $1,013,341,219 
Percentage of period-end gross loans receivable3.7 %2.6 %5.1 %11.4 %
Schedule of Amortized Cost Basis of Loans on Nonaccrual
The following table presents the amortized cost basis of loans on nonaccrual status as of the beginning of the reporting period and the end of the reporting period, as well as interest income recognized on nonaccrual loans for the three and nine months ended December 31, 2023 and 2022:
Nonaccrual Loans Receivable
Customer TenureAs of December 31, 2023As of March 31, 2023
Interest Income
Recognized for the three months ended December 31, 2023
Interest Income
Recognized for the three months ended December 31, 2022
Interest Income
Recognized for the nine months ended December 31, 2023
Interest Income
Recognized for the nine months ended December 31, 2022
0 to 5 months$14,079,793 $15,781,494 $197,470 $480,947 $769,418 $1,522,535 
6 to 17 months11,853,469 18,288,714 319,474 450,877 1,168,253 1,216,091 
18 to 35 months15,380,814 15,551,806 396,720 544,689 1,249,102 1,741,780 
36 to 59 months19,379,244 19,745,397 547,608 555,085 1,728,965 1,606,466 
60+ months51,666,613 49,285,814 1,497,757 1,711,201 4,785,842 4,975,538 
Tax advance loans50,950 19,603  —  — 
Unearned interest, insurance and fees(29,880,847)(32,158,640) —  — 
Total$82,530,036 $86,514,188 $2,959,029 $3,742,799 $9,701,580 $11,062,410 
v3.24.0.1
LEASES (Tables)
9 Months Ended
Dec. 31, 2023
Leases [Abstract]  
Schedule of Lease Cost
The following table reports information about the Company's lease cost for the three and nine months ended December 31, 2023 and 2022:
Three months ended December 31,Nine months ended December 31,
 2023202220232022
Lease Cost
Finance lease cost$ $— $ $205,975 
Amortization of right-of-use assets —  204,552 
Interest on lease liabilities —  1,423 
Operating lease cost$6,163,762 $6,746,965 $19,000,163 $21,013,997 
Variable lease cost$888,119 $920,991 $2,808,845 $2,772,620 
Total lease cost$7,051,881 $7,667,956 $21,809,008 $23,992,592 

The following table reports other information about the Company's leases for the three and nine months ended December 31, 2023 and 2022:
Three months ended December 31,Nine months ended December 31,
 2023202220232022
Other Lease Information
Cash paid for amounts included in the measurement of lease liabilities$6,265,527 $6,550,184 $18,965,468 $19,998,398 
Operating cash flows from finance leases —  1,423 
Operating cash flows from operating leases6,265,527 6,550,184 18,965,468 19,916,908 
Financing cash flows from finance leases —  80,067 
Right-of-use assets obtained in exchange for new operating lease liabilities$4,568,169 $3,447,091 $13,560,648 $13,912,470 
Weighted-average remaining lease term — finance leases —  — 
Weighted average remaining lease term — operating leases6.9 years7.1 years6.9 years7.1 years
Weighted-average discount rate — finance leases %— % %— %
Weighted-average discount rate — operating leases6.3 %6.1 %6.3 %6.1 %
Schedule of Operating Lease Maturity
The aggregate annual lease obligations as of December 31, 2023 are as follows:
Operating Leases
Remainder of 2024$6,054,892 
202521,532,117 
202618,010,788 
202713,832,252 
202811,124,461 
Thereafter31,854,653 
Total undiscounted lease liability$102,409,163 
Imputed interest19,938,057 
Total discounted lease liability$82,471,106 
Schedule of Finance Lease Maturity
The aggregate annual lease obligations as of December 31, 2023 are as follows:
Operating Leases
Remainder of 2024$6,054,892 
202521,532,117 
202618,010,788 
202713,832,252 
202811,124,461 
Thereafter31,854,653 
Total undiscounted lease liability$102,409,163 
Imputed interest19,938,057 
Total discounted lease liability$82,471,106 
v3.24.0.1
AVERAGE SHARE INFORMATION (Tables)
9 Months Ended
Dec. 31, 2023
Earnings Per Share [Abstract]  
Summary of Basic and Diluted Average Common Shares Outstanding
The following is a summary of the basic and diluted average common shares outstanding:
Three months ended December 31,Nine months ended December 31,
2023202220232022
Basic:  
Weighted average common shares outstanding (denominator)5,772,503 5,761,954 5,775,108 5,743,094 
Diluted:  
Weighted average common shares outstanding5,772,503 5,761,954 5,775,108 5,743,094 
Dilutive potential common shares287,614 95,536 121,608 — 
Weighted average diluted shares outstanding (denominator)5,860,117 5,857,490 5,896,716 5,743,094 
v3.24.0.1
STOCK-BASED COMPENSATION (Tables)
9 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Performance Shares Vesting Based on EPS Targets
The Performance Share performance targets are set forth below.
Trailing 4-Quarter EPS Targets for
September 30, 2018 through March 31, 2025
Restricted Stock Eligible for Vesting
(Percentage of Award)
$16.3540%
$20.4560%
The Performance Option performance target is set forth below.
Trailing 4-Quarter EPS Targets for
September 30, 2018 through March 31, 2025
Options Eligible for Vesting
(Percentage of Award)
$25.30100%
Schedule of Fair Value was Estimated at Grant Date Using the Weighted-Average
Fair value was estimated at grant date using the weighted-average assumptions listed below:
Three months ended December 31,Nine months ended December 31,
2023202220232022
Dividend yield—%—%—%—%
Expected volatility62.54%57.46%62.55%57.09%
Average risk-free rate4.70%3.91%4.69%3.59%
Expected life4.6 years5.8 years4.6 years5.8 years
Schedule of Stock Option Activity
Option activity for the nine months ended December 31, 2023 was as follows:
 SharesWeighted Average Exercise
Price
Weighted Average
Remaining
Contractual Term
Aggregate Intrinsic Value
Options outstanding, beginning of period314,742 $104.41   
Granted during period2,598 124.67   
Exercised during period(22,847)88.34   
Forfeited during period(11,027)122.25   
Expired during period(2,682)162.17   
Options outstanding, end of period280,784  3$104.66 5.2 years$8,250,477 
Options exercisable, end of period128,057 $105.11 5.1 years$3,919,056 
Schedule of Intrinsic Value of Options Exercised The total intrinsic value of options exercised during the periods ended December 31, 2023 and 2022 was as follows:
December 31,
2023
December 31,
2022
Three months ended$369,543 $51,106 
Nine months ended$810,853 $481,572 
Summary of the Status and Changes Restricted Stock
A summary of the status of the Company’s restricted stock as of December 31, 2023, and changes during the nine months ended December 31, 2023, are presented below:
 SharesWeighted Average Fair Value at Grant Date
Outstanding at March 31, 2023460,614 $101.82 
Granted during the period3,993 120.12 
Vested during the period(62,983)103.85 
Forfeited during the period(13,047)116.56 
Outstanding at December 31, 2023388,577 $101.18 
Schedule of Share-Based Compensation Included as a Component of Net Income (Loss)
Total stock-based compensation included as a component of personnel expenses in the Company's Consolidated Statements of Operations during the three and nine month periods ended December 31, 2023 and 2022 was as follows:
Three months ended December 31,Nine months ended December 31,
2023202220232022
Stock-based compensation related to equity classified awards:
Stock-based compensation (reversal) related to stock options4$189,582 $425,120 $(3,871,348)$1,869,879 
Stock-based compensation (reversal) related to restricted stock, net of adjustments and exclusive of cancellations5(690,699)(679,443)1,475,151 5,512,434 
Total stock-based compensation (reversal) related to equity classified awards$(501,117)$(254,323)$(2,396,197)$7,382,313 
v3.24.0.1
ACQUISITIONS (Tables)
9 Months Ended
Dec. 31, 2023
Business Combination and Asset Acquisition [Abstract]  
Schedule of Business Acquisitions, by Acquisition
The following table sets forth the Company's acquisition activity for the nine months ended December 31, 2023 and 2022:
 Nine months ended December 31,
20232022
Acquisitions:
Number of loan portfolios acquired through asset purchases 43 
Total acquisitions 43 
Purchase price$ $22,314,902 
Tangible assets: 
Loans receivable, net 27,105,078 
Purchase price amount below carrying value of net tangible assets6$ $(4,790,176)
v3.24.0.1
DEBT (Tables)
9 Months Ended
Dec. 31, 2023
Debt Disclosure [Abstract]  
Schedule of Aggregate Annual Maturities of the Notes Payable
The aggregate annual maturities of the Company's debt arrangements as of December 31, 2023 are as follows:

Amount
Remainder of 2024$— 
2025— 
2026— 
2027587,699,480 
2028— 
Total future debt payments$587,699,480 
v3.24.0.1
SUMMARY OF SIGNIFICANT POLICIES (Details) - USD ($)
$ in Millions
Dec. 31, 2023
Mar. 31, 2023
Accounting Policies [Abstract]    
Unamortized deferred origination fees and costs $ 5.6 $ 4.9
v3.24.0.1
FAIR VALUE (Details) - USD ($)
Dec. 31, 2023
Mar. 31, 2023
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Senior unsecured notes payable, net $ 279,915,756 $ 287,352,892
Senior notes payable 305,089,480 307,910,824
Fair Value, Inputs, Level 1 | Carrying Value    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Cash and cash equivalents 12,775,524 16,508,935
Fair Value, Inputs, Level 1 | Estimated Fair Value    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Cash and cash equivalents 12,775,524 16,508,935
Fair Value, Inputs, Level 3 | Carrying Value    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Loans receivable, net 907,229,249 887,788,486
Fair Value, Inputs, Level 3 | Carrying Value | Senior notes    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Senior notes payable 305,089,480 307,910,824
Fair Value, Inputs, Level 3 | Estimated Fair Value    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Loans receivable, net 907,229,249 887,788,486
Fair Value, Inputs, Level 3 | Estimated Fair Value | Senior notes    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Senior notes payable 305,089,480 307,910,824
Fair Value, Inputs, Level 2 | Carrying Value | Senior notes    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Senior unsecured notes payable, net 282,610,000 290,860,000
Fair Value, Inputs, Level 2 | Estimated Fair Value | Senior notes    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Senior unsecured notes payable, net $ 257,517,058 $ 218,127,548
v3.24.0.1
LOANS RECEIVABLE AND ALLOWANCE FOR CREDIT LOSSES (Gross Loans Receivable By Customer Tenure) (Details) - USD ($)
Dec. 31, 2023
Mar. 31, 2023
Financing Receivable, Recorded Investment [Line Items]    
Gross loans receivable $ 1,400,621,989 $ 1,390,015,568
Tax advance loans    
Financing Receivable, Recorded Investment [Line Items]    
Gross loans receivable 7,894 2,562,054
0 to 5 months | 30 - 60 days past due    
Financing Receivable, Recorded Investment [Line Items]    
Gross loans receivable 88,474,205 81,803,668
6 to 17 months | 30 - 60 days past due    
Financing Receivable, Recorded Investment [Line Items]    
Gross loans receivable 83,641,505 133,650,188
18 to 35 months | 30 - 60 days past due    
Financing Receivable, Recorded Investment [Line Items]    
Gross loans receivable 154,272,047 135,396,187
36 to 59 months | 30 - 60 days past due    
Financing Receivable, Recorded Investment [Line Items]    
Gross loans receivable 212,663,970 244,414,255
60+ months | 30 - 60 days past due    
Financing Receivable, Recorded Investment [Line Items]    
Gross loans receivable $ 861,562,368 $ 792,189,216
v3.24.0.1
LOANS RECEIVABLE AND ALLOWANCE FOR CREDIT LOSSES (Payment Performance On A Recency Basis) (Details) - USD ($)
Dec. 31, 2023
Mar. 31, 2023
Financing Receivable, Recorded Investment [Line Items]    
Gross loans receivable $ 1,400,621,989 $ 1,390,015,568
Loans    
Financing Receivable, Recorded Investment [Line Items]    
Financing receivable, up to 1 year ago 1,309,148,620 1,309,447,905
Financing receivable, between 1 and 2 years ago 84,865,452 75,283,901
Financing receivable, between 2 and 3 years ago 6,320,434 2,411,623
Financing receivable, between 3 and 4 years ago 184,121 261,137
Financing receivable, between 4 and 5 years ago 75,310 36,864
Financing receivable, more than 5 years ago 20,158 12,084
Loans | Consumer Loan    
Financing Receivable, Recorded Investment [Line Items]    
Gross loans receivable 1,400,614,095 1,387,453,514
Loans | 30 - 60 days past due    
Financing Receivable, Recorded Investment [Line Items]    
Financing receivable, up to 1 year ago 39,988,200 40,791,746
Financing receivable, between 1 and 2 years ago 5,754,817 4,689,867
Financing receivable, between 2 and 3 years ago 604,508 160,956
Financing receivable, between 3 and 4 years ago 28,282 42,700
Financing receivable, between 4 and 5 years ago 15,556 8,504
Financing receivable, more than 5 years ago 3,633 2,988
Gross loans receivable 46,394,996 45,696,761
Loans | 61 - 90 days past due    
Financing Receivable, Recorded Investment [Line Items]    
Financing receivable, up to 1 year ago 25,958,915 26,319,250
Financing receivable, between 1 and 2 years ago 3,677,614 2,572,733
Financing receivable, between 2 and 3 years ago 285,870 92,088
Financing receivable, between 3 and 4 years ago 14,542 40,281
Financing receivable, between 4 and 5 years ago 18,404 884
Financing receivable, more than 5 years ago 1,843 0
Gross loans receivable 29,957,188 29,025,236
Loans | 91 or more days past due    
Financing Receivable, Recorded Investment [Line Items]    
Financing receivable, up to 1 year ago 43,659,995 41,832,821
Financing receivable, between 1 and 2 years ago 7,522,539 5,944,645
Financing receivable, between 2 and 3 years ago 512,369 160,361
Financing receivable, between 3 and 4 years ago 21,530 29,494
Financing receivable, between 4 and 5 years ago 5,091 4,430
Financing receivable, more than 5 years ago 5,778 2,233
Gross loans receivable 51,727,302 47,973,984
Tax advance loans    
Financing Receivable, Recorded Investment [Line Items]    
Financing receivable, up to 1 year ago 7,894 2,542,860
Financing receivable, between 1 and 2 years ago 0 19,194
Financing receivable, between 2 and 3 years ago 0 0
Financing receivable, between 3 and 4 years ago 0 0
Financing receivable, between 4 and 5 years ago 0 0
Financing receivable, more than 5 years ago 0 0
Gross loans receivable 7,894 2,562,054
Tax advance loans | 30 - 60 days past due    
Financing Receivable, Recorded Investment [Line Items]    
Financing receivable, up to 1 year ago 2,508 609,844
Financing receivable, between 1 and 2 years ago 0 736
Financing receivable, between 2 and 3 years ago 0 0
Financing receivable, between 3 and 4 years ago 0 0
Financing receivable, between 4 and 5 years ago 0 0
Financing receivable, more than 5 years ago 0 0
Gross loans receivable 2,508 610,580
Tax advance loans | 61 - 90 days past due    
Financing Receivable, Recorded Investment [Line Items]    
Financing receivable, up to 1 year ago 3,092 0
Financing receivable, between 1 and 2 years ago 0 4,845
Financing receivable, between 2 and 3 years ago 0 0
Financing receivable, between 3 and 4 years ago 0 0
Financing receivable, between 4 and 5 years ago 0 0
Financing receivable, more than 5 years ago 0 0
Gross loans receivable 3,092 4,845
Tax advance loans | 91 or more days past due    
Financing Receivable, Recorded Investment [Line Items]    
Financing receivable, up to 1 year ago 0 409
Financing receivable, between 1 and 2 years ago 0 10,089
Financing receivable, between 2 and 3 years ago 0 0
Financing receivable, between 3 and 4 years ago 0 0
Financing receivable, between 4 and 5 years ago 0 0
Financing receivable, more than 5 years ago 0 0
Gross loans receivable 0 10,498
Performing Financing Receivable | Loans    
Financing Receivable, Recorded Investment [Line Items]    
Financing receivable, up to 1 year ago 1,199,541,510 1,200,504,088
Financing receivable, between 1 and 2 years ago 67,910,482 62,076,656
Financing receivable, between 2 and 3 years ago 4,917,687 1,998,218
Financing receivable, between 3 and 4 years ago 119,767 148,662
Financing receivable, between 4 and 5 years ago 36,259 23,046
Financing receivable, more than 5 years ago 8,904 6,863
Performing Financing Receivable | Loans | Consumer Loan    
Financing Receivable, Recorded Investment [Line Items]    
Gross loans receivable 1,272,534,609 1,264,757,533
Performing Financing Receivable | Tax advance loans    
Financing Receivable, Recorded Investment [Line Items]    
Financing receivable, up to 1 year ago 2,294 1,932,607
Financing receivable, between 1 and 2 years ago 0 3,524
Financing receivable, between 2 and 3 years ago 0 0
Financing receivable, between 3 and 4 years ago 0 0
Financing receivable, between 4 and 5 years ago 0 0
Financing receivable, more than 5 years ago 0 0
Gross loans receivable $ 2,294 $ 1,936,131
v3.24.0.1
LOANS RECEIVABLE AND ALLOWANCE FOR CREDIT LOSSES (Payment Performance On A Contractual Basis) (Details) - USD ($)
Dec. 31, 2023
Mar. 31, 2023
Financing Receivable, Recorded Investment [Line Items]    
Gross loans receivable $ 1,400,621,989 $ 1,390,015,568
Loans    
Financing Receivable, Recorded Investment [Line Items]    
Financing receivable, up to 1 year ago 1,309,148,620 1,309,447,905
Financing receivable, between 1 and 2 years ago 84,865,452 75,283,901
Financing receivable, between 2 and 3 years ago 6,320,434 2,411,623
Financing receivable, between 3 and 4 years ago 184,121 261,137
Financing receivable, between 4 and 5 years ago 75,310 36,864
Financing receivable, more than 5 years ago 20,158 12,084
Loans | Consumer Loan    
Financing Receivable, Recorded Investment [Line Items]    
Gross loans receivable 1,400,614,095 1,387,453,514
Loans | 30 - 60 days past due    
Financing Receivable, Recorded Investment [Line Items]    
Financing receivable, up to 1 year ago 39,988,200 40,791,746
Financing receivable, between 1 and 2 years ago 5,754,817 4,689,867
Financing receivable, between 2 and 3 years ago 604,508 160,956
Financing receivable, between 3 and 4 years ago 28,282 42,700
Financing receivable, between 4 and 5 years ago 15,556 8,504
Financing receivable, more than 5 years ago 3,633 2,988
Gross loans receivable 46,394,996 45,696,761
Loans | 61 - 90 days past due    
Financing Receivable, Recorded Investment [Line Items]    
Financing receivable, up to 1 year ago 25,958,915 26,319,250
Financing receivable, between 1 and 2 years ago 3,677,614 2,572,733
Financing receivable, between 2 and 3 years ago 285,870 92,088
Financing receivable, between 3 and 4 years ago 14,542 40,281
Financing receivable, between 4 and 5 years ago 18,404 884
Financing receivable, more than 5 years ago 1,843 0
Gross loans receivable 29,957,188 29,025,236
Loans | 91 or more days past due    
Financing Receivable, Recorded Investment [Line Items]    
Financing receivable, up to 1 year ago 43,659,995 41,832,821
Financing receivable, between 1 and 2 years ago 7,522,539 5,944,645
Financing receivable, between 2 and 3 years ago 512,369 160,361
Financing receivable, between 3 and 4 years ago 21,530 29,494
Financing receivable, between 4 and 5 years ago 5,091 4,430
Financing receivable, more than 5 years ago 5,778 2,233
Gross loans receivable 51,727,302 47,973,984
Tax advance loans    
Financing Receivable, Recorded Investment [Line Items]    
Financing receivable, up to 1 year ago 7,894 2,542,860
Financing receivable, between 1 and 2 years ago 0 19,194
Financing receivable, between 2 and 3 years ago 0 0
Financing receivable, between 3 and 4 years ago 0 0
Financing receivable, between 4 and 5 years ago 0 0
Financing receivable, more than 5 years ago 0 0
Gross loans receivable 7,894 2,562,054
Tax advance loans | 30 - 60 days past due    
Financing Receivable, Recorded Investment [Line Items]    
Financing receivable, up to 1 year ago 2,508 609,844
Financing receivable, between 1 and 2 years ago 0 736
Financing receivable, between 2 and 3 years ago 0 0
Financing receivable, between 3 and 4 years ago 0 0
Financing receivable, between 4 and 5 years ago 0 0
Financing receivable, more than 5 years ago 0 0
Gross loans receivable 2,508 610,580
Tax advance loans | 61 - 90 days past due    
Financing Receivable, Recorded Investment [Line Items]    
Financing receivable, up to 1 year ago 3,092 0
Financing receivable, between 1 and 2 years ago 0 4,845
Financing receivable, between 2 and 3 years ago 0 0
Financing receivable, between 3 and 4 years ago 0 0
Financing receivable, between 4 and 5 years ago 0 0
Financing receivable, more than 5 years ago 0 0
Gross loans receivable 3,092 4,845
Tax advance loans | 91 or more days past due    
Financing Receivable, Recorded Investment [Line Items]    
Financing receivable, up to 1 year ago 0 409
Financing receivable, between 1 and 2 years ago 0 10,089
Financing receivable, between 2 and 3 years ago 0 0
Financing receivable, between 3 and 4 years ago 0 0
Financing receivable, between 4 and 5 years ago 0 0
Financing receivable, more than 5 years ago 0 0
Gross loans receivable 0 10,498
Performing Financing Receivable | Loans    
Financing Receivable, Recorded Investment [Line Items]    
Financing receivable, up to 1 year ago 1,199,541,510 1,200,504,088
Financing receivable, between 1 and 2 years ago 67,910,482 62,076,656
Financing receivable, between 2 and 3 years ago 4,917,687 1,998,218
Financing receivable, between 3 and 4 years ago 119,767 148,662
Financing receivable, between 4 and 5 years ago 36,259 23,046
Financing receivable, more than 5 years ago 8,904 6,863
Performing Financing Receivable | Loans | Consumer Loan    
Financing Receivable, Recorded Investment [Line Items]    
Gross loans receivable 1,272,534,609 1,264,757,533
Performing Financing Receivable | Tax advance loans    
Financing Receivable, Recorded Investment [Line Items]    
Financing receivable, up to 1 year ago 2,294 1,932,607
Financing receivable, between 1 and 2 years ago 0 3,524
Financing receivable, between 2 and 3 years ago 0 0
Financing receivable, between 3 and 4 years ago 0 0
Financing receivable, between 4 and 5 years ago 0 0
Financing receivable, more than 5 years ago 0 0
Gross loans receivable 2,294 1,936,131
Contractual basis    
Financing Receivable, Recorded Investment [Line Items]    
Gross loans receivable 1,400,621,989 1,390,015,568
Contractual basis | 30 - 60 days past due    
Financing Receivable, Recorded Investment [Line Items]    
Gross loans receivable 44,380,218 51,702,239
Contractual basis | 61 - 90 days past due    
Financing Receivable, Recorded Investment [Line Items]    
Gross loans receivable 32,316,308 36,094,628
Contractual basis | 91 or more days past due    
Financing Receivable, Recorded Investment [Line Items]    
Gross loans receivable 71,136,457 70,771,312
Contractual basis | Loans    
Financing Receivable, Recorded Investment [Line Items]    
Financing receivable, up to 1 year ago 1,309,148,619 1,309,447,906
Financing receivable, between 1 and 2 years ago 84,865,452 75,283,901
Financing receivable, between 2 and 3 years ago 6,320,435 2,411,623
Financing receivable, between 3 and 4 years ago 184,121 261,137
Financing receivable, between 4 and 5 years ago 75,310 36,863
Financing receivable, more than 5 years ago 20,158 12,084
Contractual basis | Loans | Consumer Loan    
Financing Receivable, Recorded Investment [Line Items]    
Gross loans receivable 1,400,614,095 1,387,453,514
Contractual basis | Loans | 30 - 60 days past due    
Financing Receivable, Recorded Investment [Line Items]    
Financing receivable, up to 1 year ago 40,230,196 47,346,331
Financing receivable, between 1 and 2 years ago 3,897,049 3,661,493
Financing receivable, between 2 and 3 years ago 250,587 77,857
Financing receivable, between 3 and 4 years ago 941 6,714
Financing receivable, between 4 and 5 years ago 1,006 0
Financing receivable, more than 5 years ago 0 0
Gross loans receivable 44,379,779 51,092,395
Contractual basis | Loans | 61 - 90 days past due    
Financing Receivable, Recorded Investment [Line Items]    
Financing receivable, up to 1 year ago 28,592,002 33,012,804
Financing receivable, between 1 and 2 years ago 3,484,278 3,030,052
Financing receivable, between 2 and 3 years ago 236,372 44,129
Financing receivable, between 3 and 4 years ago 1,646 7,643
Financing receivable, between 4 and 5 years ago 0 0
Financing receivable, more than 5 years ago 296 0
Gross loans receivable 32,314,594 36,094,628
Contractual basis | Loans | 91 or more days past due    
Financing Receivable, Recorded Investment [Line Items]    
Financing receivable, up to 1 year ago 52,200,038 54,851,010
Financing receivable, between 1 and 2 years ago 16,832,332 14,940,345
Financing receivable, between 2 and 3 years ago 1,888,635 735,493
Financing receivable, between 3 and 4 years ago 128,681 182,547
Financing receivable, between 4 and 5 years ago 61,820 31,721
Financing receivable, more than 5 years ago 19,210 10,593
Gross loans receivable 71,130,716 70,751,709
Contractual basis | Tax advance loans    
Financing Receivable, Recorded Investment [Line Items]    
Financing receivable, up to 1 year ago 7,894 2,542,860
Financing receivable, between 1 and 2 years ago 0 19,194
Financing receivable, between 2 and 3 years ago 0 0
Financing receivable, between 3 and 4 years ago 0 0
Financing receivable, between 4 and 5 years ago 0 0
Financing receivable, more than 5 years ago 0 0
Gross loans receivable 7,894 2,562,054
Contractual basis | Tax advance loans | 30 - 60 days past due    
Financing Receivable, Recorded Investment [Line Items]    
Financing receivable, up to 1 year ago 439 609,844
Financing receivable, between 1 and 2 years ago 0 0
Financing receivable, between 2 and 3 years ago 0 0
Financing receivable, between 3 and 4 years ago 0 0
Financing receivable, between 4 and 5 years ago 0 0
Financing receivable, more than 5 years ago 0 0
Gross loans receivable 439 609,844
Contractual basis | Tax advance loans | 61 - 90 days past due    
Financing Receivable, Recorded Investment [Line Items]    
Financing receivable, up to 1 year ago 1,714 0
Financing receivable, between 1 and 2 years ago 0 0
Financing receivable, between 2 and 3 years ago 0 0
Financing receivable, between 3 and 4 years ago 0 0
Financing receivable, between 4 and 5 years ago 0 0
Financing receivable, more than 5 years ago 0 0
Gross loans receivable 1,714 0
Contractual basis | Tax advance loans | 91 or more days past due    
Financing Receivable, Recorded Investment [Line Items]    
Financing receivable, up to 1 year ago 5,741 409
Financing receivable, between 1 and 2 years ago 0 19,194
Financing receivable, between 2 and 3 years ago 0 0
Financing receivable, between 3 and 4 years ago 0 0
Financing receivable, between 4 and 5 years ago 0 0
Financing receivable, more than 5 years ago 0 0
Gross loans receivable 5,741 19,603
Contractual basis | Performing Financing Receivable | Loans    
Financing Receivable, Recorded Investment [Line Items]    
Financing receivable, up to 1 year ago 1,188,126,383 1,174,237,761
Financing receivable, between 1 and 2 years ago 60,651,793 53,652,011
Financing receivable, between 2 and 3 years ago 3,944,841 1,554,144
Financing receivable, between 3 and 4 years ago 52,853 64,233
Financing receivable, between 4 and 5 years ago 12,484 5,142
Financing receivable, more than 5 years ago 652 1,491
Contractual basis | Performing Financing Receivable | Loans | Consumer Loan    
Financing Receivable, Recorded Investment [Line Items]    
Gross loans receivable 1,252,789,006 1,229,514,782
Contractual basis | Performing Financing Receivable | Tax advance loans    
Financing Receivable, Recorded Investment [Line Items]    
Financing receivable, up to 1 year ago 0 1,932,607
Financing receivable, between 1 and 2 years ago 0 0
Financing receivable, between 2 and 3 years ago 0 0
Financing receivable, between 3 and 4 years ago 0 0
Financing receivable, between 4 and 5 years ago 0 0
Financing receivable, more than 5 years ago 0 0
Gross loans receivable $ 0 $ 1,932,607
v3.24.0.1
LOANS RECEIVABLE AND ALLOWANCE FOR CREDIT LOSSES (Company’s Gross Charge-Offs By Year of Origination) (Details) - USD ($)
3 Months Ended 9 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Financing Receivable, Recorded Investment [Line Items]        
Financing receivable, gross charge-offs, prior $ 1,958 $ 656 $ 9,686 $ 10,102
Financing receivable, gross charge-offs, four years before 2,448 19,203 19,986 39,797
Financing receivable, gross charge-offs, three years before 32,909 158,346 177,372 334,091
Financing receivable, gross charge-offs, two years before 943,234 441,199 5,589,791 2,591,494
Financing receivable, gross charge-offs, one year before 15,175,276 19,277,228 96,000,342 125,988,768
Financing receivable, gross charge-offs, current 38,579,157 66,486,250 55,431,437 99,768,152
Total 54,734,982 86,382,882 157,228,614 228,732,404
Loans        
Financing Receivable, Recorded Investment [Line Items]        
Financing receivable, gross charge-offs, prior 1,958 656 9,686 10,102
Financing receivable, gross charge-offs, four years before 2,448 19,203 19,986 39,797
Financing receivable, gross charge-offs, three years before 32,909 158,346 177,372 334,091
Financing receivable, gross charge-offs, two years before 943,234 441,199 5,589,791 2,591,494
Financing receivable, gross charge-offs, one year before 15,175,088 19,276,965 95,994,906 125,968,883
Financing receivable, gross charge-offs, current 38,460,870 66,102,716 54,171,402 97,354,602
Total 54,616,507 85,999,085 155,963,143 226,298,969
Tax advance loans        
Financing Receivable, Recorded Investment [Line Items]        
Financing receivable, gross charge-offs, prior 0 0 0 0
Financing receivable, gross charge-offs, four years before 0 0 0 0
Financing receivable, gross charge-offs, three years before 0 0 0 0
Financing receivable, gross charge-offs, two years before 0 0 0 0
Financing receivable, gross charge-offs, one year before 188 263 5,436 19,885
Financing receivable, gross charge-offs, current 118,287 383,534 1,260,035 2,413,550
Total $ 118,475 $ 383,797 $ 1,265,471 $ 2,433,435
v3.24.0.1
LOANS RECEIVABLE AND ALLOWANCE FOR CREDIT LOSSES (Roll Forward of the Allowance for Credit Losses on Our Gross Loans Receivable) (Details) - USD ($)
3 Months Ended 9 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Financing Receivable, Allowance for Credit Loss [Roll Forward]        
Beginning balance $ 128,892,192 $ 155,892,100 $ 125,552,733 $ 134,242,862
Provision for credit losses 40,631,994 59,608,655 127,697,072 214,051,068
Charge-offs (54,734,982) (86,382,882) (157,228,614) (228,732,404)
Recoveries 6,292,864 15,421,670 25,060,877 24,978,017
Net charge-offs (48,442,118) (70,961,212) (132,167,737) (203,754,387)
Ending Balance $ 121,082,068 $ 144,539,543 $ 121,082,068 $ 144,539,543
v3.24.0.1
LOANS RECEIVABLE AND ALLOWANCE FOR CREDIT LOSSES (Summary of Past Due Receivables) (Details) - USD ($)
Dec. 31, 2023
Mar. 31, 2023
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable $ 1,400,621,989 $ 1,390,015,568
Unearned interest, insurance and fees (5,600,000) (4,900,000)
Tax advance loans    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 7,894 2,562,054
30 - 60 days past due | 0 to 5 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 88,474,205 81,803,668
30 - 60 days past due | 6 to 17 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 83,641,505 133,650,188
30 - 60 days past due | 18 to 35 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 154,272,047 135,396,187
30 - 60 days past due | 36 to 59 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 212,663,970 244,414,255
30 - 60 days past due | 60+ months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 861,562,368 792,189,216
Recency Basis    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 1,400,621,989 1,390,015,568
Unearned interest, insurance and fees (372,310,672) (376,674,349)
Total net loans $ 1,028,311,317 $ 1,013,341,219
Financing receivable, percent past due 9.10% 8.90%
Recency Basis | Tax advance loans    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable $ 7,894 $ 2,562,054
Recency Basis | 0 to 5 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 88,474,205 81,803,668
Recency Basis | 6 to 17 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 83,641,505 133,650,188
Recency Basis | 18 to 35 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 154,272,047 135,396,187
Recency Basis | 36 to 59 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 212,663,970 244,414,255
Recency Basis | 60+ months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 861,562,368 792,189,216
Recency Basis | Current    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 1,272,536,903 1,266,693,664
Unearned interest, insurance and fees (340,464,381) (343,255,876)
Total net loans 932,072,522 923,437,788
Recency Basis | Current | Tax advance loans    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 2,294 1,936,131
Recency Basis | Current | 0 to 5 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 70,723,005 64,615,314
Recency Basis | Current | 6 to 17 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 70,403,444 113,946,833
Recency Basis | Current | 18 to 35 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 136,529,566 120,125,821
Recency Basis | Current | 36 to 59 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 191,171,843 223,734,062
Recency Basis | Current | 60+ months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 803,706,751 742,335,503
Recency Basis | 30 - 60 days past due    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 46,397,504 46,307,341
Unearned interest, insurance and fees (9,305,045) (12,548,627)
Total net loans $ 37,092,459 $ 33,758,714
Financing receivable, percent past due 3.30% 3.30%
Recency Basis | 30 - 60 days past due | Tax advance loans    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable $ 2,508 $ 610,580
Recency Basis | 30 - 60 days past due | 0 to 5 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 5,258,173 5,451,276
Recency Basis | 30 - 60 days past due | 6 to 17 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 4,322,410 6,527,355
Recency Basis | 30 - 60 days past due | 18 to 35 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 6,306,026 5,336,994
Recency Basis | 30 - 60 days past due | 36 to 59 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 7,712,458 8,070,011
Recency Basis | 30 - 60 days past due | 60+ months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 22,795,929 20,311,125
Recency Basis | 61 - 90 days past due    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 29,960,280 29,030,081
Unearned interest, insurance and fees (8,165,777) (7,866,737)
Total net loans $ 21,794,503 $ 21,163,344
Financing receivable, percent past due 2.10% 2.10%
Recency Basis | 61 - 90 days past due | Tax advance loans    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable $ 3,092 $ 4,845
Recency Basis | 61 - 90 days past due | 0 to 5 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 4,431,184 4,407,751
Recency Basis | 61 - 90 days past due | 6 to 17 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 2,974,763 4,655,441
Recency Basis | 61 - 90 days past due | 18 to 35 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 4,251,454 3,727,331
Recency Basis | 61 - 90 days past due | 36 to 59 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 5,057,386 4,839,000
Recency Basis | 61 - 90 days past due | 60+ months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 13,242,401 11,395,713
Recency Basis | 91 or more days past due    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 51,727,302 47,984,482
Unearned interest, insurance and fees (14,375,469) (13,003,109)
Total net loans $ 37,351,833 $ 34,981,373
Financing receivable, percent past due 3.70% 3.50%
Recency Basis | 91 or more days past due | Tax advance loans    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable $ 0 $ 10,498
Recency Basis | 91 or more days past due | 0 to 5 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 8,061,843 7,329,327
Recency Basis | 91 or more days past due | 6 to 17 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 5,940,888 8,520,559
Recency Basis | 91 or more days past due | 18 to 35 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 7,185,001 6,206,041
Recency Basis | 91 or more days past due | 36 to 59 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 8,722,283 7,771,182
Recency Basis | 91 or more days past due | 60+ months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 21,817,287 18,146,875
Recency Basis | Total Past Due    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 128,085,086 123,321,904
Unearned interest, insurance and fees (31,846,291) (33,418,473)
Total net loans 96,238,795 89,903,431
Recency Basis | Total Past Due | Tax advance loans    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 5,600 625,923
Recency Basis | Total Past Due | 0 to 5 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 17,751,200 17,188,354
Recency Basis | Total Past Due | 6 to 17 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 13,238,061 19,703,355
Recency Basis | Total Past Due | 18 to 35 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 17,742,481 15,270,366
Recency Basis | Total Past Due | 36 to 59 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 21,492,127 20,680,193
Recency Basis | Total Past Due | 60+ months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 57,855,617 49,853,713
Contractual basis    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 1,400,621,989 1,390,015,568
Unearned interest, insurance and fees (372,310,672) (376,674,349)
Total net loans $ 1,028,311,317 $ 1,013,341,219
Financing receivable, percent past due 10.60% 11.40%
Contractual basis | Tax advance loans    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable $ 7,894 $ 2,562,054
Contractual basis | 0 to 5 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 88,474,205 81,803,668
Contractual basis | 6 to 17 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 83,641,505 133,650,188
Contractual basis | 18 to 35 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 154,272,047 135,396,187
Contractual basis | 36 to 59 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 212,663,970 244,414,255
Contractual basis | 60+ months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 861,562,368 792,189,216
Contractual basis | Current    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 1,252,789,006 1,231,447,389
Unearned interest, insurance and fees (336,138,470) (333,704,639)
Total net loans 916,650,536 897,742,750
Contractual basis | Current | Tax advance loans    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 0 1,932,607
Contractual basis | Current | 0 to 5 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 69,745,014 61,850,142
Contractual basis | Current | 6 to 17 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 68,600,697 109,694,389
Contractual basis | Current | 18 to 35 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 134,132,918 115,711,782
Contractual basis | Current | 36 to 59 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 187,676,345 217,821,239
Contractual basis | Current | 60+ months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 792,634,032 724,437,230
Contractual basis | 30 - 60 days past due    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 44,380,218 51,702,239
Unearned interest, insurance and fees (8,303,761) (14,010,568)
Total net loans $ 36,076,457 $ 37,691,671
Financing receivable, percent past due 3.20% 3.70%
Contractual basis | 30 - 60 days past due | Tax advance loans    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable $ 439 $ 609,844
Contractual basis | 30 - 60 days past due | 0 to 5 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 5,057,373 5,320,659
Contractual basis | 30 - 60 days past due | 6 to 17 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 3,932,710 6,892,610
Contractual basis | 30 - 60 days past due | 18 to 35 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 5,933,072 5,721,694
Contractual basis | 30 - 60 days past due | 36 to 59 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 7,282,389 8,991,995
Contractual basis | 30 - 60 days past due | 60+ months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 22,174,235 24,165,437
Contractual basis | 61 - 90 days past due    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 32,316,308 36,094,628
Unearned interest, insurance and fees (8,796,156) (9,781,128)
Total net loans $ 23,520,152 $ 26,313,500
Financing receivable, percent past due 2.30% 2.60%
Contractual basis | 61 - 90 days past due | Tax advance loans    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable $ 1,714 $ 0
Contractual basis | 61 - 90 days past due | 0 to 5 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 4,433,801 4,864,498
Contractual basis | 61 - 90 days past due | 6 to 17 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 3,077,743 5,613,468
Contractual basis | 61 - 90 days past due | 18 to 35 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 4,509,138 4,499,010
Contractual basis | 61 - 90 days past due | 36 to 59 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 5,443,963 6,078,488
Contractual basis | 61 - 90 days past due | 60+ months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 14,849,949 15,039,164
Contractual basis | 91 or more days past due    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 71,136,457 70,771,312
Unearned interest, insurance and fees (19,072,285) (19,178,014)
Total net loans $ 52,064,172 $ 51,593,298
Financing receivable, percent past due 5.10% 5.10%
Contractual basis | 91 or more days past due | Tax advance loans    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable $ 5,741 $ 19,603
Contractual basis | 91 or more days past due | 0 to 5 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 9,238,017 9,768,369
Contractual basis | 91 or more days past due | 6 to 17 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 8,030,355 11,449,721
Contractual basis | 91 or more days past due | 18 to 35 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 9,696,919 9,463,701
Contractual basis | 91 or more days past due | 36 to 59 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 12,261,273 11,522,533
Contractual basis | 91 or more days past due | 60+ months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 31,904,152 28,547,385
Contractual basis | Total Past Due    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 147,832,983 158,568,179
Unearned interest, insurance and fees (36,172,202) (42,969,710)
Total net loans 111,660,781 115,598,469
Contractual basis | Total Past Due | Tax advance loans    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 7,894 629,447
Contractual basis | Total Past Due | 0 to 5 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 18,729,191 19,953,526
Contractual basis | Total Past Due | 6 to 17 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 15,040,808 23,955,799
Contractual basis | Total Past Due | 18 to 35 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 20,139,129 19,684,405
Contractual basis | Total Past Due | 36 to 59 months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable 24,987,625 26,593,016
Contractual basis | Total Past Due | 60+ months    
Financing Receivable, Recorded Investment, Past Due [Line Items]    
Gross loans receivable $ 68,928,336 $ 67,751,986
v3.24.0.1
LOANS RECEIVABLE AND ALLOWANCE FOR CREDIT LOSSES (Narrative) (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Receivables [Abstract]        
Charge offs $ 3.7 $ 11.4 $ 16.2 $ 11.4
Proceeds from prior write offs, prior periods 0.8 8.4 5.7 8.4
Proceeds from prior write offs, current period $ 2.9 $ 3.0 $ 10.5 $ 3.0
v3.24.0.1
LOANS RECEIVABLE AND ALLOWANCE FOR CREDIT LOSSES (Nonaccrual) (Details) - USD ($)
3 Months Ended 9 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Mar. 31, 2023
Financing Receivable, Nonaccrual [Line Items]          
Uncollected accrued interest reversed $ (6,971,318) $ (9,444,392) $ (20,348,458) $ (29,852,859)  
Financing receivable, nonaccrual 82,530,036   82,530,036   $ 86,514,188
Interest Income Recognized 2,959,029 3,742,799 9,701,580 11,062,410  
Nonaccrual status          
Financing Receivable, Nonaccrual [Line Items]          
Unearned interest, insurance and fees (29,880,847)   (29,880,847)   (32,158,640)
Tax advance loans          
Financing Receivable, Nonaccrual [Line Items]          
Financing receivable, nonaccrual 50,950   50,950   19,603
Interest Income Recognized 0 0 0 0  
0 to 5 months          
Financing Receivable, Nonaccrual [Line Items]          
Uncollected accrued interest reversed (1,358,755) (1,813,804) (3,904,031) (8,117,103)  
Financing receivable, nonaccrual 14,079,793   14,079,793   15,781,494
Interest Income Recognized 197,470 480,947 769,418 1,522,535  
6 to 17 months          
Financing Receivable, Nonaccrual [Line Items]          
Uncollected accrued interest reversed (777,293) (1,627,586) (2,651,226) (4,605,102)  
Financing receivable, nonaccrual 11,853,469   11,853,469   18,288,714
Interest Income Recognized 319,474 450,877 1,168,253 1,216,091  
18 to 35 months          
Financing Receivable, Nonaccrual [Line Items]          
Uncollected accrued interest reversed (946,820) (1,285,309) (2,609,760) (3,862,834)  
Financing receivable, nonaccrual 15,380,814   15,380,814   15,551,806
Interest Income Recognized 396,720 544,689 1,249,102 1,741,780  
36 to 59 months          
Financing Receivable, Nonaccrual [Line Items]          
Uncollected accrued interest reversed (1,065,935) (1,365,428) (3,211,393) (3,543,651)  
Financing receivable, nonaccrual 19,379,244   19,379,244   19,745,397
Interest Income Recognized 547,608 555,085 1,728,965 1,606,466  
60+ months          
Financing Receivable, Nonaccrual [Line Items]          
Uncollected accrued interest reversed (2,822,515) (3,352,265) (7,972,048) (9,724,169)  
Financing receivable, nonaccrual 51,666,613   51,666,613   $ 49,285,814
Interest Income Recognized $ 1,497,757 $ 1,711,201 $ 4,785,842 $ 4,975,538  
v3.24.0.1
LEASES (Narrative) (Details)
Dec. 31, 2023
Minimum  
Lessee, Lease, Description [Line Items]  
Operating lease, term of contract 3 years
Maximum  
Lessee, Lease, Description [Line Items]  
Operating lease, term of contract 5 years
v3.24.0.1
LEASES (Lease Cost) (Details) - USD ($)
3 Months Ended 9 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Leases [Abstract]        
Finance lease cost $ 0 $ 0 $ 0 $ 205,975
Amortization of right-of-use assets 0 0 0 204,552
Interest on lease liabilities 0 0 0 1,423
Operating lease cost 6,163,762 6,746,965 19,000,163 21,013,997
Variable lease cost 888,119 920,991 2,808,845 2,772,620
Total lease cost 7,051,881 7,667,956 21,809,008 23,992,592
Cash paid for amounts included in the measurement of lease liabilities 6,265,527 6,550,184 18,965,468 19,998,398
Operating cash flows from finance leases 0 0 0 1,423
Operating cash flows from operating leases 6,265,527 6,550,184 18,965,468 19,916,908
Financing cash flows from finance leases 0 0 0 80,067
Right-of-use assets obtained in exchange for new operating lease liabilities $ 4,568,169 $ 3,447,091 $ 13,560,648 $ 13,912,470
Weighted average remaining lease term — operating leases 6 years 10 months 24 days 7 years 1 month 6 days 6 years 10 months 24 days 7 years 1 month 6 days
Weighted-average discount rate — finance leases 0.00% 0.00% 0.00% 0.00%
Weighted-average discount rate — operating leases 6.30% 6.10% 6.30% 6.10%
v3.24.0.1
LEASES (Aggregate Annual Lease Obligations) (Details) - USD ($)
Dec. 31, 2023
Mar. 31, 2023
Operating Leases    
Remainder of 2024 $ 6,054,892  
2025 21,532,117  
2026 18,010,788  
2027 13,832,252  
2028 11,124,461  
Thereafter 31,854,653  
Total undiscounted lease liability 102,409,163  
Imputed interest 19,938,057  
Total discounted lease liability $ 82,471,106 $ 83,735,002
v3.24.0.1
AVERAGE SHARE INFORMATION (Details) - shares
3 Months Ended 9 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Basic:        
Weighted average common shares outstanding (in shares) 5,772,503 5,761,954 5,775,108 5,743,094
Diluted:        
Weighted average common shares outstanding (in shares) 5,772,503 5,761,954 5,775,108 5,743,094
Dilutive potential common shares (in shares) 87,614 95,536 121,608 0
Weighted average diluted shares outstanding (in shares) 5,860,117 5,857,490 5,896,716 5,743,094
Anti-dilutive shares (in shares) 291,826 332,275 299,904 338,154
v3.24.0.1
STOCK-BASED COMPENSATION (Narrative) (Details)
3 Months Ended 9 Months Ended
Dec. 31, 2023
USD ($)
installment
$ / shares
shares
Sep. 30, 2023
USD ($)
Jun. 30, 2023
$ / shares
shares
Dec. 31, 2022
USD ($)
$ / shares
Dec. 31, 2023
USD ($)
installment
$ / shares
shares
Dec. 31, 2022
USD ($)
$ / shares
Mar. 31, 2023
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Number of shares available for grant (in shares) | shares 165,196       165,196    
Vesting percentage         100.00%    
Weighted-average fair value at the grant date (in dollars per share) | $ / shares $ 68.52     $ 44.23 $ 69.00 $ 53.51  
Stock-based compensation (reversal) related to equity classified awards         $ (2,396,197) $ 7,382,313  
Employee Stock Option              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Shares of authorized common stock reserved for issuance (in shares) | shares 3,350,000       3,350,000    
Options outstanding (in shares) | shares 280,784       280,784   314,742
Total unrecognized stock-based compensation expense related to non-vested stock options $ 600,000       $ 600,000    
Weighted average period for recognition         1 year 3 months 18 days    
Stock-based compensation (reversal) related to equity classified awards $ 189,582     $ 425,120 $ (3,871,348) 1,869,879  
Employee Stock Option | Scenario 1              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Options outstanding (in shares) | shares 43,862       43,862    
Employee Stock Option | Scenario 2              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Options outstanding (in shares) | shares 108,865       108,865    
Employee Stock Option | Minimum              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Vesting period         3 years    
Employee Stock Option | Maximum              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Stock option, expiration period         10 years    
Vesting period         6 years    
Restricted Stock              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Number of installments | installment 6       6    
Awards granted (in shares) | shares     3,250   3,993    
Grant date fair value (in dollars per share) | $ / shares     $ 129.85   $ 120.12    
Unvested restricted stock awards $ 1,900,000       $ 1,900,000    
Stock based compensation expense (reversal) (700,000)     (2,100,000)      
Forfeiture credit 1,400,000     2,800,000      
Stock-based compensation (reversal) related to equity classified awards $ (690,699)     $ (679,443) $ 1,475,151 $ 5,512,434  
Service Option              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Vesting period         10 years    
Performance Shares              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Vesting period         10 years    
Weighted average period for recognition         10 months 24 days    
Stock based compensation expense (reversal)   $ 4,900,000          
v3.24.0.1
STOCK-BASED COMPENSATION (Share and Options Performance Targets) (Details)
9 Months Ended
Dec. 31, 2023
$ / shares
Target 1  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
EPS target (in dollars per share) $ 16.35
Vesting percentage 40.00%
Target 2  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
EPS target (in dollars per share) $ 20.45
Vesting percentage 60.00%
Target 3  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
EPS target (in dollars per share) $ 25.30
Vesting percentage 100.00%
v3.24.0.1
STOCK-BASED COMPENSATION (Grants Date Using The Weighted-Average Assumptions) (Details)
3 Months Ended 9 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]        
Dividend yield 0.00% 0.00% 0.00% 0.00%
Expected volatility 62.54% 57.46% 62.55% 57.09%
Average risk-free rate 4.70% 3.91% 4.69% 3.59%
Expected life 4 years 7 months 6 days 5 years 9 months 18 days 4 years 7 months 6 days 5 years 9 months 18 days
v3.24.0.1
STOCK-BASED COMPENSATION (Stock Option Activity and Intrinsic Value) (Details) - Stock Options Plans - USD ($)
3 Months Ended 9 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Options Activity [Roll Forward]        
Options outstanding, beginning of year (in shares)     314,742  
Granted (in shares)     2,598  
Exercised (in shares)     (22,847)  
Forfeited (in shares)     (11,027)  
Expired (in shares)     (2,682)  
Options outstanding, end of period (in shares) 280,784   280,784  
Options exercisable, end of period (in shares) 128,057   128,057  
Weighted Average Exercise Price        
Options outstanding, beginning of year (in dollars per share)     $ 104.41  
Granted (in dollars per share)     124.67  
Exercised (in dollars per share)     88.34  
Forfeited (in dollars per share)     122.25  
Expired (in dollars per share)     162.17  
Options outstanding, end of period (in dollars per share) $ 104.66   104.66  
Options exercisable, end of period (in dollars per share) $ 105.11   $ 105.11  
Stock Option Activity Additional Disclosures [Abstract]        
Weighted-average remaining contractual term, options outstanding, end of period     5 years 2 months 12 days  
Weighted-average remaining contractual terms, options exercisable, end of period     5 years 1 month 6 days  
Aggregate intrinsic value, options outstanding, end of period $ 8,250,477   $ 8,250,477  
Aggregate intrinsic value, options exercisable, end of period 3,919,056   3,919,056  
Intrinsic value of options exercised $ 369,543 $ 51,106 $ 810,853 $ 481,572
v3.24.0.1
STOCK-BASED COMPENSATION (Company Restricted Stock and Total Stock-Based Compensation) (Details) - USD ($)
3 Months Ended 9 Months Ended
Dec. 31, 2023
Jun. 30, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Weighted Average Fair Value at Grant Date          
Stock-based compensation (reversal) related to equity classified awards       $ (2,396,197) $ 7,382,313
Restricted Stock          
Shares          
Outstanding at beginning of year (in shares)   460,614   460,614  
Granted during the period (in shares)   3,250   3,993  
Vested during the period (in shares)       (62,983)  
Forfeited during the period (in shares)       (13,047)  
Outstanding at end of period (in shares) 388,577     388,577  
Weighted Average Fair Value at Grant Date          
Outstanding at beginning period (in dollars per share)   $ 101.82   $ 101.82  
Granted during the period (in shares)   $ 129.85   120.12  
Vested during the period (in dollars per share)       103.85  
Forfeited during the period (in dollars per share)       116.56  
Outstanding at ending period (in dollars per share) $ 101.18     $ 101.18  
Stock-based compensation (reversal) related to equity classified awards $ (690,699)   $ (679,443) $ 1,475,151 5,512,434
Stock Options Plans          
Weighted Average Fair Value at Grant Date          
Stock-based compensation (reversal) related to equity classified awards 189,582   425,120 (3,871,348) 1,869,879
Equity Securities          
Weighted Average Fair Value at Grant Date          
Stock-based compensation (reversal) related to equity classified awards $ (501,117)   $ (254,323) $ (2,396,197) $ 7,382,313
v3.24.0.1
ACQUISITIONS (Details)
Dec. 31, 2023
USD ($)
acquisition
Dec. 31, 2022
USD ($)
acquisition
Business Acquisition [Line Items]    
Number of loan portfolios acquired through asset purchases | acquisition 0 43
Total acquisitions | acquisition 0 43
Loans receivable, net $ 0 $ 27,105,078
Purchase price amount below carrying value of net tangible assets 0 (4,790,176)
Series of Individually Immaterial Business Acquisitions    
Business Acquisition [Line Items]    
Purchase price $ 0 $ 22,314,902
v3.24.0.1
ACQUISITIONS (Narrative) (Details) - USD ($)
6 Months Ended 9 Months Ended
Sep. 30, 2023
Dec. 31, 2023
Dec. 31, 2022
Business Acquisition [Line Items]      
Gain on acquisition, net of income tax   $ 0 $ 3,708,344
Income tax related to asset acquisition $ 1,100,000    
Insurance And Other Income, Net      
Business Acquisition [Line Items]      
Gain on acquisition, net of income tax $ 4,800,000    
v3.24.0.1
DEBT (Narrative) (Details)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 27, 2021
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Mar. 31, 2023
USD ($)
Nov. 09, 2023
USD ($)
Line of Credit Facility [Line Items]            
Letters of credit outstanding, amount   $ 524,000 $ 524,000      
Gain on extinguishment of senior unsecured notes payable     1,162,581 $ 0    
Senior Notes Due 2026 | Senior notes            
Line of Credit Facility [Line Items]            
Interest rate, percentage 7.00%          
Aggregate principal amount $ 300,000,000          
Redemption price, percentage of equity offerings 40.00%          
Repurchased and extinguished amount of debt     8,250,000   $ 9,100,000  
Debt issuance costs   88,100 88,100   100,000  
Reacquisition price   7,000,000 7,000,000   $ 7,200,000  
Gain on extinguishment of senior unsecured notes payable   600,000 1,200,000      
Senior Notes Due 2026 | Senior notes | Period One            
Line of Credit Facility [Line Items]            
Redemption price percent 100.00%          
Senior Notes Due 2026 | Senior notes | Period Two            
Line of Credit Facility [Line Items]            
Redemption price percent 107.00%          
Revolving Credit Facility            
Line of Credit Facility [Line Items]            
Maximum borrowing capacity   580,000,000 580,000,000      
Accordion feature   730,000,000 730,000,000      
Amount outstanding   $ 305,100,000 $ 305,100,000      
Extension period     1 year      
Interest rate, percentage   3.50% 3.50%      
Commitment fee percentage     0.50%      
Unused borrowing capacity, fee     $ 1,300,000 $ 900,000    
Interest rate, effective percentage   9.80% 9.80%   7.00%  
Unused amount available   $ 274,400,000 $ 274,400,000      
Debt covenants minimum net worth     $ 325,000,000      
Fixed conversion ratio     2.0      
Expiration period     60 days      
Revolving Credit Facility | Scenario 1            
Line of Credit Facility [Line Items]            
Debt covenant, maximum ratio of total debt     2.5      
Debt covenant, maximum collateral performance indicator percentage     26.00%      
Fixed conversion ratio     1.25      
Revolving Credit Facility | Scenario 2            
Line of Credit Facility [Line Items]            
Debt covenant, maximum ratio of total debt     2.25      
Debt covenant, maximum collateral performance indicator percentage     28.00%      
Fixed conversion ratio     1.15      
Revolving Credit Facility | Scenario 3            
Line of Credit Facility [Line Items]            
Debt covenant, maximum ratio of total debt     2.0      
Fixed conversion ratio     1.50      
Revolving Credit Facility | Scenario4            
Line of Credit Facility [Line Items]            
Debt covenant, maximum ratio of total debt     2.25      
Fixed conversion ratio     2.0      
Revolving Credit Facility | Scenario 5            
Line of Credit Facility [Line Items]            
Fixed conversion ratio     2.25      
Revolving Credit Facility | Minimum            
Line of Credit Facility [Line Items]            
Interest rate, percentage   4.50% 4.50%      
Revolving Credit Facility | SOFR            
Line of Credit Facility [Line Items]            
Basis spread on variable rate (in hundredths)     0.10%      
Revolving Credit Facility | Eleventh Amendment            
Line of Credit Facility [Line Items]            
Maximum borrowing capacity           $ 20,000,000
Net income available for fixed charges to fixed charges           2.0
Revolving Credit Facility | Sub-Facility            
Line of Credit Facility [Line Items]            
Maximum borrowing capacity   $ 1,500,000 $ 1,500,000      
v3.24.0.1
DEBT (Debt Maturities) (Details)
Dec. 31, 2023
USD ($)
Debt Disclosure [Abstract]  
Remainder of 2024 $ 0
2025 0
2026 0
2027 587,699,480
2028 0
Total future debt payments $ 587,699,480
v3.24.0.1
INCOME TAXES (Details) - USD ($)
3 Months Ended 9 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Mar. 31, 2023
Income Tax Contingency [Line Items]          
Total gross unrecognized tax benefits including interest $ 1,000,000   $ 1,000,000   $ 1,100,000
Unrecognized tax benefits 800,000   800,000   900,000
Gross unrecognized tax benefits, limitations and settlement with taxing authorities 400,000   400,000    
Accrued gross interest 296,800   296,800    
Gross interest expense     3,900    
Historic Tax Credit Investment          
Income Tax Contingency [Line Items]          
Equity method investment 19,400,000   19,400,000   $ 23,000,000
Historic tax credit investments amortization 1,200,000 $ 400,000 3,200,000 $ 1,700,000  
Tax benefits from these investments $ 1,200,000 $ 500,000 $ 3,600,000 $ 1,500,000  

World Acceptance (NASDAQ:WRLD)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more World Acceptance Charts.
World Acceptance (NASDAQ:WRLD)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more World Acceptance Charts.